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ABSTRACT 
Acute myeloid leukaemia is a malicious disease. Although the initial chemotherapeutic 
treatment often leads to a complete remission (a disappearance of all manifestations of 
disease), the effective survival rate is only (30-40) % over 4 years due to a high relapse 
rate. This relapse is attributed to leukaemic stem cells residing in the protective environ-
ment of the bone marrow niche. There are two major approaches aiming at achieving 
better long-term therapeutic results. The first is to make the leukaemic stem cells more 
susceptible to chemotherapeutic agents and the second is to increase the efficiency of 
haematopoietic stem cell transplants, which are used to regenerate the haematopoietic 
system after failure due to chemotherapy. 
When searching for a receptor-ligand pair suitable as target for therapeutic agents, the 
prerequisite is that it must exhibit differences between the interaction it mediates in 
healthy and leukaemic cells. A detailed understanding of the mediated interaction and 
the differences would then allow exploitation of these to selectively mobilise the 
leukaemic stem cells increasing their susceptibility for chemotherapeutic drugs. In this 
work the flow-induced rolling interaction of leukaemic cells with hyaluronic acid was 
studied in detail using a suspension and an epithelial model cell line. It could be 
demonstrated, that the flow induced rolling interaction on hyaluronic acid observed for 
these cells was solely mediated by the cell surface receptor CD44 and that it was 
independent of the cell type tested. Next to a detailed validation and characterisation of 
this dependency and the properties of the interaction, the relevance of this interaction 
for the haematopoietic system and for leukaemic cells was evaluated. Therefore, the 
CD44 mediated interaction with hyaluronic acid of healthy haematopoietic progenitor 
cells from umbilical cord blood, mobilised peripheral blood and the bone marrow with 
that of leukaemic blasts was compared. Throughout the cell types tested two forms of 
interaction with hyaluronic acid were observed; a flow induced rolling and an immobile 
adhesion. It could be shown that while the rolling interaction was comparable for all cell 
types tested, the immobile adhesion to hyaluronic acid and its susceptibility to a 
monoclonal CD44 antibody (clone BU52) were not. The immobile adhesion was found 
predominantly in leukaemic cells, only playing a subordinate role in the interaction of 
healthy cells with hyaluronic acid. It could be demonstrated that a vicinity of the cells to 
the bone marrow upon isolation was directly correlated to an incomplete suppression of 
the immobile adhesion by BU52. Furthermore, this incomplete suppression could be 
linked to a non-response to induction chemotherapy and subsequently to a poor 
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therapeutic outcome. Besides investigating the interaction with surfaces artificially 
coated with hyaluronic acid, the possibility of using surfaces covered with mesenchymal 
stromal cells isolated from the bone marrow as more realistic binding partners was 
explored. Furthermore, the effect of a routinely used mobilisation reagent, namely 
Plerixafor®, on the migration and cell-surface interaction under flow was investigated. It is 
not only of great interest to understand the mechanisms of retention in the niche, but 
also to develop more sophisticated methods of in vitro stem cell expansion. In this 
context the slow and continuous release of e.g. cytokines or growth factors is of great 
interest. The cavities in porous materials present the unique opportunity of achieving just 
that by being pre-loaded with such agents. These can then under the right conditions be 
released to the cells. Amongst the porous materials the metal-organic frameworks 
protrude due to their high structural and chemical flexibility. In this work a novel 2-D 
metal-organic framework structure, namely SURMOF 2, was tested towards its 
biocompatibility and smart-release properties. It could be shown that SURMOF 2 was 
highly stable in protein free aqueous media and that its building units did not impair the 
growth of rat embryonic fibroblasts. Although the stability in cell culture medium is still 
limited, the water stability and the biocompatibility of the components are the starting 
point for future SURMOF 2 cell culture applications. A first application of SURMOF 2 as a 
smart-release matrix was achieved with the marine bacterium Cobetia marina under salt 
water conditions. The results demonstrated the general applicability of SURMOF 2 as 
bioactive substrates with responsive properties. For the future, fine-tuning of the stability 
of SURMOFs will allow to tailor drug release systems for cytokine or growth factor 
delivery in in vitro stem cell cultures. 
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KURZFASSUNG 
Die akute myeloische Leukämie ist eine heimtückische Erkrankung. Obwohl die 
Induktionstherapie häufig zu einer kompletten Remission (der vollständige Wegfall aller 
Krankheitssymptome) führt, liegt die effektive Überlebenschance lediglich bei (30-40) % 
über einen Zeitraum von 4 Jahren. Dies geht auf eine hohe Rezidivrate zurück, welche auf 
die sogenannten leukämischen Stammzellen zurückgeführt wird. Diese leukämischen 
Stammzellen verweilen in der geschützten Umgebung der Knochenmarksnische. Es gibt 
zwei primäre Ansätze, die darauf abzielen bessere Langzeitresultate zu erreichen. Der 
eine ist es die leukämischen Stammzellen für Chemotherapeutika empfänglicher zu 
machen und der andere ist es die Effizienz der Transplantation gesunder hämato-
poietischer Stammzellen zu verbessern. Diese Stammzelltransplantation dienen zur durch 
die Chemotherapie notwendigen Regeneration des hämatopoietischen Systems. 
Wenn man ein Rezeptor-Liganden-Paar sucht, welches das Ziel therapeutischer Agenzien 
sein kann, ist die Grundvoraussetzung, dass es Unterschiede zwischen der Wechsel-
wirkung aufweist, die es in gesunden und leukämischen Zellen mediiert. Ein genaues 
Verständnis der Wechselwirkung und der Unterschiede würde es dann ermöglichen diese 
auszunutzen um gezielt die leukämischen Stammzellen zu mobilisieren. Dies würde dann 
ihre Empfänglichkeit für chemotherapeutische Agenzien erhöhen. In dieser Arbeit wurde 
das flussinduzierte Rollen leukämischer Zellen auf Hyaluronsäure mit Hilfe einer 
Suspensions- und einer Epithelzelllinie en détail untersucht. Es konnte gezeigt werden, 
dass das flussinduzierte Rollen dieser Zellen auf Hyaluronsäure allein von CD44 mediiert 
wurde und dass es unabhängig von dem Zelltyp war bei dem es auftrat. Nebst einer 
sicheren Validierung dieser Abhängigkeit und einer Charakterisierung der Wechsel-
wirkungseigenschaften wurde die Relevanz dieser Wechselwirkung für das 
hämatopoietische System und für leukämische Zellen untersucht. Dies wurde erreicht 
indem die CD44 mediierte Wechselwirkung gesunder hämatopoietischer Progenitorzellen 
aus Nabelschnurblut, mobilisiertem Peripherblut und dem Knochenmark mit Hyaluron-
säure mit der leukämischer Blasten verglichen wurde. In allen getesteten Zelltypen 
konnten zwei Formen der Wechselwirkung mit Hyaluronsäure beobachtet werden; ein 
flussinduziertes Rollen und eine unbewegliche Adhäsion. Es konnte gezeigt werden, dass 
das Rollverhalten aller untersuchten Zelltypen vergleichbar war. Dies was für die 
unbewegliche Adhäsion und deren Empfänglichkeit für die Unterdrückung durch einen 
monoklonalen CD44 Antikörper (Klon BU52) nicht der Fall. Diese unbewegliche Adhäsion 
wurde vor allem in leukämischen Zellen beobachten. Für die Wechselwirkung gesunder 
VIII 
 
Zellen mit Hyaluronsäure spielte sie lediglich eine untergeordnete Rolle. Es konnte gezeigt 
werden, dass eine Nähe zum Knochenmark bei der Gewinnung der Zellen, direkt mit einer 
Unvollständigen Unterdrückung der unbeweglichen Adhäsion durch BU52 korrelierte. Des 
Weiteren, korrelierte die Resistenz gegen BU52 mit einem Misserfolg der Induktions-
therapie und somit mit einem schlechten langfristigen klinischen Verlauf. Im Folgenden 
wurden erste Tests durchgeführt, die die Erweiterung der Analyse von künstlichen mit 
Hyaluronsäure beschichteten Oberflächen hin zu mit aus der Knochenmarksnische 
isolierten mesenchymalen Stammzellen bedeckten Oberflächen zum Ziel hatten. Zudem 
wurde der Einfluss des vielfach verwendeten Mobilisierungsreagenzes Plerixafor® auf die 
Migration und auf die Zell-Oberflächen Interaktion unter Fluss untersucht. Es ist nicht nur 
von großer Wichtigkeit die Mechanismen der Retention der Zellen in der Nische zu 
verstehen, sondern auch hochentwickelte Methoden zur in vitro Stammzellkultivierung zu 
entwickeln. In diesem Zusammenhang ist die langsame und kontinuierliche Freisetzung 
von beispielsweise Zytokinen oder Wachstumsfaktoren von großem Interesse. Die Hohl-
räume in porösen Materialien bieten die einzigartige Möglichkeit genau das zu erreichen 
indem sie vorab mit solchen Agenzien beladen werden. Diese können dann unter den 
richtigen Bedingungen an die Zellen abgegeben werden. Unter den porösen Materialien 
stechen die metall-organischen Gerüststrukturen durch ihre hohe strukturelle und 
chemische Flexibilität hervor. In dieser Arbeit wurde die neuartige 2-D metall-organische 
Gerüststruktur „SURMOF 2“ in Bezug auf ihre Biokompatibilität und Smart-Release 
Eigenschaften hin untersucht. Es konnte gezeigt werden, dass SURMOF 2 in proteinfreien 
wässrigen Medien äußerst stabil ist und dass die Bausteine das Wachstum von 
Fibroblasten in keiner Weise beeinträchtigt. Obwohl die Stabilität in Zellkulturmedium 
noch beschränkt war, waren die Wasserstabilität und die Biokompatibilität der Bausteine 
ein erster Schritt in Richtung der Applikation von SURMOF 2 in der Zellkultur. SURMOF 2 
konnte jedoch nichtsdestotrotz bereits in Salzwasser mit dem marinen Bakterium Cobetia 
marina als Smart-Release Oberfläche zum Einsatz gebracht werden. Die Beobachtungen 
demonstrierten die generelle Anwendbarkeit von SURMOF 2 als bioaktives Substrat mit 
reaktiven Eigenschaften. In Zukunft wird das Feintuning der Stabilität von SURMOF 2 es 
erlauben gezielt Drug-Release-Oberflächen für die Zytokin- oder Wachstumsfaktorfrei-
setzung in der in vitro Stammzellkultivierung zu designen. 
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1 INTRODUCTION 
Acute myeloid leukaemia (AML) is the most common form of acute leukaemia in adults. 
The Swedish Acute Leukemia Registry lists 98 % of all patients diagnosed with AML 
between 1997 and 2005 in Sweden. Analysis of the data collected in this registry showed 
that approximately 15 new cases were diagnosed annually per 100,000 citizens under the 
age of 60. This value drastically increased with age reaching over 120 new diagnoses 
annually per 100,000 citizens between the age of 80 and 84. The median age of first 
diagnosis was 72.[1] This demonstrates the threat posed by this disease, especially for the 
elderly. While most patients treated for AML reach complete remission (CR) after initial 
chemotherapy, the relapse rate is high and the overall survival rate is only 30-40 % over 
4 years. The general consent is that leukaemic cells are generated by stem cells, similar to 
healthy blood cells in haematopoiesis.[2-3] These leukaemic stem cells (LSC) are thought to 
share the haematopoietic stem cells (HSC) capability of self-renewal, their vicinity to the 
bone marrow (BM) niche and most inconveniently their chemotherapy resistance.[4] The 
proposed interactions of LSC with their niche are schematically depicted in Figure 1.  
 
Figure 1: Schematic depicting the microanatomy of the leukemic stem cell niche and strategies to target 
the LSC in its niche. Strategies include the blocking of cytokines or adhesion molecules like CD44 or 
integrins, the mobilisation of LSCs out of their niche by GCS-F or AMD3100. Image taken from [5]. The 
interactions with the niche targeted in this work are marked in yellow. 
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The sketch also presents some strategies applicable when aiming at increasing the 
efficiency of the apoptosis induction in LSC by cytostatic and/or chemotherapeutic 
agents. Some of the targets studied in this work are marked in yellow. Thus far targeting 
of adhesion molecules, e.g. CD44 or integrins, could reduce the interaction of LSC with 
their niche[6-7] or the adhesion to fibronectin in the BM microenvironment,[8] respectively. 
Furthermore, the necessity of CD44 for the homing and engraftment of healthy 
haematopoietic progenitor cells (HPC) to the BM niche could be established.[9] Due to the 
apparent relevance of CD44 in this context the interaction of this receptor with its major 
ligand hyaluronic acid (HA) was the main focus of this work. The capability of leukaemic 
cells and HPC from umbilical cord blood expressing CD44 to exhibit a catch-bond like, 
flow-induced rolling interaction with HA under flow conditions was recently 
demonstrated in our workgroup.[10] A microfluidic shear force setup, developed by 
C. Christophis in our workgroup,[11-12] was applied to characterise this interaction. During 
the initial characterisation phase the general dependency of this form of interaction with 
HA on CD44 was verified and the properties of the CD44-HA interaction, such as the 
rolling velocity and its dependency on the availability of the receptor, were illuminated. 
Furthermore, it was determined whether this form of interaction is specific for 
suspension cells, such as HPC, or whether it can also be found in other CD44 expressing 
cells, such as epithelial liver cancer cells. Following the determination of the similarities 
and differences between these two fundamentally unalike cell types, a comparison was 
made between the CD44-HA interaction of HPC from different sources and leukaemic 
blasts (as surrogates for LSC as blasts can be acquired in larger quantities than LSC). In this 
context the interaction of HPC from umbilical cord blood, mobilised peripheral blood and 
the bone marrow was compared to that of leukaemic blasts isolated either from the 
peripheral blood or the BM. The aim was to identify differences that may in the future be 
targeted for the specific mobilisation of LSC from the niche. This would allow the 
application of milder chemotherapeutic agents, sparing the HSC, while still inducing 
apoptosis in the LSC and thereby preventing relapse of the leukaemia. 
The BM niche, in which HSC and/or LSC dwell, is comprised of a variety of cells. All of 
these, less the HSC, can be derived from mesenchymal stromal cells (MSC).[13-14] For this 
reason MSC are widely used as model system for the BM niche. In the context of studying 
the CD44-HA interaction, MSC feeder layers were used instead of artificial HA-coated 
substrates. The aim was to establish a protocol for the growth and measurement 
procedure on MSC feeder layers and to investigate whether a similar interaction could be 
observed on MSC as it could on artificially coated HA surfaces. 
The chemokine stem cell derived factor 1 alpha (SDF-1α) is secreted by MSC in the BM 
niche.[15] This chemokine and its receptor are reported to play a major role in the 
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induction of chemotaxis in HPC[16-18] and in the process of homing of HSC to the BM 
niche.[19] Furthermore, as indicated in Figure 1, mobilisation of the LSC with granulocyte-
colony stimulating factor (G-CSF)[20-22] or AMD3100 (also known as Plerixafor®), which 
antagonises SDF-1α,[23] has also proven promising in increasing chemotherapeutic 
success. First tests concerning the effect of Plerixafor® and SDF-1α on the migration of 
HPC and on the CD44-HA interaction were conducted in this study. 
The haematopoietic stem cell transplantation (HSCT) is commonly applied in the 
treatment of patients with BM failure states often originating from high dosage 
chemotherapy. To achieve maximal tumour-kill efficiency higher doses of chemo-
therapeutic agents are applied and the haematopoietic organ is rescued by HSCT.[24] 
Today, over 350 centres in Europe perform a total of more than 18,000 HSCT per year.[25] 
One has to distinguish between autologous transplantations, which employ a patient’s 
own BM tissue, and allogeneic transplantations, which are conducted between two 
genetically different individuals (with the rare exceptions of transplantations between 
identical twins; often referred to as syngeneic transplantations).[26] The possibility of 
conducting HSCT is often limited by the availability of a donor and by the amount of HSC 
in the graft, which is important to ensure successful engraftment.[27-28] To increase the 
amount of available HSC, it has often been attempted to culture HSC in vitro. Some 
studies could demonstrate modest, transient expansion of long-term repopulating HSC in 
vitro in response to particular cytokines. However, in most cases the in vitro proliferation 
of HSC led to differentiation or apoptosis.[29-34] Ideally the proliferation inducing cytokines 
should be added continuously, as would be the case in vivo. A possibility of doing so 
would be the application of porous materials such as e.g. zeolites or porous silicon. Due 
to the possibility of storing small molecules in their pores, these materials have often 
been applied in areas such as catalysis, sensors and gas filtering or storage.[35-42] Just this 
capability of storing small molecules could be the key to a continuous release of pro-
liferation inducing cytokines during culture. Providing the pore size is sufficient, the 
cytokines would need to be loaded into the pores and then either a continuous release of 
the same or a slow degradation of the host structure, also slowly releasing the incorp-
orated cytokines, would need to be induced. A class of porous materials which is highly 
flexible in its structural and chemical properties are the metal-organic frameworks.[43-45] 
In this study the first analysis of a novel 2-D surface bound metal-organic framework 
(SURMOF) structure, namely SURMOF 2, was conducted investigating the stability in 
aqueous media and the biocompatibility of the building units. Application a as smart-
release surface that responds to the presence of bacteria under marine conditions 
demonstrated the potential of SURMOFs as bioactive surfaces for in vitro culture of HSC 
in the future. 
2 Theoretical Background 
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2 THEORETICAL BACKGROUND 
In this chapter the theoretical background relevant to this work is discussed. The roles of 
the haematopoietic stem cell and its niche as well as the question of what happens when 
haematopoiesis fails and an illness such as leukaemia arises are examined. The cell 
surface receptor CD44 is known to be involved in the homing and engraftment of both 
healthy haematopoietic and leukaemic stem cells. Therefore, the interaction mediated by 
this receptor is reviewed and in this context the mechanism of cellular rolling on surfaces 
as possibility for extravasation from the blood stream is discussed. Finally, possibilities to 
measure and analyse this interaction in vitro are presented and a class surface coatings, 
namely the surface bound metal-organic frameworks, which may find application in cell 
culture someday, are introduced. 
2.1 HAEMATOPOIESIS, HAEMATOPOIETIC STEM CELLS 
AND THEIR NICHE 
Blood is a highly complex bodily fluid composed of the blood plasma and blood cells. The 
plasma, which is mostly water, carries both nutrients such as proteins, glucose or 
minerals and the blood cells. The blood cells in turn are composed of myeloid cells, e.g. 
erythrocytes, granulocytes and macrophages, and lymphoid cells, e.g. T-lymphocytes, B-
lymphocytes and natural killer cells. In a healthy adult human being each cubic millilitre of 
blood contains approximately (4-6) million cells that circulate in the blood stream for up 
to 120 days.[46] This limited cell life span makes it obvious that new cells must be 
produced continuously. This mammoth task is shouldered by a set of immature HSC 
located in the BM after birth.[47] The most striking characteristics of these HSC are the 
capability of self-renewal and the ability to differentiate into cells of multiple linages as 
schematically shown in Figure 2.[48-51] The differentiation is undergone in steps. The HSC 
develop from multi-potent progenitors (MPP also known and from here on referred to as 
haematopoietic progenitor cells HPC), which still possess the capability of self-renewal, 
over common myeloid progenitors (CMP) or common lymphoid progenitors (CLP) and a 
couple of further differentiation grades to the respective fully developed cell.[26,51] That 
this system is highly effective, can easily be seen from the fact that (2-3) million red blood 
cells alone are released into the blood stream from the BM every second in order to 
maintain steady state levels in the peripheral circulation.[46] 
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Figure 2: Haematopoiesis of bone cells and marrow stromal cells. Each differentiation of an HSC results in 
one daughter cell that leaves the marrow and differentiates and one that remains in the niche. The first 
daughter cell then differentiates via a multipotent progenitor (MPP) into various linages. In the marrow the 
HSC are surrounded by osteoblasts, endothelial cells and mesenchymal stromal cells (MSC). The 
differentiation scheme of the MSC is also depicted. Abbreviations used in this scheme: common myeloid 
progenitor (CMP); common lymphoid progenitor (CLP); granulocyte/macrophage progenitor (GMP); 
megakaryocyte erythroid progenitor (MKEP); multipotent progenitor stem cell (MPP); osteoclast progenitor 
(OC); spindle-shaped N-cadherin
+
CD45
–
 osteoblastic cell (SNO cell); trabecular bone area (TBA). Image taken 
from Yin et al., 2006.
[51]
 
The capability of HSC to self-renewal is the key to the constant cell division required for 
the generation of the vast amount of cells necessary to replenish the blood stream. The 
ability of HSC to an asymmetric division,[52] in turn, makes this continuous self-renewal 
possible. While one daughter cell remains a HSC populating the niche the other daughter 
cell undergoes further differentiation.[53] So far it is not fully understood what exactly 
governs the mechanism of self-renewal and differentiation. The importance of such a 
mechanism is clear, however, as the stem cell population would deplete in the case of cell 
differentiation overwhelming self-renewal. Similarly, unchecked self-renewal would lead 
to an increased risk of tumourigenesis.[51,54] The idea of a stem cell niche as a confined 
microenvironment in the BM was first described by Schofield in 1978.[55] This stem cell 
niche is thought to provide the conditions to control proliferation and differentiation of 
HSC. It could be demonstrated that a vicinity of HSC to a stem cell supporting 
microenvironment could induce asymmetric differentiation.[56-57] This could not be 
induced by cytokines alone[58] and thus demonstrates the relevance of the stem cell niche 
for the longevity of the HSC. If HSC are separated from the BM niche, e.g. by endogenous 
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mobilisation,[59-60] induced mobilisation,[61] or after being transplanted[62] they migrate 
back to the BM niche. This process is known as ‘homing’. Figure 3 shows the major steps 
involved in HSC homing. Similar to the homing of leukocytes to sites of inflammation 
(discussed in section 2.3),[63-67] homing of HSC to the BM niche involves tethering and 
rolling on the endothelium, then sticking and subsequent transmigration through the 
endothelium. 
 
Figure 3: Schematic outlining the major steps in HSC homing. The process of HSC homing involves rolling 
on the endothelium, sticking and transmigration before the HSC migrates to the niche where it is capable of 
self-renewal and asymmetric division. Image inspired by Barrett et al., 2008.
[68]
 
In the context of homing it was shown that the cytokine stem-cell-derived factor-1 alpha 
(SDF-1α or C-X-C motif ligand 12; CXCL12) is essential for the process, as HSC home 
towards an SDF-1α gradient.[9,16,69-70] This is produced by a type of cells found in 
abundance in the BM niche; the mesenchymal stromal cells (MSC). In fact, MSC can 
differentiate into all cell types less the HSC found in the niche (indicated in Figure 2).[14,71] 
It was shown that MSC could fully re-establish the BM microenvironment in irradiated 
mice.[72] Considering the abundance of MSC in the BM niche, it is not surprising that they 
play a significant role for maintaining the self-renewal potential of HSC/HPC.[73-75] MSC are 
defined as plastic adherent under standard culture conditions. Furthermore, they must 
present the antigens CD73, CD90 and CD105 and lack haematopoietic antigens (CD45, 
CD34, CD14 or CD11b, CD79alpha or CD19 and HLA-DR surface molecules) and they must 
be capable of differentiating into osteoblasts, adipocytes and chondroblasts under in vitro 
conditions.[76-77] The mechanisms of interaction of HSC with the niche are vast. They range 
from cell-cell interactions, over interactions with the extracellular matrix (ECM) to the 
recognition of soluble factors.[78] Figure 4 shows an overview over some of the possible 
interactions between HSC and MSC, the ECM and some soluble factors expressed by 
MSC.[27]  
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Figure 4: Interactions between HSC and their surrounding microenvironment. Interaction with the HSC 
takes place via soluble factors, cell-cell interactions, extracellular matrix components and metabolites and 
oxygen tension. The interaction between the receptor CD44 and HA is of special interest for this study and 
is therefore highlighted. Image taken from Wagner et al., 2008.
[27]
 
2.2 ACUTE MYELOID LEUKAEMIA 
Leukaemia is a carcinoma of the blood. It has been suggested that leukaemia evolves 
when the proliferation of HSC, as described in the last section, is undergone in an 
uncontrolled manner by cells termed leukaemic stem cell (LSC). These cells originate from 
genetic (mutations of the DNA) and/or epigenetic (other heritable modifications) changes 
in HSC or progenitors. The undergone changes detach the LSC from the regulated 
haematopoietic system, thereby, enabling the uncontrolled proliferation of the cells, 
which in turn leads to the flooding of the BM niche and later the circulatory system with 
immature cells.[79-84] Figure 5 demonstrates the progression of leukaemia from healthy 
HSC to leukaemic blasts. With each cellular mutation the rate of proliferation can be 
increased. At some point the transformed cells no longer differentiate into mature cells, 
but rather remain at a very primitive level often even with the capability of self-renewal. 
These primitive blasts flood the haematopoietic system and interfere with normal 
haematopoiesis, resulting in anaemia, thrombocytopenia and neutropenia. 
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Figure 5: Leukaemic progression at the haematopoietic stem cell level. Proliferation of normal HSC yields 2 
HSC, one of which undergoes differentiation. A) Preleukaemic progression of LSC development. Here two 
events are depicted. Each event (2 shown) leads to cells capable of outperforming healthy HSC in terms of 
proliferation. B) Proliferation of HSC leads to progenitors and mature cells (left). Partially transformed cells 
still yield progenitors and mature cells, but in far larger amounts (centre). In fully transformed cells the 
development of mature cells is blocked and large amounts of primitive blast cells are produced (right). 
These cells can be HSC-like or self-renewing transformed progenitors. Image taken from Yin et al., 2006.
[51]
 
Acute myeloid leukaemia (AML) is characterised by the uncontrolled production of 
myeloid blasts. Due to the many different differentiation stages in the myeloid 
differentiation pathway at each of which the leukaemic transformation can take place, 
AML is a highly heterogeneous disease. Though the predominant pathologic cell type is 
not the origin of the disease, different leukaemias are mostly classified by these cell types 
and/or the clinical course of the disease.[26] Two systems are widely used to classify the 
different AML. The French-American-British (FAB) system relies mainly on the final step of 
blast differentiation,[85-86] while the system of the World Health Organisation (WHO) takes 
cytogenetic and molecular factors into account that are known to impact the 
prognosis.[87-88] 
Treatment of AML is undergone by induction chemotherapy (one to two intervals of 
intensive chemotherapy to achieve complete remission (CR)) followed by post-remission 
therapy (to sustain the results achieved during induction therapy). Generally treatment of 
AML with chemotherapy is highly effective and often results in CR. However, the relapse 
rate is also high, resulting in an overall survival rate of only (30-40) % over 4 years. The 
LSC are held responsible for this high relapse rate.[2-3] Lapidot et al. showed that 
CD34+/CD38- cells (these are typical markers for HSC)[89-91] isolated from patients with 
AML could initiate AML in severe combined immunodeficiency (SCID) mice, thus, proving 
the relevance of these cells for the establishment of leukaemia in an organism. As these 
LSC share the vicinity to the niche and the chemotherapeutic resistance of the HSC,[4] high 
dosage chemotherapy is applied to achieve maximum tumour-kill efficiency. As this 
harms the whole haematopoietic system, it subsequently rescued by haematopoietic 
stem cell transplantation (HSCT).[24] This has been done since 1959.[26,92] For 
2.3 Cell Adhesion and Rolling 
 
9 
 
transplantation donor HSC are mobilised from the BM niche to the blood stream from 
where they can easily be isolated. In the clinical environment this is achieved by a 
treatment with Plerixafor® (syn.: AMD3100; 1,1-[1,4-phenylene-bis(methylene)]-bis-
1,4,8,11-tetra-azacyclo-tetradecane).[93-95] Although the exact mechanism of the 
treatment with Plerixafor® is not yet fully understood,[96-97] it has been shown to block the 
CXCR4 receptor.[98] This is the receptor for the chemokine stem cell derived factor 1 alpha 
(SDF-1α), which is known to play a major role in the induction of chemotaxis in HPC[16-18] 
and in the process of homing of HSC to the BM niche.[19] Both are essential for the 
repopulation of the niche by HSC/HPC, e.g. after autologous or allogeneic HSCT.[99-101] 
2.3 CELL ADHESION AND ROLLING 
Cellular interactions are involved in a broad range of basic cell functions. Some of these 
are cell growth,[102] differentiation[103] and migration.[104] Furthermore, cell adhesion and 
changes of the same are involved in tissue development,[105] wound healing,[106] cancer 
metastasis[107] and the development of leukaemia.[108] The overall interaction of cells can 
be classified as firm adhesion and short-term adhesion. 
Firm adhesion of cells is of great relevance for the connective tissue, wound healing, 
growth and immune defence processes. Cells express various receptors responsible for 
the binding to different substrates or cells. They may bind to other cells via e.g. tight 
junctions, desmosomes or adherence junctions or to the ECM via e.g. hemidesmosomes 
or focal contacts. The receptors involved in these binding patterns are selectins, integrins, 
cadherins or receptors from the immunoglobulin superfamily.[109-110] 
In contrast to this firm, long-term adhesion stand methods of transient, short-term 
interactions, e.g. the rolling of cells over a surface such as the endothelium. For 
leukocytes, for example, rolling across endothelial cells in blood vessels is a key step in 
the extravasation process at sites of inflammation. Leukocyte rolling, adhesion and 
transmigration was described in the nineteenth century[111-112] and this selectin- and 
integrin-mediated extravasation has been extensively studied ever since.[63-67] A good 
overview is presented in the book ‘The selectins’.[113] A schematic overview of the steps of 
the extravasation process with the most important receptors and binding partners is 
given in Figure 6. Margination is the process of leukocytes moving away from the central 
blood stream towards the endothelium,[114] where the capture may take place. Upon 
inflammation, endothelial cells rapidly express P-selectin which can interact with the 
glycoprotein ligand 1 (PSGL-1) present on the surface of leukocytes.[115] Next to the mere 
presence of selectins and their ligands, threshold fluid shear forces of approximately 
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(0.4-0.5) dyn/cm² are required to promote the P-, E-, or L-selectin-mediated rolling of 
leukocytes on endothelial cells.[116-117] Beyond this value the number of rolling leukocytes 
increases with the shear stress until the optimum level is reached at shear stresses of 
approximately 1 dyn/cm². After surpassing this shear stress level the number of rolling 
cells was reported to then decrease with increasing shear stress.[118] These values 
correspond well with the wall shear stress found in postcapillary venules (approximately 
(1-4) dyn/cm²), where the extravasation of leukocytes mostly occurs.[119] L-selectin is 
supposed to play the most important role in capture and initiation of rolling. P-selectin is 
also reported to be involved in cellular capture, but its importance in this context is 
seemingly inferior to that of L-selectin. Only in the absence of L-selectin, the capture 
becomes P-selectin dependent.[120] The rolling velocity is greater though in this case, 
suggesting a weaker binding to L-selectin than to P-selectin.[113] The overall rolling velocity 
of leukocytes was found to be in the range of (20-40) µm/s under physiologic flow 
rates.[121] It was shown that this value is strongly dependent on the tissue with which the 
leukocytes interact. A span of (5-100) µm/s was observed for the rolling on different 
tissues.[113,122-126] Inflammatory endothelial cells also express E-selectin in response to the 
treatment with inflammatory cytokines. E-selectin participates in the conversion of rolling 
to firm adhesion. It binds to sialylated carbohydrates present in surface proteins of 
leukocytes and reduces the rolling velocity. This speed reduction is important for the 
leukocyte to firmly bind to the endothelium via integrins e.g. VLA-4, which binds to the 
receptor VCAM-1 present on the endothelial cells.[64] 
 
Figure 6: Leukocyte Extravasation. The process of leukocyte extravasation is mainly governed by the steps 
of cell capture, rolling, firm adhesion and transmigration of the cell through the endothelium. Image 
inspired by Ley et al., 2007 and Albelda et al., 1994.
[64,115]
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2.4 CELL SURFACE RECEPTOR CD44 
However, not only the selectin family is capable of mediating a flow-induced interaction. 
It was shown that the transmembrane glycoprotein CD44 also mediates a flow-induced 
rolling interaction of cells on hyaluronic acid (HA). This could be demonstrated for the 
leukaemic suspension cell line KG-1a (Figure 7) on surfaces coated with HA in our 
workgroup by Christophis et al..[10] It was shown that the flow induced interaction was 
only observed for the CD44 positive cell line KG-1a and only on HA. Furthermore, the 
characteristics of the rolling on HA were remarkably similar to those observed for the 
selectin mediated rolling of leukocytes discussed in section 2.3. For the CD44 positive cell 
line, flow induced rolling was observed beyond a threshold shear stress of approximately 
0.2 dyn/cm², with the maximum fraction of interacting cells reached at a shear stress of 
roughly 1 dyn/cm².[10,12] 
 
Figure 7: Interaction of CD44 negative and positive cells with different surfaces. The interaction of the 
CD44 negative leukaemic suspension cell line Jurkat (A) and of the CD44 positive leukaemic suspension cell 
line KG-1a (B) was analysed in the microfluidic setup also used in this study.
[11-12]
 Only the KG-1a cells 
showed the flow induced interaction with HA and not with either of the control surfaces (alginate and 
glass). Image adapted from Christophis et al., 2011.
[10]
 
The cell surface receptor CD44, responsible for this interaction, is an integral membrane 
protein belonging to the link module superfamily.[127-128] It was first identified by Underhill 
and Toole.[129] CD44 mainly binds to HA,[130-132] but is also capable of recognising other 
binding partners,[133] such as collagen,[134] laminin,[134] fibronectin,[135] osteopontin[136] and 
itself.[137] As diverse as the binding partners of CD44 are, as diverse are its functions in the 
body. It has been reported to be involved in morphogenesis and organogenesis,[138-140] in 
haematopoiesis,[141-142] in migration,[143] in homing and proliferation of haematopoietic 
stem cells,[9,144-145] in cancer metastasis[146] and in the activation[141] and rolling[147] of 
leukocytes. 
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The structure of each receptor, as of every other protein generated in the body, is 
encoded in the genome. CD44 is encoded in a single gene containing 20 exons.[148] 
Alternative N- and O-glycosylation[149-155] as well as variability in the mRNA splicing lead to 
a variety of CD44variant isoforms. As shown in Figure 8 the standard isoform CD44s is 
composed of the first and last 5 exons (1-5 and 16-20, standard exon s1-10). This is not 
only the smallest but also the most common isoform. The remaining ten exons (6-15, 
variant exons v1-10) have the potential of being alternatively mRNA spliced during gene 
expression and added to the standard isoform as shown in Figure 9. This results in ten 
isoforms CD44v1-10.[148,156-158] Binding to HA is possible for all CD44variant isoforms, but 
it is strongest for CD44s.[159] The exact mode of interaction between the HA binding 
domain of CD44 and HA has been extensively studied by comparison to other HA binding 
sites, by NMR and by X-ray crystallography. HA is composed of repeating disaccharide 
units of N-acetyl-D-glucosamine and D-glucuronate, connected by β-1,4 and β-1,3 
linkages. It was shown that at least three to five of these disaccharide units are required 
for binding to CD44, that the binding is dependent on the interaction of HA with arginine 
and tyrosine in the binding pocket and that the binding to HA induces a structural 
rearrangement in CD44.[160-164] These structural analyses also undermined the findings of 
a dependency of the CD44 activity on the grade of glycosylation. Glycosylation is, next to 
mitogens and the phosphorylation of specific serine-side chains in the cytoplasmic 
domain, an important regulator of CD44 activity in general. It is because of these 
dependencies that the presence of CD44 on a cell cannot be directly linked to an 
interaction with HA.[159,165-167] Such regulation is mandatory because of the high 
expression of CD44 in mammalian cells[130-132] and because of the variety of processes 
(mentioned above[9,138-147]) in which CD44 is involved. A good example for the regulation 
of the CD44 activity is that while it expressed in most haematopoietic cells in the 
mouse,[168] binding to HA is either often not detectable[169-170] or requires stimulation.[171] 
 
Figure 8: Scheme of the CD44 gene. The scheme shows the standard exons s1-10 and the variant exons 
v1-10. Alternative splicing occurs between s5 and s6. Image taken from Goodison et al., 1999.
[133]
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Figure 9: Scheme of the structure of CD44. The schematic shows the HA binding domain and the region at 
which the alternative slicing occurs. Image taken from Goodison et al., 1999.
[133]
 
2.5 ANALYSIS OF CELL-SURFACE INTERACTIONS 
The methods of characterising the interaction between cells and surfaces are vast. This 
section gives an overview over the most common techniques used for analysis of these 
interactions.  
2.5.1 TECHNIQUES FOR ADHESION STRENGTH MEASUREMENT 
Analysis of the adhesion strength of cells interacting with surfaces varies dramatically 
with e.g. changes of the topography or surface energy. Measurement of the adhesion 
strength can be achieved by a centrifugal force assay or a variety of micromanipulation 
techniques (atomic force microscopes (AFM), microplates,[172] optical tweezers,[173] 
magnetic tweezers[174] and micropipette aspiration[175]) some of which shall briefly be 
described in this section. 
The centrifugal force assay allows a high throughput screening of the adhesion strengths 
of cells under different conditions. Figure 10 gives an overview over the setup and the 
basic functional aspects. Multiwell plates are mounted in a centrifuge (each well can bare 
a different cell treatment such as antibodies, surface type and so forth) and is spun at a 
given rotational speed.  
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Figure 10: Centrifugal force assay. The cells are detached from the surface by centrifugal forces. Image 
taken from Christ et al., 2010.
[176]
 
The force F applied to the cells can be calculated from the cell volume      , the relative 
centrifugal force     and the difference in density between the cell       and the 
medium        . The calculation of     in turn is based on the distance between the 
cell and the rotor centre  , the angular rotor speed  and the gravitational acceleration   
as shown in Equation (1). The formula for the overall force is shown in Equation (2). 
    
   
 
 (1) 
 
  (             )            (2) 
The downside of the technique, opposing the large number of samples that can be 
studied simultaneously, is that only one force may be applied in each experimental run 
making it laborious to determine the actual adhesion strength of a cell sample. 
The cytodetachment technique is a common example for a micromanipulation technique. 
Here a cantilever used in atomic force microscopy is used to detach a cell from a surface 
as shown in Figure 11.  
The force   applied to the 
cantilever in order to detach the cell 
from the sample surface is 
measured in form of the deflection 
of the cantilever   and the stiffness 
of the sample   as shown in 
Equation (3). 
     (3) 
This technique is highly flexible and can apply high forces, allowing the evaluation of the 
adhesion strength of even fully adhered cells. 
 
Figure 11: Cytodetachment technique. An AFM cantilever 
tip is used to detach a cell from a surface. Image inspired by 
Christ et al., 2010.
[176]
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2.5.2 HYDRODYNAMIC SHEAR FORCE ASSAYS 
Hydrodynamic shear force assays are also applied for the measurement of the adhesion 
strength of cells to surfaces. The distinctiveness of these assays is, however, that they 
apply shear forces generated by the drag of a liquid along a wall and some of them can, 
therefore, in principle also be used for the observation of the interaction of cells with 
surfaces under shear force conditions. The flow is in all setups kept in the laminar flow 
region, as defined by a Reynold’s number Re < 2300.[177] 
The spinning disc setup allows the determination of the shear stress required to detach 
cells from a surface.[178-179] To achieve 
this cells are seeded on a circular disc 
(hence the name), which is then spun 
in a liquid. The rotation of the disc 
inside the liquid generates a shear 
stress   that is, at a given rotational 
speed   with the viscosity   and 
density   of the fluid, dependent on 
the distance between the cell and the 
disc centre   as shown in 
Equation (4). 
         (    ) (4) 
In the radial flow chamber the shear stress is generated by an active liquid flow. As 
shown in Figure 13 the liquid is 
injected at the centre of the chamber 
and then spreads homogeneously in 
all directions over the surface. With 
increasing distance from the chamber 
centre r the flow and directly propor-
tional to that also the shear stress   
decreases.[180-182] This connection is 
easily deducible from Equation 
(5).[180,182] 
  
   
    
 
    
       
 (5) 
With   being the flow rate,   the viscosity and   the density of the liquid and   the 
distance between the top and bottom plate of the chamber. 
 
Figure 12: Spinning disc setup. The rotation of the disc 
inside a liquid induces a shear force on the cells. Image 
inspired by Christ et al., 2010.
[176]
 
 
Figure 13: Radial flow setup. The liquid is injected at the 
middle of the chamber and flows in all directions. Image 
inspired by Christ et al., 2010.
[176]
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The parallel plate flow chamber is in its theory closely related to the radial flow chamber. 
Liquid is moved through a rectangular 
channel system (Figure 14) either by 
hydrostatic pressure[183] or pumps.[184] 
The shear stress   in a parallel plate 
flow chamber can be described 
according to Equation (6) if the width 
of the channel is far greater than its 
height.[185-188] 
   
   
   
 (6) 
With   being the volume flow,   the viscosity of the liquid,   the height and   the width 
of the chamber. 
As the parallel plate flow chamber presents the theoretical basis of the channel system 
used in this work it shall be described in more detail later in section 3.8.3, where the 
microfluidic shear force device will be discussed, as well as in the Appendix 
(section 7.1.1.2 and 7.1.1.3). 
2.6 SURFACE-BOUND METAL-ORGANIC FRAMEWORKS 
Metal-organic frameworks (MOF), also known as porous coordination polymers (PCP), are 
a relatively new class of solid state inorganic-organic hybrid materials, which are typically 
characterised by a high crystallinity. They are extremely intriguing due to their structural 
specifications. Similar to zeolites they exhibit a high porosity though lacking the 
restrictions in reagent choice of zeolites. MOFs consist of metal ions or metal oxide 
clusters which coordinate organic linker molecules, hence the name. The combinational 
possibilities are vast resulting in a broad spectrum of MOFs structures with varying pore 
sizes and specific surface areas. According to IUPAC porous materials are classified 
according to the pore size d as micro- (< 2 nm), meso- (2-50 nm) and macroporous 
(> 50 nm).[189] So far micro- and meso-porous MOFs have been synthesised with pore 
sizes of up to 10 nm and specific surface areas of up to 6,000 m²/g clearly exceed those of 
zeolites.[190-191] MOF assembly generally follows the rules of Werner complexes. The 
classical method of MOF synthesis is the deposition from a solvothermal parent solution. 
Hereby, the metals are added to the reaction solution as precursors which coordinate the 
organic linkers to form structures dominated by the preferred coordination geometry of 
the metals.[192] After a short time at RT to 250 °C MOF crystals form from the solution, 
 
Figure 14: Parallel plate setup. The liquid flows through 
rectangular channel. Image inspired by Christ et al., 
2010.
[176]
 
h
wQ τ
2.6 Surface-Bound Metal-Organic Frameworks 
 
17 
 
yielding the typical MOF powder. Variation of the metal precursor or the organic linker 
group allows the fine tuning of the MOF structure and properties. The variability was 
nicely demonstrated by Rowsell et al. at the example of a series of isoreticular MOFs 
(IRMOFs). The basis of this series was MOF-5, which is synthesised from tetrahedral 
Zn4O
6+-metal clusters and terephthalate linkers. As shown in Figure 15 while all 
frameworks are of a cubic nature, variation of the organic linker allows the preparation of 
different pore sizes and functionalities.[193-194] Due to the presence of metals and/or metal 
oxides in the MOFs they can also exhibit electrical or magnetic properties.[195] Many 
applications such as size-, shape-, and enantio-selective catalysis, gas/vapour separation, 
drug storage and delivery or in sensors have been achieved or at least proposed.[191,196-200] 
 
Figure 15: Variation of pore size and functionality by application of different organic linkers. A series of 
IRMOFs demonstrates how variable the synthesis of MOFs is. Image taken from Rowsell et al., 2004.
[194]
 
For some of these applications, e.g. the use in sensors, electrochemistry and chromato-
graphic applications, the deposition of MOFs on solid substrates[201-202] in the form of thin 
films is of crucial importance. The first realisation of such a surface bound MOF (SURMOF) 
was the anchoring of MOF-5 on modified gold substrates.[203] Recently, a number of 
approaches have been presented to yield such porous coatings including quasi-epitaxial 
methods which lead to the formation of structurally nearly perfect, oriented and 
homogeneous coatings.[204-205] The liquid phase epitaxy is an easily controllable method 
for the synthesis of such SURMOFs.[206-209] Here a self-assembled monolayer (SAM) not 
only functions as anchor for the MOF to the surface, but it also controls the orientation in 
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which the MOF crystal grows.[210] For synthesis the SAM is subsequently bought into 
contact with either a solution of the metal precursor or the organic linker as shown in 
Figure 16. Between each step the surface is cleaned, usually by rinsing with the solvent. 
This way, one layer of MOF can be generated in each step allowing for controlled growth 
of the MOF on the substrate and the variation of the building units used in each step.[206-
210] The layer-by-layer method not only allowed the controlled growth of the SURMOF, 
but it also enabled the analysis of the growth in each step. This made an investigation of 
the influence of the structure of the metal precursor possible. Here, it was revealed that 
precursors already exhibiting the coordination sphere present in the MOF later strongly 
supported the growth of the MOF.[210] 
 
 
Figure 16: Liquid phase epitaxy for the synthesis of SURMOF structures. In the method of liquid phase 
epitaxy a SAM and later the SURMOF are brought in turn into contact with solutions of the metal precursor 
and the organic linker. In each step a defined layer of MOF is grown on the surface.
[206-207,210]
 Image adapted 
from Shekhah et al., 2010.
[206]
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3 MATERIALS AND METHODS 
This chapter gives an overview over the techniques used in this work. The theoretical 
background and the practical parameters of the analytical techniques used to 
characterise the surfaces and cells are presented. Further, the methods of surface 
preparation and characterisation are outlined in this section. As a variety of cell lines and 
primary cell materials was used in this study, their isolation, culture and treatment 
protocols are also introduced in this section. Finally, the microfluidic shear force setup 
applied for the cell rolling and adhesion strength measurements is presented and the 
experimental details are discussed. 
3.1 ANALYTICAL TECHNIQUES 
3.1.1 CONTACT ANGLE GONIOMETRY 
Contact angle goniometry is an easy technique to determine the wettability and thereby 
indirectly the free surface energy of a substrate. 
In an ideal planar system without gravitational forces the interaction between a water 
droplet and a surface can be described by three surface tensions (solid/liquid    , 
solid/vapour    , liquid/vapour   ) and Young´s contact angle    between the interfaces 
solid/liquid and liquid/vapour. The relation between these values is given by Young´s 
equation, shown in Equation (7).[211] 
      
       
   
 (7) 
As shown in Figure 17 surfaces with a high energy and high wettability have low water 
contact angles (0° <   < 90°) and are known as hydrophilic, while low energy, non-
wettable surfaces are known as hydrophobic surfaces and exhibit high water contact 
angles (90° <   < 180°). 
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Figure 17: Contact angle of a hydrophilic surface (A) and a hydrophobic surface (B). 
In non-ideal, non-planar systems the surface roughness must be taken into account. The 
first relation considering the surface roughness was the Wenzel equation.[212] Wenzel´s 
contact angle    is related to Young´s contact angle    by a correction factor, the 
roughness ratio   , which is defined as the ratio between the absolute surface area and 
the projected surface area. The relation is shown in Equation (8).[212] 
               (8) 
However, this model is only valid for fully wetted surfaces (Figure 18 A). In the case of 
incompletely wetted surfaces (Figure 18 B), wetting can be described by the Cassie-Baxter 
equation.[213] The Cassie-Baxter contact angle     is related to the material specific 
Young´s contact angle    via the surface contact fraction   as shown in Equation (9).   is 
defined as the ratio between the actually wetted surface area and the maximum possibly 
wettable surface area. 
         (       )    (9) 
 
Figure 18: Theoretical contact of a water droplet as described by the Wenzel (A) and the Cassie-Baxter (B) 
model for wetting. 
In this work contact angle goniometry was used to determine the water contact angles of 
SAMs and polysaccharides bound to surfaces and to thereby verify the quality of these 
substrates. Sessile water droplet contact angles were measured with a custom-built 
contact angle goniometer under ambient conditions.[12] At least three measurements 
were conducted on each sample. Contact between the tip and the droplet was avoided 
during measurement. 
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3.1.2 SPECTRAL ELLIPSOMETRY 
Spectral ellipsometry is an optical technique that allows the determination of material 
properties, e.g. the thickness of thin layers or the refractive index, by measurement of the 
change of the polarisation state of light induced by the interaction with a substrate.[214] 
Linearly polarised light (λ = 280 nm to 800 nm), resulting from the combination of s- 
(perpendicular to the plane of incidence) and p-polarised (parallel to the plane of 
incidence) light of the same phase and amplitude (Figure 19A), is reflected off the sample 
substrate and directed at a detector. Refraction in the substrate changes the phase of the 
beams components leading to a shift from linear polarisation to an elliptical polarisation 
(Figure 19B), hence the name ‘spectral ellipsometry’. The reflected beam passes through 
an analyser and the phase shift of the beam components is measured. The change in 
polarisation can be expressed by the ratio r of the reflection coefficients    and    in the 
form of Equation (10).[215-216] 
  
  
  
    ( )     (  ) (10) 
The phase shift between the p and s components is given by the parameter   and the 
amplitude ratio is denoted by  . As the change between   and   is measured it is not 
necessary to measure a reference beam. This makes the setup robust against external 
disturbances and allows measurement at ambient conditions. The optical constants have 
to be calculated by regression analysis from the experimental data. Therefore a model 
has to be introduced representing the substrate with all known optical properties. With 
knowledge of the substrate´s thickness the optical constants can be determined and vice 
versa.[217] This method allows the calculation of layer thicknesses with sub-nanometre 
precision. In the case of multilayer systems each layer needs to be modelled separately. 
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Figure 19: Polarisation of the light beam before (A) and after (B) being reflected on the sample surface. 
Image taken from S. Bauer (diploma thesis), 2011
[218]
 adapted from jawoollam.com.
[219]
 
In this study spectral ellipsometry was used to verify coupling reactions and to measure 
the thicknesses of SAMs and polysaccharides bound to glass substrates. The film 
thicknesses were measured using a M-44 multiple wavelength ellipsometer 
(J. A. Woollam Co., Inc., Lincoln, NE, USA) aligned at a nominal incidence angle of 
approximately 75 ° to the surface normal (Figure 19C). The light source used was a xenon 
lamp with a polychromatic spectrum. SAM and HA thicknesses were determined with the 
modelling software WVASE™ from J. A. Woollam Co. using a single ‘Cauchy’ model 
layer[214] on a underlying ‘void’ layer. The ‘Cauchy’ relationship shown in Equation (11) 
describes the wavelength dependent refractive index of transparent organic materials.  
 ( )    
 
  
 
 
  
  (11) 
Here,  ,   and   are parameters which are adjusted to match the refractive index of the 
material. From literature values of the refractive index for protein film on surfaces are 
known to be in the range of 1.45-1.50.[220] From this the ‘Cauchy’ parameters were 
chosen as  
                 
On each sample at least three measurements were conducted at different positions. 
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3.1.3 FLUORESCENCE ACTIVATED CELL SORTING 
Fluorescence activated cell sorting (FACS) is a method that allows the high-throughput 
analysis and sorting of heterogeneous cell samples on a single cell basis. Each cell is 
separately passed by a laser beam in a liquid flow and analysed by measurement of the 
interaction with the light. The photons are scattered from the cells and both the 
scattering and the emission pattern are measured. From this different cell properties can 
be determined. 
The intensity of the forward scattered light (FSC) is roughly proportional to the size of the 
cells. Strictly speaking this is only true for homogeneous spherical objects, which cells are 
not, but the relation is sufficient whatsoever. Light, which is scattered orthogonally to the 
incident beam, is known as side scattered light (SSC). Empirical measurements could show 
that the SSC is mainly scattered by internal cell structures and is therefore correlatable to 
the granularity of the cell. These cell properties are known as intrinsic features as they 
can be measured without the addition of exogenous reagents. Extrinsic features can be 
the presence of e.g. cell surface receptors. These must be marked with fluorescent 
antibodies prior to measurement. During FAC sorting, the fluorophor is excited and light is 
emitted in 360° around the cell. Typically this light is measured in the same optical system 
as the SSC. It is guided to different detectors, which measure the intensity at a given wave 
length, i.e. the presence of the stained receptor (Figure 20).[221] 
 
Figure 20: The optical setup of a single-laser flow cytometer with detection of 5 parameters. (FSC/SSC and 
three further parameters FL1, FL2, FL3). FSC = Forward Scatter; SSC = Side Scatter; DM = Dichroic Mirror; SP 
= Short Pass Filter; LP = Long Pass Filter; BP = Band Pass Filter. Image taken from Fruehauf et al.
[221]
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FACS analysis was used in this study to verify the binding of certain antibodies as well as 
to determine the presence of given receptors on cells. The measurements were 
performed on a FACScan flow cytometry system (Becton Dickinson, Heidelberg, Germany) 
by Isabel Hoffmann from the workgroup of Prof. Ho at the University Hospital Heidelberg. 
3.1.4 SCANNING ELECTRON MICROSCOPY 
The scanning electron microscope (SEM) was first designed in 1937[222] and has since been 
developed into one of the most commonly used analytical techniques.[223] The great 
advantage of the SEM over microscopic methods such as light microscopy is the far better 
spatial resolution. While the typical resolution limit of optical microscopes lies in the 
micrometre range, that of an SEM lies roughly three orders of magnitude below that. This 
is due to the use of an electron beam instead of light or more precisely the shorter 
wavelength of electrons compared to photons. Abbe´s diffraction limit   is the minimal 
feature size that can be imaged. The formula to calculate δ is shown in Equation (12).[224] 
  
 
      
 (12) 
The opening angle   of the lens and the refractive index   of the medium, through which 
the beam travels, are the two factors unaffected by the use of electrons instead of 
photons. They are often found combined as the numerical aperture         . The 
third variable in Equation (12) is the wavelength  . The de Broglie relation,[225] which gives 
a relation between the wavelength and the impulse of a particle/wave, is given in 
Equation (13). 
  
 
 
 
 
√      
 (13) 
Where   is Planck´s constant,   the impulse,   the particle´s/wave´s mass and      the 
kinetic energy of the particle/wave. Together with Equation (12) it clearly demonstrates 
that higher energies of the particle/wave and larger masses lead to shorter wavelengths 
and thereby directly to a better resolution. If the wavelength of an electron that is 
accelerated with energies typical for SE microscopes (100 eV) is calculated, the result lies 
in the Angstrom regime. This is roughly three orders of magnitude below that of visual 
light (~ 400 nm to 800 nm).  
SEM is applicable only for conductive samples, as the electrons interacting with the 
sample need to be removed preventing charging of the substrate. For this biological 
samples need to be coated with either graphite of gold in order to gain conductivity and 
contrast. The main components of a SEM are the electron gun, the optics, the 
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measurement chamber and the detector with its electronics. The electron gun is a 
cathode from which electrons are emitted, either by heating (thermionic emission) or by 
applying high voltage (field emission), and an anode which is used to accelerate the 
electrons. The electron beam is then focused by electromagnetic fields and lenses. 
Scanning coils are used to deflect the beam, scanning the area of interest. An aperture is 
used to control the current density. The electrons then ‘hit’ the surface and are either 
deflected as back-scattered electrons (BSE) or induce the emission of secondary electrons 
(SE). These two types of electrons can be measured separately yielding different contrasts 
due to their different penetration depth.  
The microscope used in this work was a LEO 1530 (Zeiss, Oberkochen, Germany). Images 
were recorded with Isabel Thomé and Linlin Xiao from our workgroup. 
3.1.5 X-RAY PHOTOELECTRON SPECTROSCOPY 
X-ray photoelectron spectroscopy (XPS) is an analytical technique used to investigate the 
chemical composition of surfaces. It is based on the photoelectric effect, which describes 
the capability of electromagnetic waves to induce the emission of electrons out of an 
atomic hull. The sample is probed with X-rays, thereby inducing the emission of electrons 
out of the hull of atoms in the top 
layers of the surface. Measurement 
of the kinetic energy of the emitted 
electrons can be used to character-
ise the elemental composition of the 
surface. This is possible because the 
binding energy of electrons is dis-
crete and element specific. As shown 
in Figure 21 and in Equation (14), 
subtraction of the kinetic energy 
     of the electrons and the work 
function of the device         (a 
device specific constant) from the 
energy of the X-rays (  , given by 
the electron source) results in the binding energy   . Therefore, measurement of      
allows the direct calculation of the binding energy of the core level electrons. 
                   (14) 
XPS not only allows the characterisation of the elemental composition of a substrate, but 
also the determination of the film thickness. For electromagnetic waves the empirically 
 
Figure 21: Scheme depicting the photoelectric effect. 
Interaction of X-rays of the energy     with electrons 
results in the emission of these from the atomic orbitals. 
Image based on Ratner et al., 2011
[226]
 
Fermi level
2p3/2
2p1/2
2s
1s
EB
e- Ekin
3 Materials and Methods 
 
26 
 
determined Lambert-Beer’s law gives a correlation between the properties of the 
material through which the wave passes and the absorption in the same.[227] For thin film 
a slightly modified version of this law applies and allows the calculation of the thickness 
of the film based on the attenuation of the signal of the underlying substrate due to the 
film. This correlation is given by Equation (15). 
          
  
 ( )
 (15) 
 ( ) is the signal intensity after attenuation,    is the substrate signal intensity without a 
film present,    is the attenuation length of photoelectrons with a given      and   is the 
take-off angle. With knowledge of    a measurement of the substrate without the film (  ) 
and with the film ( ( )) is sufficient to calculate the film thickness. The attenuation length 
of the Au 4f signal (   = 37.6 Å), as calculated for organic overlayers according to an 
empirical model presented by Seah and Dench,[228] was used for the calculation of the 
thickness of SAMs or protein layers on gold. 
XP spectra were measured and analysed by Stella Bauer from our workgroup. Using a 
Leybold-Heraeus MAX 200 X-ray photoelectron spectrometer with a polychromatic 
magnesium anode as X-ray source (   = 1253.6 eV). Peak fitting was performed with the 
software XPSPeak 4.1 (Prof. R.W.M. Kwok, Department of Chemistry, University of Hong 
Kong) after using a Shirley background subtraction.[229]  
3.1.6 X-RAY DIFFRACTION 
X-ray diffraction (XRD) spectroscopy is an analytical technique that allows the charac-
terisation of crystalline materials. It is based on the diffraction of X-rays on ordered 
geometries such as crystals or quasicrystals. The diffraction can be described by the Bragg 
and Laue equations, which are equivalent. Bragg´s law is given in Equation (16).[230-231] 
          (16) 
With   being the diffraction order (an integer),   the wavelength of the beam,   the 
distance between the atomic planes and   the angle between the incident beam and the 
atomic plane. As seen in Equation (16) and in Figure 22 the phase difference between the 
two reflected beams (the distance C-D-E) must be equal to        for the scattered 
waves to interfere constructively. 
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Next to the determination of the 
crystallinity of a given sample XRD 
spectroscopy can be used to determine 
the distance between the atomic planes, 
the orientation of crystals, their 
periodicity, the lattice parameter or the 
space group of a given material. 
In this study XRD spectroscopy was 
applied to determine the crystallinity of 
surface bound metal-organic frameworks 
(SURMOFs). Measurements were 
conducted by Hasan K. Arslan or 
Zhengbang Wang from the workgroup of 
Prof. Christof Wöll (IFG, KIT, Karlsruhe, 
Germany). For all SURMOF samples, out-
of-plane XRD  -   scans were recorded after synthesis and after the immersion into 
different solutions. XRD measurements were performed using a Bruker D8-Advance 
diffractometer with  -   geometry and Cu   radiation (  = 1.54 Å) as X-Ray source. 
Measurements were recorded by a PSD detector (MBraun, Garching, Germany) by a 
copper    radiation at 40 kV/30 mA, with a step size of 0.007° and scan time of 3 s in the 
range of    = (5-30)°. 
3.1.7 INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROMETRY 
Inductively coupled plasma optical emission spectrometry (ICP OES) is an analytical 
method which allows the rapid determination of the atomic composition of a sample.  
For analysis the sample is injected into a plasma jet (typically argon plasma as this gas is 
comparatively cheap and chemically inert). This heat of the plasma jet (5,000 to 10,000 K 
depending on the region of the plasma) completely destroys that the sample with only 
atoms and ions remaining. This is of great benefit to the analysis as it eliminates all 
chemical effects such as e.g. the bond order. The plasma, furthermore, excites the atoms 
and ions to emit light. Spectral analysis of the emitted light gives information about the 
elements contained in the sample, with the intensity of the respective peak being 
proportional to the concentration of the element in the sample. As all elements are 
simultaneously exited they can also be detected simultaneously or in rapid succession. 
This results in very fast measurements (in the range of minutes). This inherent sample 
 
Figure 22: Geometry of a Bragg reflection. The 
incident beams A and B are reflected on the atoms of 
each atomic plane. If the path difference of the beams 
A’ and B’ is equal to a multiple of   a constructive 
interference occurs. 
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orientation of the ICP OES method is one advantage over element oriented methods such 
as atomic absorption spectroscopy where the samples are scanned for a certain element 
and not all elements are analysed at once. Next to the large working range of the ICP OES 
which typically comprises of six orders of magnitude (from sub-µg/L to g/L) is another 
noteworthy advantage of the ICP OES over other analytical techniques.[232] 
Copper concentrations in SURMOF supernatants were measured by Marita Heinle from 
the workgroup of Prof. Matthias Franzreb (IFG, KIT, Karlsruhe, Germany) with an OPTIMA 
8300DV (Perkin-Elmer, USA). The sample flow was set to 1 mL/min. The high frequency 
generator operated at 1400 W. Gas flows were 15 L/min for the plasma, 0.5 L/min for the 
thrust gas and 0.55 L/min for the vaporiser gas. The copper bands analysed were the 
signals at 327.393 nm and at 324.752 nm. 
3.2 SURFACE PREPARATION TECHNIQUES 
3.2.1 PREPARATION OF POLYSACCHARIDES ON GLASS 
The glycosaminoglycans (GAGs) are a group of large polysaccharides without branching of 
the molecular structure.[128,233] Common to this type of polysaccharides are 1,4-linked 
disaccharide units containing at least one uronic acid (e.g. D-Glucuronic acid or L-Iduronic 
acid). This uronic acid is typically linked to an amino sugar by a β-1,3-glycosidic bond. The 
most prominent representatives are hyaluronic acid, chondroitin sulphate, keratin und 
heparin.[234] 
Hyaluronic acid (HA) was first isolated from the vitreous humour of the eye by Meyer and 
Palmer in 1934.[235] The structure was solved 20 years later.[236] It is a large linear polymer 
based on a repeating disaccharide units consisting of N-acetyl-D-glucosamine and D-
glucuronate, connected by β-1,4 and β-1,3 linkages. HA is one of the major components 
of the extracellular matrix. It was demonstrated in rats that HA can be found throughout 
a mammalian organism with the highest amounts located in the skin (~ 50 %), the bones 
and supporting tissues (~ 25 %) and the rest distributed in muscles and viscera.[237] This 
abundance of HA demonstrates its great importance and many functions in mammalian 
organisms. The most relevant for this study is surely its role as binding partner for CD44, 
which shall be examined in detail in section 4. 
Chondroitin sulphate (CS), which also belongs to the GAG-family, can be found among 
others in the extracellular matrix (ECM)[238] or cartilage of mammals and in the slimy fluid 
covering many fish.[239] Each of its disaccharide subunits consists of N-acetyl-D-
galactosamine (GalNAc) and glucuronic acid that are connected by β-1,3 and β-1,4 
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linkages. Due to the pronounced chemical similarities between HA and CS, CS presents an 
ideal reference when analysing the interaction of CD44 expressing cells with HA. 
For cell interaction analysis a homogeneously coated surface, which can be used more 
than once, was of great interest. This could be realised by covalent coupling of the GAGs 
of interest to glass as shown in Figure 23. The GAGs (HA, CS) were coupled to NexterionB® 
glass slides according to previously published protocols.[240-243] Silicon wafers ([100], p-
doped with boron, served as reflecting and conductive surfaces for spectroscopic 
characterisation (Table 1). 
 
Figure 23: Schematic of the coating of glass slides with polysaccharides utilising the EDC/NHS chemistry.  
Image adapted from Bauer et al., 2013.
[244]
 
The substrates were cleaned and activated in an O2-plasma (Pci PCCE, Diener plasma 
GmbH & Co. KG, Ebhausen, Germany) at 150 W power and 0.4 mbar O2 pressure for 
3 min. 3-Aminpropylotrimethoxysilane (APTMS) functionalisation was achieved by 
ultrasonification of the glass slides immersed in a solution of 5 % APTMS in dry acetone 
for 30 min. The surfaces were subsequently immersed in a solution of the GAG 
(1 mg/mL), N-hydroxysuccinimide (NHS, 0.01 M) and 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC, 0.05 M) in 2-(4-(2-hydroxyethyl)-1-piperazinyl)-ethansulphonic acid 
(HEPES)-buffer (10 mM). The reaction took place on a vibrating Table (60 rpm) at room 
temperature (RT) and was quenched after 18 h by flooding with MilliQ® water (8x 
volume). Washing with MilliQ® water was repeated daily for 3 days, before the slides 
were stored in MilliQ® water until further use. After each step of the reaction, the 
surfaces were analysed by static contact-angle measurement and spectral ellipsometry to 
verify successful grafting. 
Table 1 gives the film thickness and contact angle for the APTMS, the HA and CS layers 
prepared in this work. XP spectra of the prepared HA surfaces shown in Figure 24 were 
obtained by Stella Bauer from our workgroup. They clearly demonstrate the successful 
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preparation of an APTMS layer and the binding of HA to that surface. The C 1s spectra of 
the APTMS layer show the signals for an aliphatic carbon and for a carbon with an 
adjacent electronegative (here the amino function) group. As expected from the chemical 
structure of APTMS the two signals are observed in a ration of roughly 2:1. 
The XP spectrum of HA shows three species of carbon. This in line with the chemical 
structure of HA. A small aliphatic group of carbons is observed. This may also to a certain 
extent originate from the underlying APTMS layer. The two other species originate from 
carbons which have one (the centre peak; 287 eV) or two (the left peak; 288.5 eV) 
electronegative groups adjacent. The N 1s spectra show a small accumulation of nitrogen 
on the surface by coating with APTMS and an increased nitrogen occurrence after coating 
with HA. This too is in line with the chemical structure of the two molecules. Both APTMS 
and HA present one nitrogen atom in their monomer structure. 
Table 1: Properties of GAG-coated surfaces. 
Surface Type 
Film Thickness 
Ellipsometry 
[Å] 
Contact Angle 
[°] 
APTMS layer 12 ± 4 38 ± 6 
HA layer 19 ± 6 < 10 
CS layer 24 ± 5 13 ± 5 
 
 
 
Figure 24: XPS analysis of the prepared HA films. The C 1s XP spectra (A) show the occurrence of increasing 
amounts of carbon on the surface. This together with the increasing amounts of nitrogen, as shown in the 
N 1s spectra (B), indicates the formation of the respective layers on the surface. 
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3.2.2 PREPARATION OF GOLD SUBSTRATES 
Homogeneously coated flat gold substrates were required for the preparation of self-
assembled monolayers. The gold substrates were obtained from PVD Beschichtungen 
(Silz, Germany). Thin polycrystalline gold films were prepared by thermal vapour 
deposition of 30 nm gold (99.99 % purity) onto polished float glass slides (Nexterion B®) 
predeposited with a 5 nm titanium adhesive layer. Evaporation was performed at a 
pressure of 2 x 10⁻7 mbar and a deposition rate of 0.5 nm/s resulting in a root-mean-
square roughness of about 1 nm.[245] The gold substrates were kept in argon atmosphere 
until use. 
3.2.3 PREPARATION OF SELF-ASSEMBLED MONOLAYERS ON GOLD 
Self-assembled monolayers (SAMs) present easy to fabricate, highly reproducible surfaces 
with well-defined and tuneable properties.[246-247] While the term SAM describes a thin 
layer of self-organised organic molecules on a surface in general, the most common 
system used is an organic thiol that spontaneously self-assembles on a gold surface as 
shown in Figure 25.[247-250] In this system the driving force of assembly is the formation of 
an Au-S-bond,[249] which is an extremely strong surface bond (homolytic bond strength of 
~ 44 kcal/mol).[251] Ordering of the layers is driven by van der Waals (VdW) forces 
between the alkane chains of the different molecules leading to the formation of 
crystalline monolayers.[251] In order to maximise the VdW forces the Organo-thiols are 
tilted by (30-35)°.[252] The surface properties are now dictated by the terminal functional 
group of the organo-thiol. This explains why the surface properties of SAMs are so easily 
controllable. The use of organo-thiols with different functional end groups results in 
differently terminated surfaces.  
 
Figure 25: Self-assembly of organo-thiols on a gold surface. The organo-thiols are comprised of a thiol 
group (), a CH2-linker group () and a terminal functional group (). The thiol group interacts with the 
gold surface forming an Au-S-bond.
[249]
 The SAM is formed by self-organisation of the molecules on the gold 
surface. 
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In this study SAMs were used as reference surfaces with defined surface properties and 
as anchoring group for metal-organic frameworks to surfaces. The SAMs used for the 
preparation of metal-organic frameworks were 16-Mercaptohexadecanoic acid (MHDA) 
and hexadecane1thiol (HDT) SAMs. These were prepared Hasan K. Arslan (MHDA and 
HDT) and Zhengbang Wang (MHDA) form the workgroup of Prof. Christof Wöll (IFG, KIT, 
Karlsruhe, Germany). 
Prior to the SAM formation, the gold substrates where treated with UV radiation for 2-3 h 
for cleaning. The gold slides were then rinsed with EtOH p.a., cleaned in EtOH p.a. in an 
ultrasonic bath for 3 min and again rinsed with EtOH p.a.. The substrates were then dried 
in a nitrogen stream. Each surface was measured as a reference for later ellipsometric 
measurement of the SAM layer thickness 
MHDA SAMs was prepared on the Au coated glass slides using the following procedure: A 
solution of MHDA was prepared as described by Arnold et al.[253] by dissolving the thiol in 
a 10/90 volume mixture of acetic acid (AcOH) and EtOH to reach the desired 
concentration of 20 μM. To prepare MHDA SAMs, a clean gold substrate was placed in 
this solution for 72 h and then rinsed with the EtOH p.a. and gently dried under nitrogen 
flux. Next to the ellipsometric and the contact angle measurement (Table 2) the MHDA 
SAMs were characterised by Infrared Reflection Absorption Spectroscopy (IRRAS) as 
shown in the supplementary Figure S12 (Appendix section 7.3.1). 
For the preparation of Dodecane-1-thiol (DDT), 11-mercapto-1-undecanol (11-hydroxy-
undecan-1-thiol, HUDT) and HDT SAMs the clean gold substrates were immersed in 1 mM 
ethanolic thiol solutions. After 24 h the substrates were removed from the thiol solution 
and rinsed with EtOH p.a., treated in an ultrasonic bath for 3 min to remove non 
chemisorbed thiols and rinsed again. 
The samples were blown dry in a 
nitrogen stream and were either used 
instantly or kept under argon 
atmosphere until use. The samples 
were characterised by contact angle 
measurement and spectral ellipso-
metry (Table 2). 
The preparation of patterned Cu2+ 
based SURMOF 2 substrates for the 
cell attachment studies was accom-
plished by micro-contact printing 
(CP) of two different SAMs on a gold 
Table 2: Properties of the different SAMs after self-
assembly. The table gives the film thickness as 
determined by spectral ellipsometry and the contact 
angle as measured by contact angle goniometry. The 
error is the standard deviation (SD). 
Surface Type 
Film 
Thickness 
[Å] 
Contact 
Angle 
[°] 
30 nm gold slides --- 65 ± 2 
MHDA SAM 14 ± 2 26 ± 3 
HDT SAM 15 ± 2 98 ± 5 
HUDT SAM 12 ± 2 36 ± 4 
DDT 11 ± 2 101 ± 5 
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substrate.[254] A polydimethylsiloxane (PDMS) stamp with elevated 50 µm x 50 µm 
squares was inked with a 5 mM ethanolic solution of MHDA, dried and gently pressed 
against the gold substrate for 120 s. The bare areas (stripes) between the squares were 
coated with HDT SAMs as described above. The characterisation was done by 
ellipsometric and contact angle measurement (Table 2). 
3.2.4 PREPARATION OF SURMOF SUBSTRATES 
Metal-organic frameworks (MOFs) are a class of highly porous coordination polymers 
which presently attract enormous interest with regard to a broad variety of rather 
different applications ranging from storage of small molecules to nanotechnology and 
applications in drug release.[198,255-256] In this study the stability of different surface-
anchored MOFs (SURMOF) as well as the biocompatibility of the respective SURMOF was 
studied. The spray method, one of the preparation techniques used in this study, is shown 
in Figure 26. Synthesis of the different SURMOF substrates was done by Hasan K. Arslan 
and Zhengbang Wang form the workgroup of Prof. Christof Wöll (IFG, KIT, Karlsruhe, 
Germany). 
 
Figure 26: Setup of a spry coater as used for the preparation of SURMOF 2 substrates in this study. The 
two building units of the SURMOF (B and C) and EtOH p.a. (A) are in turns sprayed on the substrate (5). A 
computer (8) controls the spraying sequence. Image taken from Arslan et al., 2011.
[208]
 
HKUST-1  
To grow the HKUST-1 SURMOF, MHDA SAM substrates were immersed in a 1 mM 
ethanolic solution of Cu(II)Ac2∙2H2O for 15 min and subsequently in a 0.1 mM ethanolic 
solution of benzene-1,3,5-tricarboxylic acid (btc) for 30 min at 50 °C. The samples were 
rinsed with ethanol containing 0.5 % (by volume) of water for 2 min and dried under a 
flow of nitrogen between each step. The cycles were repeated 40 times, thus obtaining a 
40 layer HKUST-1 SURMOF.[257] 
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SURMOF 2 / spray method 
Cu-SURMOF 2 layers were grown on MHDA SAMs on Au substrates by employing the 
spray-method shown in Figure 26[208] with (a) a 1 mM ethanolic solution of Cu(II)Ac2∙2H2O 
respectively for 10 seconds and then (b) with a 0.2 mM ethanolic solution of benzene-1,4-
dicarboxylic acid (bdc) for 20 s at RT. Between each step the substrates were rinsed with 
ethanol for 3 s. 
SURMOF 2 / pump system 
Cu-SURMOF 2 layers were grown on MHDA SAMs on Au substrates. The freshly prepared 
substrates were then immersed subsequently (a) in a 1 mM ethanolic solution of 
Cu(II)Ac2∙2H2O for 30 min and (b) in a 0.2 mM of bdc ethanol solution for 1 h at RT. 
Between each step the substrates were rinsed with ethanol for 2 min and dried under a 
flow of nitrogen between each step. 
All SURMOFs were characterised by XRD in a  -   geometry using Cu   radiation before 
all subsequent measurements were carried out. Characterisation of the SURMOFs shall be 
discussed in the context of the stability analysis in section 5.1. 
3.3 MEDIA STABILITY ANALYSIS OF SURMOFS 
To investigate the stability of Cu-/Zn-SURMOF 2 against MilliQ® water, artificial sea water 
(ASW, type: Instant Ocean®), phosphate buffered saline buffer (PBS), 1 mg/mL fibrinogen 
in PBS and the cell culture medium Dubelcco´s modified eagle medium (DMEM) 
supplemented with 10 % FCS and 5 % L-Glutamine, the Cu-/Zn-SURMOF 2 substrates were 
incubated in the different media in a beaker and shaken for (1-2) h on a vibrational table 
at 90 rpm. Then the samples were removed from the solution and carefully rinsed with 
MilliQ® water before they were used for surface characterisation. The stability of the 
HKUST-1 SURMOF in water was studied analogously but with shorter incubation times as 
the MOF was highly unstable in water. 
3.4 PROTEIN ADHESION ASSAY 
Protein resistance of different SAMs and the Cu-SURMOF 2s was characterised following 
established protocols.[220] The proteins were dissolved in PBS (filtered once with a 
0.45 µm syringe filter; protein concentration: 2 mg/mL) under constant stirring at RT. 
Sample surfaces were preincubated in PBS buffer (10 mL, filtered once) in a 50 mL-beaker 
for 20 min. The clear protein solution was added to the PBS buffer solution, in which the 
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samples were incubated, diluting the protein concentration to 1 mg/mL. After 30 min of 
incubation at RT the adsorption was stopped by careful flooding with 1 l deionised-water. 
The samples were then carefully rinsed with MilliQ® water and dried in a nitrogen stream. 
3.5 CULTURE OF MODEL CELL LINES 
While the interaction of primary human cell material with surfaces is generally of more 
interest than that of cell lines, the cell lines represent the only sensible way of undergoing 
broad mechanistic studies with large amounts of comparable cell material. In this study 
the cell lines were used as model systems for the interaction of cells with HA and as 
references for the analysis of the biocompatibility of SURMOF substrates. 
3.5.1 CULTURE OF SUSPENSION CELL LINES 
The suspension cell lines KG-1a, Jurkat and Kasumi-1 were cultured in 75 cm² culture 
flasks in 10 mL of RPMI 1640 (PAA Laboratories GmbH, Engelsbach, Germany) 
supplemented with 10 % FCS, 1 % penicillin/streptomycin and 1 % L-glutamine. The cells 
were split every 3-4 days in the range of 1:5 to 1:10. Therefore the cell suspension was 
diluted in PBS buffer and centrifuged for 5 min at 1200 rpm. The solution was then 
removed from the pellet, which was subsequently resuspended in fresh medium and 
stored in in a humidified incubator with ~ 5 % CO2 at 37 °C. 
For experiments, the cell concentration was determined with a Neubauer 
haemocytometer for cell counting before the cells were washed and adjusted to a cell 
concentration of 106 cells/mL. 
3.5.2 CULTURE OF ADHERENT CELL LINES 
REF52WT Cells 
REF52WT were cultured in Dubelcco´s modified eagle medium (DMEM) supplemented 
with 10 % FCS, 1 % penicillin/streptomycin and 1 % L-glutamine. They were harvested at 
full confluence from T-25 tissue culture flasks by rinsing with 10 mL PBS buffer and 
subsequent incubation with 2.5 mL 0.05 % trypsin–EDTA solution for 3 min at 37 °C in an 
incubator. Then the suspension was diluted with 10 mL culture medium and centrifuged 
for 3 min at 800 rpm. The cell pellet was resuspended with fresh medium and used for 
experiments instantly. For continuous cultivation the cells were split 1:10 and seeded in 
T-25 tissue culture flasks. Confluent passages were obtained every 2-3 days. 
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For experiments, the cell concentration was determined with a Neubauer 
haemocytometer for cell counting before the cells were washed and adjusted to a cell 
concentration of 106 cells/mL. 
HepG2 and HepG2Iso Cells 
Culture and preparation for microfluidic experiments of HepG2 and HepG2Iso were 
performed by Katharina Fuchs (workgroup of Dr. Véronique Orian-Rousseau, ITG, KIT, 
Karlsruhe, Germany). For culture the cells were grown in either tissue culture flasks or 
plates in DMEM supplemented with 10 % FCS. To passage the cells the old growth 
medium was removed by aspiration. The cells were then washed with PBS. To detach the 
cells from the plate trypsin containing solution (Trypsin 0.25% (w/v) EDTA) was added and 
incubated at 37 °C for approximately 3-10 min. Trypsin-dependent digestion was then 
stopped with serum containing medium, the cells were collected by centrifugation at 
1.200 rpm, resuspended in fresh DMEM and distributed in new tissue culture flasks or 
plates. 
For experiments 3∙106 cells were seeded in 10 cm plates and cultured for 24 h. After 24 h 
of starvation, the cells were washed 3 times with PBS. The following steps were 
performed on ice. The cells were harvested by 5 mM EDTA in PBS and afterwards washed 
three times with PBS. After that, the cells were counted and diluted to a concentration of 
1∙106 cells/mL in DMEM without FCS. They were stored on ice and used within a few 
hours. 
An overview over all cell lines used in this work is given in Table 3. 
Table 3: Overview over the cell lines used in this work. 
Cell line Organism Tissue Description Reference 
KG-1a 
(CCL-246.1) 
Human Bone marrow 
Myeloblast, 
suspension 
[258-259] 
Jurkat 
(TIB-152) 
Human T-cell leukaemia 
Lymphoblast, 
suspension 
[260] 
Kasumi-1 
(CRL-2724) 
Human Peripheral blood 
Myeloblast, 
suspension 
[261] 
REF52WT Rat Embryo 
Fibroblast, 
adherent 
[262] 
HepG2Iso Human Liver 
hepatocellular 
carcinoma, adherent 
[263] 
HepG2 Human Liver 
hepatocellular 
carcinoma, adherent 
[263] 
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3.6 ISOLATION AND CULTURE OF HEALTHY AND 
LEUKAEMIC HAEMATOPOIETIC CELLS 
The progression from the model cell line interaction with HA under flow conditions was 
the analysis of primary material under identical conditions. For this written informed 
consent was obtained according to the guidelines approved by the Ethics Committee of 
the Medical Faculty of Heidelberg for the collection of fresh umbilical cord blood (CB), 
bone marrow from healthy donors (BM), peripheral blood from healthy donors (PB) or G-
CSF-mobilised peripheral blood from healthy donors (mPB) and bone marrow and 
peripheral blood from patients with newly diagnosed AML (PB blasts or BM blasts). 
Collection and purification was conducted by the group of Prof. Anthony D. Ho 
(Department of Medicine V, University of Heidelberg) following established protocols.[264-
265] 
Mononuclear cells (MNC) from healthy donors were isolated by density gradient 
centrifugation on Ficoll-Hypaque from healthy PB. Leukocytes (lymphocytes, monocytes 
and granulocytes) from healthy PB were sorted by FACS (FACSAria, Becton Dickinson) 
based on CD45 expression and SSC characteristics after red blood cell lysis with BD Pharm 
Lyse™. 
CD34+ cells from CB, mPB or BM were selected by magnetic-activated cell sorting (MACS) 
using a monoclonal anti-CD34 antibody labelled with magnetic beads on an affinity 
column (MiltenyiBiotec, Bergisch-Gladbach, Germany). 
Leukaemia blast samples from patients with AML were sorted by fluorescence-activated 
cell sorting (FACS) (FACSAria, Becton Dickinson) based on CD45 expression and SSC 
characteristics (CD45dimSSClow). Between acquisition and use in this study, the AML 
samples were stored in liquid nitrogen at -196 °C. Most samples were isolated from the 
bone marrow of the respective patient. Samples isolated from the peripheral blood are 
marked appropriately in the text. 
Both healthy and leukaemic cells were cultivated in StemlineTM II Haematopoietic Cell 
Expansion Medium supplemented with 100 ng/mL TPO, 100 ng/mL G-CSF, 100 ng/mL SCF, 
500 ng/mL Flt-3L, 2 mmol/L L-glutamine, 1,000 U/mL penicillin and 100 U/mL 
streptomycin for 24 h.[266] The cell density was adjusted to 106 cells/mL, and the cells 
were analysed in the microfluidic cell detachment assay. 
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3.7 CELL TREATMENT AND MODIFICATION 
To characterise the interaction of cells it is often necessary to modulate their binding 
properties. This for example offers the opportunity to determine dependencies on certain 
receptors or on the amount in which these are available for interaction. In this study the 
interaction of both model cell lines and human haematopoietic cells with HA was 
characterised in detail. To achieve this, the cell surface receptor CD44, responsible for a 
flow-induced interaction with HA, was modified and the effects of this modification were 
analysed in a microfluidic shear force device. The treatment with antibodies and siRNA is 
described in this section. It is also described how cells were prepared for SEM imaging. 
3.7.1 ANTIBODY TREATMENT 
The cell surface expression of CD44 in different HPC subpopulations, leukaemic blasts, 
leukocytes and KG-1a cells was investigated by staining with anti-CD44-phycoerythrin or 
anti-CD44-allophycocyanin (clone G44-26, Becton Dickinson) and subsequent FACS 
measurement.  
For antibody blocking experiments, the cells were pre-incubated with different 
concentrations of the monoclonal CD44 antibody clone BU52 (hereafter referred to as 
BU52) or the isotype control anti-IgG1 (hereafter referred to as IgG1) for 30 min. The 
effectiveness of the binding of both BU52 and the isotype control IgG1 was verified by 
FACS measurement using FITC-marked BU52 (hereafter referred to as BU52-FITC, using 
the same protocol as for BU52) or by staining the cells previously incubated with IgG1 for 
20 min with a FITC-marked anti-IgG1 antibody (hereafter referred to as FITC-IgG1). 
3.7.2 SIRNA OLIGONUCLEOTIDES AND TRANSFECTION 
Transfection of HepG2Iso cells with siRNA oligonucleotides were done by Katharina Fuchs 
from the workgroup of Dr. Véronique Orian-Rousseau (ITG, KIT, Karlsruhe, Germany). 
Aliquots of HepG2Iso cells (2∙106) were seeded in 10 cm plates 24 h before transfection. 
The cells were transfected with Lipofectamin 2000, according to the manufacturer’s 
protocol. Per plate, 18 µl of Lipofectamin 2000 was diluted in 547 µl of the corresponding 
serum free cell culture medium (DMEM) and incubated for 10 min at RT. 5 nmol/L of 
CD44pan siRNA (5’-CTGAAATTAGGGCCCAATT-3’; 5’-AATGGTGCATTTGGTGAAC-3’; 5’-
CAGAAACTCCAGACCAGTT-3’), CD44v3 siRNA (5’-TGAAGATGAAAGAGACAGA-3’; 5’-
AGGCATTGATGATGATGAA-3’), CD44v6 siRNA (5’-AGTAGTACAACGGAAGAAA-3’; 5’-
GGATATCGCCAAACACCCA-3’) or control siRNA (5’-UAAUGUAUUGGAACGCAUAUU-3’; 5’-
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AGGUAGUGUAAUCGCCUUGUU-3’; 5’-UGCGCUAGGCCUCGGUUGCUU-3’) was diluted with 
medium reaching a total volume of 547 µl. The two solutions were gently mixed together 
and incubated for 20 min at RT. In the meantime, the cell medium was replaced with 
4.5 mL of fresh serum-containing medium. 1 mL of the siRNA-transfection reagent 
mixture was then applied to the cells. The cells were subsequently incubated with the 
siRNA mixture for 48 to 72 h. 
3.7.3 TRANSWELL MIGRATION ASSAYS 
Transwell migration assays were conducted in cooperation with Rainer Saffrich from the 
workgroup of Prof. Anthony D. Ho (Med.V, Universitätsklinikum Heidelberg). 24-well 
plates with transwell inlets of 3 µm pore size were used in this work. 700 µl of LTBMC 
medium were added to the well plate together with the SDF-1α (100 ng/mL) if required. 
HPC (80,000 cells to 150,000 cells in 200 µl) were either directly added to the transwell 
inlet or first mixed with the Plerixafor® solution (500 ng/mL) and then added to the 
transwell. All concentrations are given as final concentrations in the volume (900 µl) of 
the entire setup. The assay was run for 4 h in an incubator and terminated by fixing of the 
cells with 4 % PFA solution in PBS. The nuclei were marked with Hoechst 33342. The fixed 
HPC were washed into a 96-well plate and images were taken of each fraction. The 
number of migrated cells was then measured by object counting with ImageJ (National 
Institutes of Health, Bethesda, MD, USA). 
3.7.4 SAMPLE PREPARATION FOR SEM IMAGING 
REF52WT were incubated on the surfaces for at least 5 h. The cell culture medium was 
removed and the cells were carefully washed three times with PBS buffer. The PBS buffer 
was then also removed and the cells were incubated with 2 % paraformaldehyde (PFA) in 
PBS buffer for 30 min at RT. After the incubation the cells were washed three times with 
PBS buffer, which was then substituted by MilliQ® water in three dilution steps. The 
water was exchanged every 10 min with water/ethanol mixtures; the amount of ethanol 
increasing by 10 % each step beginning with 50 %. The washing with 100 % ethanol was 
repeated three times. The critical point drying with a CPD 030 (Bal-Tec, Schalksmühle, 
Germany) followed a well-established protocol.[267] The exchange of ethanol to liquid 
carbon dioxide was repeated 10 - 15 times at 10 °C. The temperature was then raised to 
40 °C. By heating the solution the pressure rose from 50 bar up to 70 - 80 bar. The system 
was kept in the critical phase for 10 min before the gas was slowly released. The dried 
samples were then directly sputtered twice with graphite to avoid surface charging 
artefacts in the SEM. 
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HepG2Iso and KG-1a were fixed with 10 % PFA in PBS buffer under flow (approximately 
1 dyn/cm²) in the microfluidic shear force setup. Therefore, the cells were injected in cell 
culture medium and the PFA/PBS solution was then sucked through the channel system 
gradually bringing the cells into contact with the solution. The cells remained in the 
PFA/PBS solution for 10 min. The following washing and drying steps were analogous to 
the procedure for REF52WT. 
3.8 MICROFLUIDIC SHEAR FORCE MEASUREMENT 
The microfluidic shear force setup used in this study was built and developed in our 
workgroup by Christof Christophis.[11-12] It allows the exact application of liquid flow 
speeds to defined channel systems containing modifiable sample surfaces, thereby 
allowing the quantification of the adhesion of objects to a surface and the observation of 
the interaction of cells with these surfaces under flow conditions. 
3.8.1 GENERAL SETUP 
The general setup consists of an inverted TE2000-U microscope (Nikon, Tokyo, Japan) 
housed in a self-built incubator (Figure 27), which allows the adjustment of the 
temperature to cell culture compatible conditions (37 °C). The incubator is further 
equipped with CO2 regulation making long-term cell experiment not only possible, but 
presenting ideal conditions for these (5 % CO2 in the atmosphere).  
 
Figure 27: Photograph (left) and schematic image (right) of the incubator housed microscope TE2000-U. 
Image taken from Christophis, PhD thesis, 2011.
[12] 
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The microfluidic setup consists of a liquid reservoir from which the carrier liquid is sucked 
through the assembled channel system to the syringe pump (Figure 28).[11-12] In detail, the 
liquid is distributed to all channels equally via a manifold. The samples are also directly 
injected into the manifold. Which channel is active is controlled by the selector located 
between the channel holder and the syringe pump. This form of setup allows a parallel 
incubation of e.g. epithelial cells inside of all four channels simultaneously. Friction in the 
tubings leads to a pressure drop, which is compensated by application of an overpressure 
applied to the liquid reservoir. To enable an equilibration of the pressure between the 
syringe pump and the liquid reservoir without requiring the opening of any of the 
channels a by-pass tubing directly connects the syringe pump to the manifold and thereby 
to the liquid reservoir.  
 
Figure 28: Flow path used for the microfluidic shear force experiments. The liquid is sucked from the liquid 
reservoir (a) through the manifold (b) that connects all channels to the reservoir through the channels (c) 
and the selector (d) that allows selection of each channel to which the flow is applied into the syringe pump 
(e) that controls the flow rate. Image taken from Christophis, PhD thesis, 2011.
[12]
 
3.8.2 CHANNEL SETUP AND ASSEMBLY 
The above mentioned channel system is a self-built ‘sandwich-like’ assembly. This allows 
the easy exchange of the substrate, which in itself presents the bottom of the assembled 
channel (Figure 29). The channel walls are a PDMS ring (overall height 130 µm with a 
140 µm high inner ring; 2.5 cm long and 1.5 mm wide, hereafter referred to as ‘25 mm 
channel’) that is cast from a brass mould. The lid is a glass slide (20 × 30 × 2 mm) into 
which 2 holes were drilled (distance = 2.4 mm) with a diamond tip drill. The holes in the 
glass lid were aligned to the beginning and end of the PDMS channel walls and to the inlet 
and outlet tubings fixed in the PDMS seal connecting the assembled channel system to 
the liquid flow path.  
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The assembly of the system is simple 
as all elements are stacked and fixed 
with screws. Solely the fixation of 
the PDMS channel walls requires a 
defined protocol. As previously 
described[12] and shown in Figure 30, 
the PDMS channel walls were rinsed 
with MilliQ® water and iso-propanol 
after each disassembly of the 
system. The channels were then 
immersed in 2 % Extran solution for 
1 h, kept in MilliQ® water over night 
and immersed in iso-propanol for 
~ 30 min (at least 5 min). Before 
channel alignment the glass lid was 
cleaned with 2 % Extran, MilliQ® water and iso-propanol using dust free wipes. A droplet 
of EtOH p.a. on the lid on which the PDMS channel ‘swam’ and two blunt cannulas were 
used to align the PDMS channel to the holes of the glass lid. When the ethanol 
evaporated the channels stuck to the glass lid and were finally rinsed with MilliQ® water. 
 
Figure 30: Cleaning and assembly process of the microfluidic channel. Image taken from [12]. 
3.8.3 MICROFLUIDIC DETACHMENT ASSAY 
The microfluidic shear force setup can be used for the observation of the interaction of 
cells or objects with different surfaces under shear force conditions or for the 
measurement of the shear force required for the detachment of cells or objects from a 
variety of surfaces. In this study both types of utilisation were applied. 
 
Figure 29: Scheme of the parts required for the assembly 
of a microfluidic channel. The in- and outlet tubings are 
held and sealed by the PDMS seal. This is stuck to the glass 
lid into which 2 holes are drilled. The holes are directly 
aligned to the in- and outlet tubing and to the beginning 
and end of the PDMS channel walls. The substrate 
completes the channel system as the bottom of the 
channel assembly. Image taken from [12]. 
Tubing
PDMS seal
Glass lid
PDMS channel walls
Substrate
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While the outcome of the two applications was of completely different nature 
(observation of cell/object-surface interaction under flow and comparison of shear stress 
required for detachment), the mode of measurement applied in the microfluidic shear 
force setup was the same. In both cases the detachment assay can be used (Figure 31).[11-
12] For measurement of such an assay the channel system was assembled as described in 
the previous section. The test objects or cells were then injected into the channel system 
via a 2-way valve connected to the manifold. Here, alteration of the selector controlled 
which channels were loaded with test objects. After injection the selector was switched 
to the bypass tubing and the 2-way valve connecting the manifold to the liquid reservoir 
was opened applying an overpressure of 0.6 bar to the entire system. As elaborated in 
detail in the Appendix (section 7.1.1.1), among other things, frictional forces led to a 
pressure loss in the microfluidic setup. This was dependent on the average flow velocity 
of the liquid, meaning that faster liquid flow increased the pressure loss. Too far 
reduction of the overall pressure by the pressure loss led to the formation of gas bubbles 
in the system. As this in essence meant the actual flow differed from the theoretically 
applied flow making an estimation of the shear stress impossible, the overpressure was 
applied in order to avoid this scenario. The timespan for which the system remained in 
this bypass-opened state depended on the type of measurement. In the case of the 
observation of cell-surface interactions and for measurement of shear forces required to 
detach particles from surfaces approximately 5 min were required for the cells/particles 
to sink to the surface and for the pressure to equilibrate between the syringe pump and 
the liquid reservoir. For measurement of the shear force required to detach cells that 
actively adhere to a surface such as e.g. epithelial cells a longer incubation time was 
required. For fibroblasts Christophis et al. demonstrated that 5 h are sufficient to allow 
reproducible adhesion while not risking detachment of the cells due to proliferation.[11] 
After the appropriate incubation time the program controlling the movement speed of 
the syringe pump was started. For nearly all measurements in this study the movement 
speed of the syringe pump and thereby the shear stress was increased by 2.33 % every 
0.5 s, resulting in a logarithmic increase of the shear stress over time (Figure 31 A). The 
only exception to this experimental procedure was necessary for the characterisation of 
the epithelial cell lines HepG2Iso and HepG2 (results shown in section 4.1). Here a pulse 
of approximately 10 dyn/cm² lasting 0.5 s preceded the stepwise increase of the shear 
stress (Figure 31 B). This pulse was necessary as the cells sometimes spontaneously 
adhered to the HA surface after injection and this ensured that all cells were detached 
from the surface at the beginning of the measurement. 
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Figure 31: Scheme of the two types of detachment assay applied in this study. A) The regular detachment 
assay. The shear stress was stepwise increased from ~ 0.01 dyn/cm² to ~ 1,000 dyn/cm² every 0.5 s. 
B) Modified detachment assay with an initial 10 dyn/cm² pulse for 0.5 s used to detach spontaneously 
adhering cells. 
The wall shear stress    applied in each step can generally be described by  
        
  (17) 
With    being the initially applied shear stress,    the growth coefficient, by which the 
shear stress was increased in each step (e.g. 1.0233 for a 2.33 % increase), and   the step 
number. However, the growth coefficient was related to the step duration    (e.g. long 
steps with large    could have the same overall shear stress increase as short steps with 
small   ). This made the comparison of the overall increase between different 
constellations (   and   ) difficult. As shown in Equation (18), substitution of    by the 
step duration independent growth rate of the shear stress    led to a more general 
description of the wall shear stress    . For further elaboration see also the Appendix 
(section 7.1.1.3). 
        
           
    
      (  
 
  )
    
    (  )
       
(18) 
    is the wall shear stress (hereafter referred to simply as ‘shear stress’) applied in a 
given step,    is the duration for which the experiment had proceeded (multiple of the 
step duration;    =     ,   = 0,1,2,3…),    (growth rate of the shear stress) is the step 
duration independent factor by which the shear stress was increased each step and    the 
initial shear stress applied to the channel system. The liquid flow rate, which was 
generated by the syringe pump, is directly correlated to the shear stress applied to the 
surface. In fact,    can be calculated from the liquid flow rate ( ), the channel dimensions 
(width  and height  ) and the viscosity of the liquid ( ) according to Equation (19). 
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 (19) 
This calculation follows the Poiseuille model for parallel plate flow channels (Figure 32) 
using the Purday approximation and the fact that the ratio between the channel height 
and the channel width was large.[185-188] The derivation of the formula can be found in the 
Appendix (section 7.1.1.3). A prerequisite for the application of the approximations made 
there is the existence of a fully developed laminar flow. Here, a defined velocity gradient 
along the y-axis (orthogonal to 
the channel bottom/top) can be 
anticipated. In such a setting the 
flow can simply be viewed as a 
stack of non-mixing layers parallel 
to the wall. In the case of turbu-
lent flow the calculation is more 
complicated. It relies on the mod-
elling of the viscosity-affected 
inner region (the near-wall re-
gion) for solving the velocity gradient along the y-axis. This is possible by either applying 
semi-empirical formulas called ‘wall functions’ (the near-wall region is bridged) or by 
‘near-wall modelling’ (the near-wall region is resolved by modifying turbulence models 
with a mesh all the way to the wall). The dimensionless Reynold´s number    can be 
applied to predict if a laminar or a turbulent flow profile develops. At Reynold´s numbers 
below 2300 the flow is laminar and a parabolic flow profile as indicated by the grey 
arrows in Figure 32 can be observed. As shown in the Appendix (section 7.1.1.2) the 
Reynold´s number    can be estimated for a flat rectangular channel (height << width) by 
Equation (20). 
   
   
  
 (20) 
With   being the liquid flow rate,   the liquid density,   the liquid viscosity and   the 
channel width. The maximum flow rate theoretically applicable by the syringe pump was 
~ 81 mL/min. Due to the pressure drop in the tubings and the channel system, the 
practically applicable maximum flow rate was roughly 40 mL/min. Beyond this flow rate 
the formation of bubbles in the setup was observable. As the viscosity   is in the 
denominator the calculation of the maximum Reynold´s number presented here was 
done for the relatively low viscosity of cell culture medium at 37 °C 
(0.72 x 10-3 kg m-1s-1).[187] The viscosity of buffer solutions such as PBS buffer at lower 
temperatures is always larger than this leading to lower Reynold’s numbers. The liquid 
 
Figure 32: Parallel plate model for unidirectional flow. A 
parabolic flow profile between two immobile parallel plates is 
shown. The height is so much smaller than the width of the 
channel that the shear at the channel sides can be neglected. 
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density   is ~ 1kg/L. The channel dimensions can be estimated as   = 135 µm and 
  = 1500 µm (which is neglectable due to the ratio   ⁄  being so large). From this the 
Reynold’s number calculates to ~ 830 (~ 1670 for the theoretically applicable 81 mL/min). 
This is well below the threshold Reynold´s number of 2300 for laminar flow.[177] 
By expressing   from Equation (19) with the Reynold´s number as given by Equation (20) 
the shear stress may also be estimated as 
  
  
  
 (21) 
This correlation emphasise the importance of maintaining small channel heights, as at a 
constant Reynold´s numbers the maximum applicable shear stress is correlated to the 
square of the channel height. 
3.8.4 DATA ANALYSIS OF ADHESION STRENGTH EXPERIMENTS 
The critical shear stress     required to detach 50 % of the adhered organisms or particles 
(both hereafter referred to as objects) was an ideal variable to compare the adhesion 
strength of objects to different surfaces. 
To determine the critical shear stress     the number of objects adherent to the surface 
at a given time  ( ) was normalised to the number of objects initially adherent to the 
surface in the field of view (FOV) Nad as 
shown in equation (22).  
 ( )     
        (22) 
    was, therefore, defined as 
     (   )     
        (23) 
with 
 (   )  
 
 
    (24) 
The critical shear stress τ50 could easily be 
derived from the plot by magnification of 
the detachment area of the curve and 
utilisation of the ‘Screen-Coordinates’-tool 
provided by OriginPro 9.1G©. For   = 0.5 the 
 -coordinate was equal to the     value of 
the given object and surface (Figure 33). 
 
Figure 33: Explanatory graph showing the 
evaluation of the detachment of adherent cells or 
particles from surfaces in the microfluidic shear 
force setup. After normalisation of the adherent 
objects  ( ) to the initially adherent objects     
the     value could easily be determined from the 
plot visually. 
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3.8.5 DATA ANALYSIS OF CELL-SURFACE INTERACTION EXPERIMENTS 
The cell concentration of the cell line suspensions injected into the channel system was 
adjusted to 106 cells/mL. In the case of primary material this was not always possible, as 
counting and resuspension of the cells directly before the experiments was avoided to 
prevent stress to the cells or the amount of cells was simply not sufficient. For this reason 
and to ensure ideal comparability between all experiments the number of cells  ( ) 
interacting with the surface at a given time (the time elapsed in the measurement was 
directly correlated to the shear stress) was normalised to the number of cells initially 
visible in the FOV    as shown in Equation (25). By doing so adhesion curves as shown in 
Figure 34 were measured.  
 ( )    
        (25) 
The supplementary Video S3 found in the 
Appendix (description found in 
section 7.1.2.1, video provided on the 
supplementary CD) demonstrates the 
direct correlation between the video 
recorded during measurement and the 
interaction curve obtained after analysis. 
From the interaction curve values such as a 
threshold shear stress, beyond which a 
flow-induced rolling on the surface took 
place, and the shear stress, at which the 
maximum fraction of interacting cells      
was observed, could be derived visually. 
In contrast to the various types of 
suspension cells used in this study, which 
all showed reproducible tendencies to interact with the test surfaces (mainly HA-coated 
substrates), the two related epithelial cell lines HepG2 and HepG2Iso showed a highly 
heterogeneous tendency to interact with the surfaces. Depending on unidentified factors, 
which may involve cellular age, culture density or storage duration on ice, this ranged 
from cells spontaneously adhering to the substrate directly after injection into the 
channel system yielding no chance of observing any interaction under flow, over slow 
adhesion and a strong tendency interact with the HA-coated surface under flow, to a 
generally weak cell-surface interaction.  
 
Figure 34: Explanatory graph showing the 
evaluation of the interaction of suspension cells 
with surfaces under flow in the microfluidic shear 
force setup. The number of interacting cells was 
normalised by the number of cells initially visible in 
the FOV  . 
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To mitigate this issue and to allow comparison of different experiments, an additional 
normalisation was applied for this specific cell type. As for the suspension cells, each 
experiment was normalised to the number of initially visible cells (normalisation to   ), 
yielding the fraction of interacting cells in per cent. In addition, the fraction of interacting 
cells of the corresponding control group (untreated cells or cells treated with siRNA, 
respectively) was defined as full interaction, with the fractions of interacting modified 
cells corresponding to this value. This value was used to compare the influence of e.g. 
antibody blocking or siRNA treatment. 
An example for this normalisation is shown in Figure 35. The two control measurements 
were averaged to the mean curve (black line, Figure 35 B). Due to the correction process 
the values were no longer given in per cent but rather in arbitrary units (a.u.). 
Furthermore, as the initial fraction of cells visible in the FOV was no longer of relevance it 
is not shown in the following graphs depicting the HepG2Iso-surface interaction. 
 
 
Figure 35: Exemplary graph showing the evaluation of the interaction of epithelial cells with surfaces 
under flow in the microfluidic shear force setup. The number of interacting cells was normalised to the 
respective control. 
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3.8.6 OPTIMISATION AND PROOF OF APPLICABILITY OF THE 
MICROFLUIDIC SHEAR FORCE DEVICE 
Earlier studies in our workgroup experienced certain short comings concerning the 
precision and reproducibility of measurements of the shear stress required to detach 
objects or cells from a given surface in the microfluidic shear force device.[268-269] The 
studies focussed on the interaction of marine bacteria and of diatoms with potentially 
adhesion-resistant surfaces. While the recent studies clearly revealed the potential of the 
microfluidic assay to differentiate adhesion strength on different surfaces, the complexity 
of a microfluidic experiment becomes obvious when small effects cannot be distinguished 
due to the variations between experiments. To further optimise the microfluidic setup 
and more importantly to prove the applicability of the same for the use in the context of 
this work, calibration measurements were conducted. The work of Maria Alles 
demonstrated that the position of measurement inside the channel system, the 
concentration of adherent objects, the channel dimensions and the possibility of pressure 
fluctuations due to the pressure reducer were not responsible for the varying critical 
shear stresses τ50 measured for one object-surface type combination.
[269] She could show 
that with a different channel assembly as used in this work (13 mm x 0.9 mm x 140 µm, 
hereafter referred to as ‘13 mm channel’) the application of an aluminium spacer could 
increase the reproducibility in one channel while only marginally improving the 
reproducibility between different assemblies of a channel system.[269] 
In this work the effect of aluminium spacers (height 130 ± 5 µm) on the reproducibility of 
the channel dimensions after reassembly, on the stability of the channel dimensions 
during the experiments and on the inter- and intra-channel reproducibility after 
reassembly was studied. The effect of the maximum flow rate applied to the channel 
system during measurements was also analysed. Therefore, the     values derived from 
successive measurements in a single channel and the corresponding channel dimensions 
were obtained. The progression of these variables and the relation between the same 
was then correlated to the presence or absence of a spacer. Finally, the applicability of 
the microfluidic shear force device for cell-surface interaction studies was demonstrated. 
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As in the study of M. Alles, carboxy-terminated poly-
styrene microspheres with a mean size of 4.5 µm (later 
referred to as particles, Figure 36) were used. 40 µl of 
the particle stock solution were diluted in 1 mL PBS 
buffer (pH = 7.4) resulting in a concentration of 
approximately 20∙106 particles/mL. The particles were 
washed thrice in PBS buffer by centrifugation 
(13,000 rpm, 4 min). The prepared particle suspension 
was stored at RT until use and was always used the day 
of preparation. SAMs were chosen as control surface as 
they present a flat surface with reproducible defined 
properties. If not mentioned otherwise the sample 
surface used in this study was a HUDT SAM on which 
the particles were incubated for 5 min prior to detachment. 
3.8.6.1 INFLUENCE OF THE CHANNEL DIMENSIONS 
Table 4 gives the mean channel dimensions observed throughout the particle 
measurements. In contrast to the improvement in the channel height fluctuation during 
assembly with a spacer found by M. Alles, no pronounced differences between the 
channel dimensions with and without a spacer were observed for the 25 mm channels. If 
differences between the measurements with and without a spacer occurred it was not 
due to the channel dimensions after assembly. This was in accordance with the findings of 
M. Alles that showed a general independence of the τ50 value measured from the channel 
dimensions after reassembly.[269] 
Table 4: Mean values measured for the channel dimensions. The table gives the values for the channel 
height and width averaged over all measurements conducted in this section. 17 independently assembled 
channels without a spacer and 13 independently assembled channels with a spacer. 
 
Channel 
height 
[µm] 
SD 
[µm] 
Error 
[%] 
Channel 
width 
[µm] 
SD 
[µm] 
Error 
[%] 
Without spacer 136.5 3.8 2.8 1484.0 73.9 5.0 
With spacer 137.0 2.4 1.8 1477.2 60.3 4.1 
 
Figure 37 shows the correlation between the progression of the     value and the channel 
dimensions in a channel lacking a spacer. It clearly shows that while the     value initially 
decreased reaching a plateau at the third run, the channel dimensions did not noticeably 
change in the relaxed state (measured between experiments, but with the overpressure 
 
Figure 36: SEM image of the 4.5 µm 
carboxy terminated polystyrene 
microspheres used in this study. 
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applied). A similar but inverted approach to a plateau is shown in Figure S3 (Appendix 
section 7.1.3.1). This means that the channel dimensions were not only independent of 
the assembly but they were also not permanently changed by running measurements, 
even though the     value changed. This finding presents an expansion of the findings of 
M. Alles that demonstrated the independence of the dimensions after initial 
assembly.[269] 
 
Figure 37: Correlation between the     values measured in succession in one single channel without 
application of a spacer and the channel dimensions. The     value increased over the first three 
measurements before reaching a plateau. The channel dimensions were measured between the 
experimental runs, thereby only representing the dimensions if no flow is applied. The errors given for the 
channel dimensions are estimated measuring errors. 
3.8.6.2 EFFECT OF CHANNEL-REASSEMBLY AND APPLICATION OF SPACERS 
Figure 38 shows the mean detachment curves 
measured in four channel systems assembled in 
parallel. It is easily seen that not only did the 
mean curves greatly differ from each other but 
the fluctuation in one channel was also appar-
ent. It need not be mentioned that the     
values greatly differed (ranging from 
~ 16 dyn/cm² to 300 dyn/cm²). This figure 
demonstrates not only that was the fluctuation 
between the channels large without application 
of a spacer but so was the fluctuation in the 
measurements in one single assembled channel 
system. For this reason the fluctuations in one 
channel were analysed by repeatedly 
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Figure 38: Detachment curves measured in 4 
different channels assembled in parallel 
with a spacer. The data stems from one 
experimental setup with at least 3 repeats 
per channel. The error bars represent the SD. 
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assembling the channel and conducting measurement series in each assembly. This was 
then compared to the same channel repeatedly assembled with a spacer. The results are 
shown in Figure 39. The overviews over all detachment curves measured with and 
without a spacer give an impression of the fluctuations observed in the one channel 
(Figure 39 A). The graphs depicting the succession of the corresponding     values 
(Figure 39 B) indicate that the fluctuation of the initial     value measured with a spacer 
was larger than that without a spacer. As this is true for this set of measurements it shall 
be mentioned here that strong fluctuations were observed in other channels without a 
spacer. This is indicated in Figure 38, which shows that the     value of channel 2 by far 
exceeded the     values otherwise discussed in this section both with and without a 
spacer. The fact that the application of a spacer did not increase the reproducibility of the 
initially measured     value was in line with the findings of M. Alles who also could not 
observe any improvement of the inter-channel reproducibility when applying a spacer.[269] 
 
 
Figure 39: Comparison between the fluctuation in measurements in one repeatedly assembled channel 
with and without a spacer. The left graph shows all detachment curves measured and the right graph 
shows the progression of the     values in each experimental series. The overviews are shown for 
measurements without (A) and with (B) a spacer. 
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Next to the initially measured shear stress the 
reproducibility in each single assembly was a 
factor that needed to be considered. This 
tendency to of variation in one channel assembly 
was directly correlated to the percentage error of 
the measurement. This error should have been 
larger in a system prone to fluctuation of the 
measured values than in one which was not. 
Figure 40 shows the course of each measurement 
series. The     values were divided by the first 
value measured in the corresponding series, 
resulting in each series beginning at the same 
value. This allowed the direct comparison of the 
course of the different measurement series. Not only did the general trend appear 
broader in the channel lacking a spacer, but outliers concerning the inter-channel 
reproducibility were also only apparent if no spacer was present. 
This observation becomes even more apparent in Figure 41. The figure shows the mean 
    values plotted against the percentage error of the respective measurement series. 
The centre scatter plot is surrounded by box plots of the     values on the abscissa and 
the percentage errors on the ordinate. The box plots give the 1st (lower box margin), 2nd 
(middle line; median) and 3rd (upper box margin) quartile of the data and the whiskers 
represent the standard deviation of the data. A detailed explanation of box plots and 
what they show is given in the Appendix (section 7.1.2.3). To ensure ideal comparability 
only the first five     values of each of the experimental series (ensuring the same 
number of measurements in each series) shown in Figure 39 were used for the calculation 
of the mean     values and the percentage errors. This way lasting trends, such as a 
continuous reduction of the     values in one series, always had the same influence on 
the overall percentage error. The graph clearly shows that, while the     values tended to 
be slightly higher if a spacer was applied, the percentage error and its fluctuation 
(represented in the SD) were lower in the presence of a spacer. The overall mean per-
centage error of the     values without a spacer was 18.1 ± 12.0 % and with that the 
mean value was roughly twice as high and the SD approximately thrice as high as that 
measured for the channel with a spacer (10.9 ± 3.9 %). The complete set of     values and 
the corresponding SD and percentage errors are shown in Table S1 (Appendix 
section 7.1.3.2). These findings demonstrate that the application of a spacer helped im-
prove the reproducibility in one assembled channel, while having nearly no effect on the 
reproducibility between independently assembled channels. Again this correlated well 
 
Figure 40: Progression of the     value of 
each measurement series. 
0 2 4 6 8 10 12 14 16
 Without spacer
 With spacer
 5
0
 [
a.
u
.]
Measurement number
3 Materials and Methods 
 
54 
 
with the findings M. Alles, who also observed an improvement of the intra-channel 
reproducibility.[269] 
 
Figure 41: Correlation between the mean critical shear stress     and the percentage error of the 
measurement in dependency of the application of a spacer. The centre graph shows the direct comparison 
of the percentage error for each set of measurements and the corresponding     value for the detachment 
of particles with and without application of a spacer. The left and right box plots show the distribution of 
the percentage errors, while the top and bottom box plots show the distribution of the corresponding mean 
    values. The box plots give the 1
st
 (lower box margin), 2
nd
 (middle line; median) and 3
rd
 (upper box 
margin) quartile of the data and the whiskers represent the standard deviation of the data.  gives the     
values,  is the mean percentage error (left, right) or the mean     value (top, bottom). The whiskers 
represent the SD. The length of each experimental series was the same (n = 5). 
3.8.6.3 DEPENDENCY ON THE EXPERIMENTAL PARAMETERS AND ON THE 
CHANNEL SYSTEM USED 
The experimental parameters (the step duration    and the initial shear stress   ) and the 
channel setup used (13 mm channel or 25 mm channel) were another set of parameters 
studied towards their influence on the reproducibility of the measurements of the critical 
shear stress    . The step duration    represents the time span for which a given shear 
stress was applied and    is the step duration independent factor by which the shear 
stress was increased in each step. Equation (18), first introduced in section 3.8.3, 
demonstrates the calculation of the shear stress     applied to the system after a given 
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time    (=     ,   = 0,1,2,3…) in dependence of the channel dimension dependent initial 
shear stress   . 
       (  )
   (18) 
The influence of the experimental parameters is illuminated first. To determine this 
influence, combinations of two step durations (   = 0.5°s and    = 5°s) and two initial 
shear stresses (   = 0.01 dyn/cm² and    = 0.1 dyn/cm²) were tested in a successive series 
of measurements in a single channel. The overall increase of the shear stress was the 
same in all measurements (   = 1.047). These parameters were chosen as they 
corresponded to those used in this work for cell-surface interaction measurements 
(   = 0.5°s,    = 0.01 dyn/cm²) or to those used by M. Alles and M.P. Arpa Sancet from our 
workgroup for the detachment of marine organisms from various surfaces (   = 5°s, both 
   = 0.01 dyn/cm² and    = 0.1 dyn/cm²).
[268-269] The channel dimensions in the relaxed 
state (between two measurements, with the overpressure applied) were recorded 
between the measurements and compared to the     values obtained from analysing the 
detachment curves. From Figure 42 it can be seen that the     values and the channel 
dimensions were completely independent of both the step duration and the initial shear 
stress applied. Comparable results are also shown in Figure S4 (Appendix section 7.1.3.3) 
demonstrating the reproducibility of this finding. 
 
 
Figure 42: Effect of the experimental procedure on the     values. The step duration    and the initial 
shear stress    were varied. A spacer was used. The     values remained nearly constant throughout the 
measurement, as did the channel dimensions. The errors given for the channel dimensions are estimated 
measuring errors. 
 
0.01 0.1 1 10 100
0
20
40
60
80
100
0
10
20
130
135
140
0 1 2 3 4 5 6 7 8 9 10
1480
1490
N
(
)*
N
-1 ad
 [
%
] 
 [dyn/cm²]
 run1 [
i
 ~ 0.1dyn/cm²] 
 run2 [
i
 ~ 0.1dyn/cm²]
 run3 [
i
 ~ 0.01dyn/cm²]
 run4 [
i
 ~ 0.01dyn/cm²]
 run5 [
i
 ~ 0.01dyn/cm²]
 run6 [
i
 ~ 0.01dyn/cm²]
 run7 [
i
 ~ 0.1dyn/cm²]
 run8 [
i
 ~ 0.1dyn/cm²]
˜ 
 5
0
 [
d
yn
/c
m
²]
t = 0.5s
t = 5s
C
h
an
n
e
l
H
e
ig
h
t 
[µ
m
]
Measurement number
C
h
an
n
e
l
W
id
th
 [
µ
m
]
3 Materials and Methods 
 
56 
 
The influence of the setup size was 
investigated by comparing the results for the 
detachment of particles from HUDT SAMs ob-
tained by M. Alles in a 13 mm setup with 
those obtained in this study with a 25 mm 
setup. All detachment curves obtained this 
way are shown in Figure 43. All in all the 
detachment curves overlapped well, with a 
shift to higher shear stresses in the 25 mm 
setup. A more detailed view of the data is 
given in Figure 44. This graph shows the 
correlation between the mean     values and 
the corresponding percentage error in each of 
the two setups. In accordance to the 
detachment curves shown in Figure 43 the 
centre scatter plot and the box plots at the 
abscissa clearly show that the mean     
values measured fluctuated in both setups. As 
each mean     value was calculated from an 
individual experimental series (successive experiments in one fully assembled channel 
system), it can be seen as a measure for the reproducibility of the     values measured 
after the reassembly of the channel (for each channel size the same channel was 
repeatedly reassembly). The fluctuation of the     values, therefore, demonstrates the 
large fluctuation upon reassembly of the channel in both channel systems tested. The fact 
that the fluctuation appears to be bigger for the 25 mm setup may be ascribed to the 
larger number of experimental repeats. Bearing in mind that the dimensions of the two 
setups were so different and that both setups were prone to the just discussed strong 
fluctuations of the     values measured, it was remarkable to see such a good correlation 
between the data obtained. Still, a small statistical indifference between the sample 
cohorts was determined (Student´s t-test; p = 0.09 > 0.05), even though the SD of the two 
sample cohorts fully overlapped. While the distribution of the mean     values gives an 
impression on the reproducibility after reassembly, the mean percentage errors and their 
distribution represent the reproducibility in each experimental series and how this 
deviated between reassemblies. The distributions of the percentage error of the 
individual measurement series were similar, with the mean lying in the range of 5-10 % 
and a clear statistical indifference between the data sets (Student´s t-test; 
p = 0.36 > 0.05). This demonstrated that the reproducibility in each experimental series 
was roughly the same for all measurements independent of the channel system tested. 
 
Figure 43: Comparison between the detach-
ment curves obtained in a 13 mm channel by 
M. Alles and those obtained in a 25 mm chan-
nel. The results were all obtained in one 
channel of each setup that was repeatedly 
reassembled with a spacer. n = 15 in the 13 mm 
channel in 5 independent reassemblies. n = 93 
in the 25 mm channel in 11 independent 
reassemblies. 
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Overall, these findings demonstrate that the error of the measurement should be sought 
for elsewhere than in the channel dimensions. The fluctuation in each of the 
experimental series in both setups was comparable and the largest deviations were 
observed upon reassembly of the channels. 
 
Figure 44: Correlation between the mean critical shear stress     and the percentage error of the 
measurement in dependency of the channel setup used. A spacer was used for all measurements 
presented in this plot. The centre graph shows the direct comparison of the percentage error for each set of 
measurements and the corresponding     value for the detachment of particles from a HUDT SAM in either 
a 13 or 25 mm channel setup. The left and right box plots show the distribution of the percentage errors of 
the mean     values.  gives the     values,  is the mean percentage error (left, right) or the mean     
value (top, bottom). The whiskers represent the SD. The length of each experimental series was the same 
(n = 3). 
3.8.6.4 DEPENDENCY ON THE MAXIMUM SHEAR STRESS APPLIED 
As can be seen from the particle detachment data discussed so far, the     values 
measured were small in comparison to the maximum shear stress that could have been 
applied with the 25 mm channel setup (~ 1,000 dyn/cm², see section 3.8.3). Therefore, an 
analysis of the effect of applying different maximum shear stresses during the 
experimental procedure was undergone (experiment aborted at ~ 200 dyn/cm² or at 
~ 1,000 dyn/cm²). The measurement procedure is shown in Figure 45. Ten measurements 
were conducted in succession in each channel assembly. The first six measurements were 
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aborted at approximately 200 dyn/cm², while the last four were ramped up to 
1,000 dyn/cm². Of these ten data points the first four were compared to the last four to 
ensure ideal comparability between the data sets. 
 
Figure 45: Measurement procedure for the analysis of the effect of the maximal applied shear stress on 
the     values. Ten measurements were conducted in succession in one single channel assembly. Of these 
measurements the first 6 were aborted when the shear stress at the channel floor reached approximately 
200 dyn/cm². The last 4 measurements were aborted only at approximately 1,000 dyn/cm². Of the obtained 
    values the first 4 were combined as ‘data set 1’ (experiment aborted at 200 dyn/cm²) and the last 4 as 
‘data set 2’ (experiment aborted at 1,000 dyn/cm²). This was done to ensure ideal comparability between 
the two data sets. 
The effect of the different maximum shear stresses applied was analysed for channels 
with and lacking a spacer. As shown in Figure 46 the percentage error was larger for 
channels lacking a spacer than it was for those with a spacer if the experiment was 
aborted when a shear stress of approximately 200 dyn/cm² was reached. This undergirds 
the findings discussed in section 3.8.6.2 as nearly the same trend was observed. The final 
measurements (application approximately 1,000 dyn/cm²) of each series exhibited a 
surprisingly low percentage error. It was not only comparable for channel with and 
without a spacer, but it was also lower than that observed during the first measurements. 
A possible explanation for this behaviour could be that the channels somehow adjusted 
themselves during the measurements enabling lower deviations after a sufficient amount 
of experimental runs. Interestingly, the channel dimensions in the relaxed state, meaning 
the state of the channel between experiments when the over-pressure was applied but 
no suction was created by the syringe pump, did not change throughout the 
measurement. As shown in the Appendix section 7.1.3.4 this was regardless of whether a 
spacer was applied or not. 
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Data set 1 Data set 2
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Figure 46: Correlation between the mean critical shear stress     and the percentage error of the 
measurement in dependency of the maximal shear stress applied. The mean values and errors for 
measurements with maximal 200 dyn/cm² applied are the mean of the first 6 values of the series, while a 
maximal application of 1,000 dyn/cm² is given by the following 4 values. The centre graphs shows the direct 
comparison of the percentage error for each set of measurements and the corresponding     value for the 
detachment of particles with either a maximum shear stress of 200 dyn/cm² or of 1,000 dyn/cm² applied. 
Each is shown with and without the application of a spacer. The box plots of the percentage errors shown 
on the outside better demonstrate the differences in the mean percentage error and the distribution of the 
same.  gives the     values,  is mean percentage error and the whiskers represent the SD. 
3.8.6.5 SYSTEM APPLICABILITY FOR THE CHARACTERISATION OF CELL-SURFACE 
INTERACTIONS AT LOW SHEAR STRESSES 
For this entire work the information whether the microfluidic shear force setup was 
capable of measuring with sufficient accuracy and reproducibility at low shear stresses to 
analyse the interaction between cells and surfaces under shear flow was of great 
importance. To gain an impression of the dependency of the behaviour of the     values 
and the percentage errors on the region of shear stress in which they were measured 
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strongly adherent surfaces were compared to the moderately adherent HUDT SAMs 
discussed in this work so far. The highly attractive DDT SAM presents a surface type on 
which high shear stresses are required to detach the particles. Figure 47 shows a 
comparison between the distribution of the     values and the percentage error obtained 
from measurements on HUDT and DDT SAMs. In both cases no spacer was applied to 
maximise the effect and to make a comparison to the cell-surface interaction experiments 
possible, as these too were conducted without spacers. From the centre scatter plot, but 
more clearly from the abscissa box plots, it can be seen that the two sets of mean     
values were clearly distinguishable from each other. This demonstrates that, although the 
measurements were prone to a certain fluctuation between measurements, the setup 
was obviously capable of differentiating between varying surface types. 
 
Figure 47: Correlation between the mean critical shear stress     and the percentage error of the 
measurement on two different SAMs (HUDT and DDT). The centre graph shows the direct comparison of 
the percentage error for each set of measurements and the corresponding     value for the detachment of 
particles from DDT or HUDT SAMs. The left and right box plots show the distribution of the values for the 
detachment from HUDT and DDT respectively.  gives the     values,  is the mean percentage error (left, 
right) or the mean     value (top, bottom). The whiskers represent the SD. The length of each experimental 
series was the same (n = 3). 
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The ordinate box plots, in turn, demonstrate that the percentage errors were not only far 
greater in measurements conducted on highly attractive DDT SAMs, but they were also 
far more diverse than on HUDT SAMs. In fact the percentage error obtained on DDT SAMs 
of (42.1 ± 24.39 dyn/cm² was nearly four times as large as that measured on HUDT SAMs, 
which was (11.9 ± 8.4) dyn/cm². Furthermore, the SD of the percentage error on DDT 
SAMs, which was thrice more than that measured on HUDT SAMs, again demonstrated 
the high fluctuation of the measurements. The complete data set is shown in Table S2 
(Appendix section 7.1.3.5). Concerning the dependency on shear stress applied to the 
system it can be said that the mean percentage error observed throughout the 
measurements was nearly quartered moving from     values in the range of 
(100-1,000) dyn/cm² for DDT SAMs to values in the range of (10-100) dyn/cm² for HUDT 
SAMs. This shows that even without the application of a spacer the fluctuations within 
the measurements decreased with the shear stress applied to the system. The 
measurement of the interaction of cells and surfaces, such as they were studied in the 
context of this work, took place at shear stresses, which were another one to two orders 
of magnitude lower. It can, therefore, be assumed that the percentage error was 
quartered at least once more under the assumption of a nearly linear correlation. This 
good reproducibility was in fact observed. Figure 48 A shows the mean interaction curves 
with hyaluronic acid measured in this work for a model cell line (KG-1a). While the reason 
for this interaction as well as the cells and surfaces involved are beyond the scope of this 
section (theory in section 2.3-2.4, experimental results in section 4.1), the graph clearly 
shows a high reproducibility of the measurement. It shows that averaging of all 
measurements for this example model cell line that were conducted throughout this work 
yielded reproducible results. In fact the height variations observed in Figure 48 A were 
most probably related to deviations in the cell conditions (cell density during culture, cell 
culture passage) or to varying numbers of initially visible cells (the fraction of interacting 
cells was normalised to this value), rather than to imprecise measurements. Figure 48 B 
shows the first two as well as the 11th measurement of a series of measurements that 
were conducted with the model cell line in succession in one assembled channel system. 
The other measurements conducted are not of interest here as treatments of the cells 
modified their behaviour. The comparison shows how well the interaction of the cell line 
with the surface was reproducible in this channel assembly even after as many as ten 
measurements. Therefore Figure 48 in total demonstrates the high reproducibility not 
only between different channels but also after many repeated measurements in one 
channel. This not only supports the notion that fluctuation of the experimental deviation 
decreased with the shear stress applied, but also nicely demonstrates the applicability of 
this setup for the analysis of cell-surface interactions as they are presented in this work. 
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Figure 48: Reproducibility of cell-surface interaction experiments. A) Average of all measurements of the 
interaction of KG-1a cells with HA under shear stress conducted for this entire study (n = 9). B) Example of 
the reproducibility in one experimental setup. After the first two measurements other cell-surface 
interaction experiments were conducted. The 11
th
 run was untreated KG-1a cells again. The interaction 
curve measured was nearly the same as that initially measured. 
3.8.6.6 DISCUSSION 
In this section the effect of different experimental parameters on the intra- and inter-
channel reproducibility was analysed. Table 5 gives an overview over the parameters 
studied in this section and their effect on the reproducibility of the microfluidic shear 
force measurements. As the shear stress applied to the channel system was calculated 
from the liquid flow and the channel dimensions (discussed in section 3.8.3 resulting in 
Equation (19)) it is obvious that a change of the channel dimensions during the 
measurement would have affected the critical shear stress     measured. It could be 
shown that in experiments conducted successively in a single channel assembly the 
channel dimensions in the relaxed state (between experimental runs, but with the 
overpressure applied to the channel) did not change even if a deviation of the     values 
was observed. This was an expansion of the findings of M. Alles that showed that the 
channel height upon assembly was not related to fluctuations between different channel 
assemblies.[269] 
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Table 5: List of parameters studied concerning the optimisation of the microfluidic shear force system.  
indicates an effect of the listed parameter on the improvement of the mean τ50 value measured or on a 
reduction of the τ50 scattering in one experimental setup.  indicates no improvement of the measurement. 
Parameter 
studied 
Effect on 
reproducibility of 
mean τ50  
(Intra-channel 
reproducibility) 
Effect on τ50 
scattering during 
measurement 
(Inter-channel 
reproducibility) 
Conclusion  
Channel 
dimensions vs. 
τ50 progression 
  
Fluctuation of     values was 
independent of channel 
dimensions 
Introduction of 
spacer 
  
Stability of measurement in each 
assembly was increased, but each 
channel differed more 
Comparison of 
sampling 
procedure 
  
Measurement precision and result 
was independent of sampling 
procedure 
Type of channel 
system used 
  
Measurement precision and result 
was independent of channel 
system used 
Maximum shear 
stress applied 
  
Measurement precision and result 
was independent of maximal shear 
stress applied 
Dependency of 
adhesion 
strength 
  
Reproducibility was dependent on 
the range of interest in the shear 
stress spectrum 
 
M. Alles could show that the application of a 130 µm high aluminium spacer to the 13 mm 
channel setup could increase both the reproducibility of the channel height after 
reassembly and the intra-channel reproducibility of the     values. Here, in the 25 mm 
channel setup it could be shown that the usage of spacers had no noticeable effect on the 
channel dimensions after reassembly. This may be related to the by far larger area of the 
outer PDMS ring of the 25 mm channels compared to that of the 13 mm channels. This 
larger area was then less easily compressed and a reproducibility of the channel 
dimensions was internally given. In contrast to this differing observation, the observation 
that the application of a spacer increased the intra-channel reproducibility could be 
confirmed for the 25 mm channel setup. 
3 Materials and Methods 
 
64 
 
Furthermore, it could be demonstrated that the quality of the measurement was 
independent of either the sampling protocol or even the channel setup itself. To 
determine the effect of the sampling protocol, the protocol was varied in successive 
measurements in a single channel assembly. It could be shown, that neither the step 
duration nor the beginning of the shear stress ramp resulted in a change of the     values 
measured. For comparison of the influence of the channel setup, data acquired by 
M. Alles in the 13 mm channel setup was compared to that measured in this work with 
the 25 mm setup. Here, no differences were apparent between the different channel 
setups. It should be noted that the high comparability between the two setups, the 
dimensions of which were so different, may indicate that the origin of the error lay 
elsewhere than in the channel 
itself. A hint to this was an 
experiment in which the in- 
and outlet tubings were 
incorrectly aligned to the holes 
in the glass lid of the channel 
(Figure 49). Here the     values 
greatly increased with each 
successive measurement. Such an error may be averted if the channel assembly were 
modified in such a manner that the tubings can no longer be misaligned to the holes in 
the glass lid. This could for example be achieved by countersinking the tubings into the 
holes of the glass and, thereby, ideally aligning them to these. 
Another factor that needs to be taken into account when conducting microfluidic shear 
force measurements is the range of shear stress at which the observation of interest 
occurs. Here, this observation was the detachment of the particles from the surface, but 
as discussed later the interaction of cells with surfaces was the major focus of interest of 
this work. To determine the influence of the range of shear stress applied, first the effect 
of the maximum shear stress applied during measurements was evaluated. It could be 
shown that the maximum shear stress applied to the channel system during 
measurement did not affect the     values measured independently of the application of 
a spacer. In fact, it seemed that high shear forces (approximately 1,000 dyn/cm²) could 
positively affect the fluctuations of the     values. This may, however, have been due to 
the protocol of the measurements. This should originally ensure the comparability of the 
data as both different maximum shear stresses tested were applied in the same channel 
system, thereby eliminating the fluctuations due to reassembly of the channel setup. It is, 
possible though that this repeated measurement in one channel may have made an 
equilibration of the channel possible that could have been responsible for the 
 
Figure 49: Progression of the     values in a misaligned channel. 
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compensation of the channel fluctuations. This should in further studies be addressed by 
comparing the percentage error of freshly assembled channels that were either ramped 
to 1,000 dyn/cm² or to only 200 dyn/cm². Furthermore, a comparison was made between 
the weakly attractive HUDT SAM and the highly attractive DDT SAM. It could be shown 
that the fluctuation of the percentage error was by far smaller for the detachment of the 
particles from the HUDT SAMs. This finding was further undergirded by averaging of all 
interaction curves of one of the model cell lines used in this study. Here, it could be 
shown that the interaction with the surface was highly reproducible. From these two 
observations it could be concluded that both the intra- and inter-channel fluctuations 
were reduced with decreasing the range of shear stress in which the observation of 
interest occurred. It is important to mention that although the fluctuations were present 
for the detachment of the particles from both the HUDT and the DDT SAMs, the two 
different chemistries were still clearly distinguishable from each other. This demonstrates 
that the microfluidic shear force setup was indeed applicable for the comparison of the 
shear stress required to detach objects from different surface chemistries. 
In conclusion, it could be shown that although shifts in the     values measured were not 
correlated to permanent changes of the channel dimensions the application of a spacer 
could improve the intra-channel reproducibility. It could also be shown that the 
measurement precision increased with decreasing shear stresses applied. Especially this 
last finding was highly relevant for this work as it clearly demonstrated the applicability of 
this setup for the analysis of cell-surface interactions at very low shear force conditions. 
3.9 ROLLING VELOCITY ANALYSIS USING QUANTUMCAT 
When analysing the rolling interaction of cells with a surface the velocity with which the 
cells roll was an interesting factor. Furthermore, the effect treatments with e.g. 
antibodies, which block the receptor responsible for rolling, had on the rolling velocity 
was also of great interest. To analyse this in detail the MatLab® (MathWorks, Natick, 
Massachusetts, USA) based analysis tool quantumCAT (quantitative analysis of two-
dimensional undirected motion by computer assisted tracking) was developed by Stojan 
Maleschlijski in our workgroup implementing a tracking core algorithm by Prof. Bodo 
Rosenhahn (Leibniz-University of Hannover, Hannover, Germany).  
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3.9.1 MEASUREMENT PROCEDURE OF QUANTUMCAT 
Videos of cells rolling on HA-coated surfaces were obtained using the microfluidic shear 
force device described in section 3.8. The cells were injected into the channel system and 
a flow rate of approximately 1 dyn/cm² was applied. The duration of the videos acquired 
was dependent only on the time for which the cells interacted with the surface. A frame 
rate of 5 fps was set for video acquisition in the imaging software NIS Elements AR 3.0 
(Nikon, Tokyo, Japan). NIS Elements AR 3.0 provided the exact time spans between each 
frame as this was mostly not perfectly constant. These exact time spans were extracted 
from the video file for later use in the calculation of the rolling velocities. For analysis the 
videos were split up into the single frames. The distance between the cell positions was 
calculated between each of those frames and together with the time between the frames 
the rolling velocities were later calculated. The cohort of rolling velocities acquired was 
later used for the comparison between the rolling behaviour of cells. 
A screenshot of the user interface of quantumCAT is shown in Figure 50. The main part of 
the screen is the video which was binarised by thresholding prior to investigation. The 
binarisation procedure was controlled by the parameter ‘Threshold max’ denoting the 
grey value used as threshold in relation to the maximum grey value available in the 
frame. Thus all values above the threshold (ideally only the objects of interest) were 
assigned the value 255 (white) and all values lower than the threshold a value of 0 
(black).The image shows a set of traces (blue lines) and the scan window of each trace 
(red box at the end of a trace). The scan window defined the area in which the tracking 
algorithm searched for the object. The size of the scan window (in pixels), the number of 
windows scanned in each direction and the direction of search could be altered in the top 
right ‘Settings’ and in the centred ‘Direction’ input field. Examples for the resulting 
scanning pattern are shown in Figure 51. As the direction of rolling of cells was dictated 
by the direction of liquid flow the setting shown in Figure 51 B was used in this work. 
Scanning in other directions as that of the flow would have been a waste of resources. 
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Figure 50: Image of quantumCAT with the most relevant functions marked. The picture shows a view of 
quantumCAT with a video loaded. The blue lines represent the traces recorded. At the end of each line is a 
red window, the scanning window. As indicated on the right, the size of the scanning window can be 
adjusted to the type of cells measured. This is also true for the number of steps measured, the direction of 
measurement and the size of the cells tracked. 
The minimal area of the cells (number of pixels) 
could be defined in the ’Thresholds’ input field. 
This allowed the elimination of objects with 
lower areas as potential errors. QuantumCAT 
also allowed the choice of different tracking 
modes. The standard mode was a fully auto-
matic mode in which tracking continued until 
the cell left the field of view. For cases in which 
cells crossed their path in the scan window and 
the software could not perform an unambiguous 
differentiation a semi-automatic mode was 
available. Here, the user must manually place 
the centroid position on the cell in a magnified 
scan window in the bottom right of the screen. 
For each tracked cell, the software created a 
‘.txt’ file, where the positions of the cell in each 
frame of the observation period were recorded, 
thus representing the trajectories of the rolling movement. From the traces (the 
coordinates) and the time spans between each frame the rolling velocities, but 
theoretically also e.g. the direction or the acceleration, could be deducted. 
 
Figure 51: Examples of the orientation of the 
scan window. The black rectangle is the 
origin in which the cell was located in the last 
frame. A) Scanning of 1 scan window in all 8 
directions. B) Scanning for 3 scan windows 
only in the x direction. The setting shown in B 
was used for the analysis of the rolling 
velocity of cells in this work. 
x
yA)
B)
x
y
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3.9.2 ANALYSIS OF QUANTUMCAT DATA 
From the distance between the coordinates of a cell centroid in two frames and the time 
span between these two frames a single momentary rolling velocity was calculated as 
shown in Equation (26). The velocity    between the frame   and the following frame 
  + 1was calculated by dividing the distance   between the two points by the time 
  (   )   elapsed between the frames. The distance, in turn, was calculated from the  , -
coordinates of the respective point. As the data was acquired in pixels a conversion factor 
      must be applied to convert the pixels to a metric distance. For the 4x PhL objective 
used for the acquisition of the videos this was       = 1.58 µm/pixel. 
   
 
 (   )  
      
√(       )  (       ) 
       
 (26) 
This led to a velocity for each cell tracked for each pair of frames. Rolling was defined as 
an interaction with the surface, which was slower than the movement of the non-
interacting cells. A threshold of maximal 100 µm/s was set beyond which the velocity was 
defined as too fast for rolling and ignored as a ‘jump’ in the later analysis. 
The velocities in their entirety were used for comparison of the effects of different cell 
treatments on the rolling velocity. The simplest approach to do so would have been to 
compare the mean values and the SD of the measurements. This would have given an 
oversimplified view of the data with very large SD indicating an imprecise measurement. 
The SD, however, was due to the natural inhomogeneities of the interaction between 
cells and a surface (CD44 expressing cells and HA-coated surfaces in the specific case of 
this study) and should not be confused with an inaccurate measurement. The large 
amount of data points (typically at least 250 for very weakly interacting cells up to 25,000 
for readily interacting cells) collected for a given treatment allowed the reliable creation 
of distribution plots such as histograms or box plots. A detailed elaboration of the values 
found in such a box plot is given in the appendix (section 7.1.2.3). 
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4 CD44: HOW STEM CELLS ROLL 
 
Figure 52: Scheme depicting the aims of this chapter. In this chapter the CD44 mediated interaction of cells 
with HA and other cells is addressed. In this context suspension and epithelial cell lines are utilised to gain a 
detailed understanding of this interaction. This knowledge is then applied in the comparison of the 
interaction of healthy HPC and leukaemic blasts with surfaces artificially coated with HA. The next step is 
the establishment of an experimental procedure to study cell-cell interaction under flow. Finally, the effect 
of the cytokine SDF-1α and its antagonist Plerixafor® on migration and the interaction with HA under flow is 
investigated. 
As presented in chapter 1 the first aim of this work was to characterise the CD44 
mediated interaction of healthy and leukaemic cells with HA in order to reveal differences 
between these cells types. Ideally, these can later be exploited for the targeted 
mobilisation of leukaemic stem cells (LSC) from the niche, thereby, making them more 
susceptible to chemotherapy. In the first section of this chapter the characterisation of 
the interaction of CD44 positive cell lines with hyaluronic acid (HA) is presented. For this a 
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comparison was made between the interaction of a leukaemic suspension model cell line 
(KG-1a) and an epithelial liver carcinoma model cell line (HepG2Iso) with HA-coated 
surfaces under flow. In this system the dependence of the interaction with HA on CD44 
was verified and it was studied whether these fundamentally different cell types 
exhibited different interact patterns with HA. In the following section some light is shed 
on the interaction of both healthy haematopoietic progenitor cells (HPC) and leukaemic 
blasts with HA, demonstrating the pronounced differences between healthy and 
leukaemic cells. Furthermore, the establishment of a method to study cell-cell 
interactions under flow is presented. In this context the interaction of both healthy and 
leukaemic cells with mesenchymal stromal cells (MSC) was investigated. Finally, the effect 
of the cytokine SDF-1α and its antagonist Plerixafor® on migration of HPC and on their 
interaction with HA under flow is discussed. 
4.1 ANALYSIS OF THE INTERACTION OF CD44 WITH 
HYALURONIC ACID 
 
Figure 53: Overview over the aims of this section. The flow-induced interaction of CD44 with HA shall be 
studied by analysis of the binding motive, the requirement of CD44 or its isoforms and the rolling velocity.  
Before the valuable and rare primary material could be studied, a detailed understanding 
of the underlying interaction motive was necessary. As mentioned above this was the 
flow-induced interaction between the cell surface receptor CD44 and the 
glycosaminoglycan HA. An overview over the findings that are presented in this section is 
given in Figure 53. Next to a comparison between two fundamentally different cell types, 
suspension cells and epithelial cells, the specificity of this interaction was verified. For this 
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a comparison was made between the interaction of the two model cell lines KG-1a and 
HepG2Iso (Figure 54) with different GAGs and between biologically similar CD44 negative 
cells with HA. Furthermore, the expression of CD44 in general (CD44pan) or different 
CD44variant isoforms was down-regulated to determine the relevance again of CD44 
generally and of the two isoforms. The possibility of blocking the flow-induced interaction 
with HA by a monoclonal antibody and short chain length HA fragments (sHA) was also 
analysed. In this context the rolling velocity of cells was studied using the analysis 
software quantumCAT. All experiments with liver carcinoma cell lines were conducted in 
cooperation with Katharina Fuchs from the workgroup of Dr. Véronique Orian-Rousseau 
(ITG, KIT, Karlsruhe, Germany). 
 
Figure 54: SEM images of the leukaemic suspension cell line KG-1a and the epithelial liver cancer cell line 
HepG2Iso. 
4.1.1 ANALYSIS OF THE BINDING PARTNER NECESSARY FOR ROLLING 
To validate that the rolling interaction with the surface was specific for HA both model 
cell lines were tested on HA- and chondroitin sulphate (CS)-coated surfaces. The chemical 
structure of HA and CS is shown in Figure 55. The only difference between the two 
molecules is the sulphated hydroxyl-group of CS, the location of which is dependent on 
the tissue it originates from and the conditions of synthesis.[270] The hypothesis was that if 
the interaction was specific for either of the two this would point towards a high binding 
partner specificity, due to the only marginal chemical differences exhibited by the 
molecules. 
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Figure 55: Chemical structures of HA (A) and CS (B). HA is composed of N-acetyl-D-glucosamine and D-
glucuronate, connected by β-1,4 and β-1,3 linkages and CS consists of N-acetyl-D-galactosamine and 
glucuronic acid that are in turn connected by β-1,3 and β-1,4 linkages. 
 
Figure 56: Comparison of the interaction between two different chemically similar GAGs. Both the KG-1a 
(A) and the HepG2Iso cells (B) showed a pronounced flow-induced interaction with HA while hardly any 
interaction with the CS-coated surface was observable (n = 4; ≥ 130 cells/FOV). For the HepG2Iso cells the 
fraction of interacting cells ranged from 72-92 % for the cells interacting with HA and from 4-22 % for the 
cells interacting with CS. 
As shown in Figure 56 the flow-induced interaction could be observed on HA for both 
model cell lines, while nearly no interaction was observable with CS. The supplementary 
Video S1 (description found in the Appendix section 7.1.2.1, video provided on the 
supplementary CD) shows an exemplary HepG2Iso cell rolling on HA. The flow-induced 
interaction showed the same characteristics as previously described by 
Christophis et al.[10] At very low flow speeds hardly any cells interacted with HA. Beyond a 
threshold shear stress level the fraction of cells interacting with the surface increased. 
The fraction of interacting cells reached its maximum at approximately (0.7-1) dyn/cm². 
The threshold of interaction was more pronounced for the epithelial cell line HepG2Iso, 
which was surely due to the adherent nature of the cells as well as the flow pulse at the 
beginning of the experiment. The system required a certain time to slow down from the 
pulse, resulting in the actual flow speed being faster than that set in the program of the 
syringe pump. This led to the epithelial cells seeming to interact at flow rates at which the 
suspension cells showed no interaction. This phenomenon could not be avoided as the 
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initial pulse was necessary to avoid crowding of the sample surface due to the 
omnipresent adherent nature of the cells. 
4.1.2 NECESSITY OF CD44 FOR FLOW-INDUCED INTERACTION 
After proving the necessity of the binding partner HA it was important to demonstrate 
that the interaction was solely mediated by CD44. One of the tests used to prove this fact 
was to analyse the interaction of different cell lines expressing and lacking CD44 with HA. 
As suspension cells the model cell line KG-1a (CD44+) was compared to the cell line Jurkat 
(CD44-). For the epithelial cells the model cell line HepG2Iso (CD44+) was compared to the 
related cell line HepG2 (CD44-). As shown in Figure 57 only the CD44 positive cell lines 
KG-1a and HepG2Iso showed the flow-induced interaction with HA. Thus, it could be 
concluded that, at least for these cell lines, CD44 was the only receptor mediating the 
flow-induced interaction with HA. 
 
Figure 57: CD44 required for rolling. A) Comparison of the interaction of two suspension cell lines with HA. 
The CD44 positive cell lines (KG-1a, HepG2Iso; black line) showed a flow-induced interaction with HA, while 
the CD44 negative cell lines (Jurkat, HepG2; red line) did not (n = 4; ≥ 150 cells/FOV). For the HepG2Iso cells 
the fraction of interacting cells ranged from 71-79 % for the untreated HepG2Iso cells and from 4-9 % for 
the HepG2 cells. 
In order to prove that the interaction with HA was mediated by the HA binding domain of 
CD44 an antibody specific for this binding domain was applied. The monoclonal CD44 
antibody (clone BU52, hereafter referred to as BU52) was chosen. Figure 58 shows the 
FACS data for the incubation of KG-1a cells with 9 µg/mL BU52 for 30 min. Figure 58 A 
and D show the cell selection gate for the untreated control (A) and the cells treated with 
BU52 (D). The propydiumiodide (Pi) vs. FSC gate in B and E was used to gate out all dead 
cells for later analysis. From this gate it can also be seen that the treatment with the 
antibody did not harm the cells, as their cellular integrity remained intact. The 
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fluorescence channel in Figure 58 C and F shows that no cells were marked in the 
autofluorescence control (C), while all cells were marked by the antibody. 
 
Figure 58: FACS analysis of the binding efficiency of BU52 to KG-1a. The auto fluorescence (A-C) is 
compared to the cells incubated with FITC-marked BU52 (D-F). The graphs show: SSC vs. FSC with the gate 
selecting only the healthy cells marked by the black line (R1; A, D); Pi vs. FSC to evaluate the amount of 
dead cells in the sample (R2; B, E) and the fluorescence channel for the FITC marked antibody BU52 vs. FSC 
(C, F). It is clearly shown that while nearly all cells were unaffected by the BU52 treatment, all were marked 
by the antibody. 
As shown in Figure 59 A the flow-induced interaction of KG-1a with HA could be inhibited 
in a concentration dependent manner by BU52. While an incubation with 1 µg/mL BU52 
already caused a significant reduction (p < 0.05; Figure 59 B) in the fraction of interacting 
cells (from  ( )   ⁄  ≈ 60 % of the initially visible cells to ~ 35 %), a nearly complete 
suppression of the flow-induced interaction required the application of ≥ 9 µg/mL BU52. 
In all subsequent experiments, 9 µg/mL BU52 was used to block the CD44 mediated 
interaction with HA. This concentration of BU52 could for example suppress the 
interaction of the model cell line HepG2Iso (Figure 60) with HA. The concentration 
dependency with a complete suppression at 9 µg/mL BU52 of the interaction was also 
undergirded by BU52 concentration dependent measurements of the accumulation of 
KG-1a on HA as shown in Figure S7 (Appendix section 7.2.2). 
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Figure 59: Dependency of the interaction of KG-1a cells with HA on the concentration of BU52. Interaction 
curves (A) and the corresponding maximum peak heights (B) measured for the reference cell line KG-1a 
(n ≥ 4 for each treatment with > 300 cells/FOV). Treatment with increasing concentrations of BU52 led to a 
decrease in the fraction of cells interacting with HA. Full suppression of all interactions was achieved with 
9 µg/mL BU52, while the same concentration of the isotype control IgG1 hardly reduced the interaction. 
* indicates a significance of p < 0.05, ** indicates a significance of p < 0.01 in a two-sided Student´s t-test. 
All error bars shown in this figure represent the SD.
[266]
 
 
 
Figure 60: Suppression of the interaction of HepG2Iso with HA by BU52. Exemplary interaction curves (A) 
and the overall maximum peak heights (B) measured for the reference cell line HepG2Iso (untreated: n = 9; 
with BU52: n = 7; with IgG1: n = 4; each treatment with > 200 cells/FOV). Full suppression of all interactions 
was achieved with 9 µg/mL BU52, while the same concentration of the isotype control IgG1 hardly had any 
effect. ** indicates a significance of p < 0.01 in a two-sided Student´s t-test. The error bars represent the 
SD. The fraction of interacting cells in the interaction curve shown ranged from 56-72 % for the untreated 
HepG2Iso cells, from 47-51 % for the HepG2 cells incubated with the IgG1 control antibody and from 1-3 % 
for the HepG2 cells incubated with BU52.  
KG-
1a
+ 9 µ
g/m
l IgG
1
+ 1 µ
g/m
l BU
52
+ 3 µ
g/m
l BU
52
+ 9 µ
g/m
l BU
52
0
10
20
30
40
50
60
70
80
N
m
ax
*N
-1 0
 [
%
]
 
0.01 0.1 1 10 100
0
10
20
30
40
50
90
100
 + 9 µg/ml BU52
 + 9 µg/ml IgG1
 Untreated KG-1a
 + 1 µg/ml BU52
 + 3 µg/ml BU52
N
(
)*
N
-1 0
 [
%
] 
 [dyn/cm²]
A)
**
*
B)
0.01 0.1 1 10 100
 Untreated HepG2Iso
 + 9 µg/ml BU52
 + 9 µg/ml IgG1
N
ko
rr
(
) 
[a
.u
.]
 
 [dyn/cm²] untreate
d HepG
2Iso
9 µg/m
l IgG
9 µg/m
l BU52
N
m
ax
*N
-1 M
C
M
 [
a.
u
.]
 
 
 
A)
**
**
B)
4 CD44: How Stem Cells Roll 
 
76 
 
Another possibility to determine the necessity of the receptor CD44 for the interaction 
was the knock down of the same by means of siRNA (CD44pan siRNA knocked down all 
CD44variant isoforms as well as the standard form). This methodology also rendered it 
possible to knock down specific CD44variant isoforms on the cells. The relevance of these 
isoforms for the interaction with HA could then also be tested. In this study the two 
isoforms CD44v3 and CD44v6 were knocked down. These isoforms were chosen as a high 
expression of the CD44v3 isoform is correlated with tumour growth and metastasis[271] 
and CD44v6 is a co-receptor for the activation of the receptor tyrosine kinase (RTK) Met 
and their collaboration is reported to be important in tumour progression and 
metastasis.[272] Figure 61 shows the Western Blots acquired by Katharina Fuchs from 
workgroup of Dr. Véronique Orian-Rousseau (ITG, KIT, Karlsruhe, Germany) after the 
treatment of HepG2Iso cells with control siRNA and the either CD44pan, CD44v3 or 
CD44v6 siRNA. The Western Blots reveal a clear repression of the respective receptor 
expression in all cases. 
The results of the microfluidic shear force analysis, shown in Figure 62, reveal that 
treatment of HepG2Iso cells with CD44pan siRNA led to a nearly complete reduction of 
the interaction with HA. This was not the case for the two CD44variant isoforms. In both 
cases no reduction of the fraction of interacting cells was observed compared to the 
siRNA control. This demonstrated that the flow induced interaction with HA was not 
solely mediated or significantly influenced by either of the two isoforms alone, but that 
suppression was only achieved by full knock-down of the CD44 receptor (CD44pan). 
 
 
Figure 61: Western Blot analysis of the siRNA treatment of HepG2Iso cells. The membrane was probed 
with an anti-CD44 antibody that recognises all isoforms (CD44pan) or one of the two CD44variant isoforms. 
An extracellular signal-regulated kinase (Erk)-antibody was used as a loading control. The numbers between 
the panels indicate the fold induction of the respective treatment. 
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Figure 62: Knock down of different CD44 isoforms on HepG2Is. The top graphs show the detachment 
curves of HepG2Iso cells transfected with control siRNA and CD44pan (A), CD44v3 (B) and CD44v6 siRNA (C) 
(n ≥ 4 for each treatment with > 250 cells/FOV). The fraction of interacting cells ranged as followed: A) From 
54-76 % for the HepG2Iso cells treated with control siRNA and from 2-20 % for the HepG2 cells treated with 
the CD44pan siRNA; B) From 21-87 % for the HepG2Iso cells treated with control siRNA and from 34-82 % 
for the HepG2 cells treated with the CD44v3 siRNA; C) From 57-74 % for the HepG2Iso cells treated with 
control siRNA and from 52-90 % for the HepG2 cells treated with the CD44v6 siRNA. The bottom bar graphs 
give the maximum peak heights with significant differences marked. ** indicates a significance of p < 0.01 in 
a two-sided Student´s t-test. All error bars shown represent the SD. 
4.1.3 ROLLING SUPPRESSION BY SOLUBLE GLYCOSAMINOGLYCANS 
As the rolling interaction occurred between CD44 and the surface bound HA the question 
arose if it could be suppressed by soluble macromolecular glycosaminoglycans (GAGs) or 
by the corresponding polysaccharide fragments. To test for this HepG2Iso cells were 
preincubated with 50 µg/ml of four different GAGs. The macromolecular GAGs used were 
HA, CS, heparin sulphate (HS) and keratane sulphate (KS). Figure 63 shows the results 
obtained from the microfluidic shear force experiments obtained with the preincubated 
cells. While a small but not significant reduction of interaction was observed for most 
macromolecular GAGs, only the incubation with HA led to a significant decrease of cells 
interacting with the HA-surface. 
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Figure 63: Effect of macromolecular GAGs on the flow-induced rolling interaction of HepG2Iso with HA. 
HepG2Iso incubated with 50 µg/ml of macromolecular HA, CS, HS and KS (n = 4 with > 150/FOV). While 
most macromolecular GAGs led to an insignificant reduction of the fraction of interacting cells, only the 
reduction by HA was significant. The bar graph (B) shows the maximum fraction of rolling cells     ( )  
     measured. * indicates a significance of p < 0.05, ** indicates a significance of p < 0.01 in a two-sided 
Student´s t-test t. All error bars shown represent the SD. The fraction of interacting cells ranged from 
15-92 % for the untreated HepG2Iso cells, from 4-62 % for the HepG2 cells incubated with HA, from 15-72 % 
for the HepG2Iso cells incubated with CS, from 15-76 % for the HepG2Iso cells incubated with HS and from 
12-76 % for the HepG2Iso cells incubated with KS. 
The blocking capabilities of HA were further studied by pre-incubation with short chain 
length HA (sHA; 6-10 DS). Prior to measurements in the microfluidic shear force system it 
was tested whether the incubation with sHA was toxic for the cells. For this the cells were 
incubated with the sHA (6-10 DS) for 1 h under culture conditions before they were 
imaged by light microscopy. The treatment did not lead to any morphological changes in 
the cells as shown in Figure S8 (Appendix section 7.2.3). This compatibility with large 
amounts of sHA allowed the study of the effect of the same on the interaction of the cells 
with HA-coated surfaces under flow conditions. The results of a representative set of 
measurements are shown in Figure 63. While the treatment with 10 µg/mL sHA did not 
lead to a significant reduction of the fraction of interacting cells, larger concentrations 
did. Both the preincubation with either 30 µg/mL or 50 µg/mL sHA led to a significant 
reduction of the fraction of interacting cells compared to the respective lower 
concentration. These findings demonstrated a concentration dependent reduction of the 
fraction of interacting cells similar to the observed for the treatment with BU52. 
Comparable results were obtained in two further independent experimental series. 
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Figure 64: Dependency of the rolling interaction of the concentration of sHA (6-10 DS). The graph shows a 
representative data set for the sHA concentration dependent reduction of the interaction of HepG2Iso cells 
with HA (n = 2, ≥ 150 cell/FOV). Treatment with sHA concentrations ranging from 10 µg/mL to 50 µg/mL 
gradually decreased the maximum fraction of HepG2Iso cells rolling on the HA-surface. * indicates a 
significance of p < 0.05, ** indicates a significance of p < 0.01 in a two-sided Student´s t-test. All error bars 
shown in this figure represent the SD. The fraction of interacting cells ranged from 71-80 % for the 
untreated HepG2Iso cells, from 66-74 % for the HepG2 cells incubated with 10 µg/ml sHA, from 43-45 % for 
the HepG2Iso cells incubated with 30 µg/ml sHA and from 16-18 % for the HepG2Iso cells incubated with 
50 µg/ml sHA. 
4.1.4 EFFECT OF BLOCKING REAGENTS ON THE ROLLING VELOCITY 
Next to the amount of cells that interact with HA following a given treatment with a 
blocking reagent (BU52, sHA), the effect of the treatment on the rolling velocity was 
analysed using the analysing MatLab© based software quantumCAT designed by 
S. Maleschijski in our workgroup.  
The effect of different concentrations of BU52 and the corresponding isotype control IgG1 
on the rolling velocity of HepG2Iso cells is shown in Figure 65. A wall shear stress of 
approximately 1 dyn/cm² was applied during the measurements. From the BU52 
concentration series conducted with KG-1a cells (section 4.1.2, Figure 59) three 
concentrations were chosen that covered the whole range from only weak blocking 
(2 µg/mL) over medium blocking capability (4.5 µg/mL) to nearly complete blocking 
(9 µg/mL). In the box plot (Figure 65, top) each box gives the 1st (lower box margin), 2nd 
(middle line; median) and 3rd (upper box margin) quartile of the data. The diamond 
symbol () gives the mean rolling velocity and the whiskers represent the standard 
deviation. Further information about the values depicted in the box plot can be found in 
section 7.1.2.3. It can be seen that both the median and the mean rolling velocity were 
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hardly influenced by the treatment with IgG1. Treatment with BU52, however, led to an 
increased rolling velocity with increasing amounts of BU52. The median rolling velocity of 
the untreated HepG2Iso cells was approximately 23 µm/s. For cells treated with 2 µg/mL 
BU52 the median was roughly 32 µm/s and increased to approximately 43 µm/s for cells 
treated with 9 µg/mL BU52. This trend can also be seen in the histograms of the rolling 
velocity (Figure 65, bottom). Here, the black arrows indicate the progression of the most 
frequent rolling velocity. Although the comparably low number of data points for the 
treatment with 9 µg/mL BU52 (280, compared to ~ 11,000 for the untreated cells; 
interaction with HA was suppressed with BU52, making rolling cells rare) yielded a 
crooked histogram, the trend was still clear. While the most frequent rolling velocity was 
approximately 20 µm/s for the untreated cells and for all concentrations of IgG1, it 
increased from approximately 25 µm/s for cells treated with 2 µg/mL BU52 to roughly 
40 µm/s for cells treated with 9 µg/mL BU52. 
 
Figure 65: Rolling velocity analysis of HepG2Iso cells after treatment with BU52 at a shear rate of 
1 dyn/cm². Box plots (top) and histograms (bottom) depicting the rolling velocity distribution for HepG2Iso 
cells treated with BU52 and the isotype control IgG1. At least 7 traces with 280 data points (for 9 µg/ml 
BU52) to ~11,000 data points (untreated cells) were recorded for each type of treatment.  is the mean 
rolling velocity. The box plots give the 1st (lower box margin), 2nd (middle line; median) and 3rd (upper box 
margin) quartile of the data. The whiskers represent the standard deviation. 
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Analogous measurements of the dependency of rolling velocity of HepG2Iso cells on the 
blocking of the CD44 receptor with sHA (6-10 DS) were also conducted. Again the rolling 
velocity was measured with a wall shear stress of approximately 1 dyn/cm² applied. 
Figure 66 shows the rolling velocities measured in dependency of the concentration of 
sHA. Both from the box plots (Figure 66, top) it can be seen that the mean rolling velocity 
continuously increased with increasing amounts of sHA. The only exception to this trend 
was the treatment with 60 µg/mL sHA. Here, a stagnation of the mean rolling velocity was 
observed. The median rolling velocity followed the same trend as the mean velocity, but 
showed a slight decrease for the highest concentration. It increased from approximately 
10 µm/s for the untreated cells to roughly 30 µm/s for cells treated with 50 µg/mL sHA. 
The same observation could be made for the most frequent rolling velocity seen in the 
histograms (Figure 66, bottom). This, too, increased with the sHA concentration and 
stagnated for the last increase of concentration. 
 
Figure 66: Analysis of the rolling velocity of HepG2Iso on HA after treatment with sHA (6-10 DS). Box plots 
(top) and histograms (bottom) depicting the rolling velocity distribution for HepG2Iso cells treated with 
different concentrations of sHA (6-10 DS). At least 13 traces with 800 data points (for 60 µg/ml) to 25,000 
data points (untreated cells) were recorded for each sHA concentration.  is the mean rolling velocity. The 
box plots give the 1st (lower box margin), 2nd (middle line; median) and 3rd (upper box margin) quartile of 
the data. The whiskers represent the standard deviation. 
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4.1.5 DISCUSSION 
In this section the flow induced interaction of the suspension cell line KG-1a and that of 
the epithelial cell line HepG2Iso with HA was studied towards its CD44 dependence, while 
comparing these two fundamentally different cell types.  
For suspension cells the basic principal of such a flow-induced interaction is well known in 
literature. A good and probably the most prominent example is the selectin- and integrin-
mediated extravasation of lymphocytes at sites of inflammation which has been 
extensively studied.[63-64,273-275] In this context it was shown that fluid shear promotes the 
P-, E-, or L-selectin mediated rolling of lymphocytes on the endothelium.[116-117] Recently, 
the capability of CD44 to mediate such a flow-induced interaction was demonstrated for 
KG-1a in our workgroup.[10] For epithelial cells this has not been shown so far. 
As different modes of glycosylation of CD44 influence the binding to HA,[159,166-167] the 
expression of CD44 alone does not directly correlate with HA binding. As this is the case, 
the first focus was to determine whether CD44 solely mediated the observed interaction 
with HA and whether this was specific for HA. This was achieved by applying the analysis 
matrix shown in Table 6 to the two model cell lines KG-1a and HepG2Iso.  
Table 6: Matrix of tests demonstrating the relevance of CD44 for the rolling interaction on HA. If the 
criteria given in the left column was fulfilled the corresponding cell line is marked by . If it was not it is 
marked by . 
Criteria 
Leukaemic 
suspension cell line 
KG-1a 
Liver cancer 
epithelial cell line 
HepG2Iso 
Rolling on HA    
Rolling on CS   
Rolling while CD44- cell line does not   
Effective blocking by BU52   
Effective suppression by CD44pan siRNA n.a.  
 
For both cells lines the HA specificity could be demonstrated by comparing the interaction 
with HA to that with CS. While the two GAGs are structurally very similar the interaction 
was highly specific for HA. Furthermore, it could be shown that the interaction with HA 
could only be observed for CD44 positive cell lines, while CD44 negative cell lines lacked 
any form of interaction with the HA-coated surfaces under flow. These findings could 
clearly validate that the flow induced interaction observed on the HA-coated surfaces was 
not only dependent on CD44 but also specific for HA. The necessity of the HA binding 
domain for this interaction was investigated by treating the cells with the CD44 antibody 
BU52. A concentration dependent blocking of the interaction with the HA-coated surfaces 
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was observed. As BU52 specifically blocks the HA binding domain of the CD44 receptor 
this proved its necessity for the flow induced interaction with HA. The concentration 
series conducted in this context also served to establish a protocol for later experiments 
with primary human cells. This sort of material was not accessible in the quantities a cell 
line was and the concentration series allowed the identification of an antibody 
concentration at which blocking could completely and reproducibly be suppressed. This 
concentration was found to be 9 µg/mL. 
The similarity of the interaction of the two model cell lines, KG-1a and HepG2Iso, 
concerning the interaction with HA was remarkable. The interaction characteristics found 
for the two cell types were highly comparable and in good accordance to earlier 
findings.[10] A threshold shear stress of approximately 0.2 dyn/cm² could be identified 
above which the interaction was observed. In the case of the HepG2Iso cells this 
threshold could not always be observed or in some cases it was shifted to apparently 
lower shear stresses. This impression may be appointed to the adhesive nature of the 
HepG2iso cells, which made an initial flow pulse necessary, slightly altering the flow 
applied in the initial phase of the experiment. This was extensively discussed in 
section 3.8.3. Again in good correlation to the first observation of the CD44-HA 
interaction[10] the maximum fraction of interacting cells was reached at roughly 
(0.7-1) dyn/cm² for both cell types, before it gradually decreased. This comparison clearly 
demonstrated the independence of the CD44-HA interaction from the model cell type. 
This prompts the conclusion that the CD44-HA interaction may generally be independent 
from the type of cell, be it suspension or epithelial. As this was deemed sufficient other 
experiments concerning the characterisation of the CD44-HA interaction were conducted 
with only one cell type, HepG2Iso. 
To undergird the finding that CD44 must be present on the cell surface for an interaction 
to take place, the effect of its down regulation was studied. It could be shown that knock 
down of CD44 in general (CD44pan) resulted in a complete suppression of the flow-
induced interaction with HA. This was not the case for the down regulation of the two 
CD44variant isoforms CD44v3 and CD44v6. As all CD44 isoforms share the same HA 
binding domain each isoform would have the possibility to compensate for the loss of 
another isoform.[276]  
As nicely reviewed by B. Toole HA has different functions depending on its chain 
length.[277] Indeed, rolling of HepG2iso cells was induced on substrates coated with 
macromolecular HA. Incubation of HepG2Iso cells with macromolecular GAGs in solution 
led to no significant reduction of the fraction of interacting cells for the treatment with 
CS, HS and KS, while a significant reduction was observed for macromolecular HA. The 
blocking by HA was further analysed by treatment with sHA (6-10 DS). It could be shown 
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that this reagent could impair the process of flow-induced rolling on HA in a 
concentration dependent manner. Furthermore, it could be shown that while the number 
of rolling cells was reduced with an increasing concentration of sHA, the rolling velocity of 
the cells was increased. The reduction of rolling by sHA may be due to competitive 
binding of sHA to CD44.[162] For example, sHA treatment might have led to a displacement 
of macromolecular HA bound to CD44,[278] thereby preventing CD44 clustering which was 
required for the binding of HA.[279] The reduced CD44 clustering would then result in 
weaker binding of CD44 to the HA surface.[280] Also, macromolecular HA may be able to 
stabilise complexes between CD44 
and itself or other cell surface 
receptors that might be required 
for rolling.[281] The treatment with 
sHA might prevent these 
complexes, thereby inhibiting the 
rolling on HA.  
As for the rolling velocity, the 
density of accessible CD44 on the 
cell surface may have been 
reduced by the sHA. This in turn 
would have led to larger distances 
between the individual receptors 
and, therefore, to a longer ‘step’ a 
cell took with each detachment-
adhesion cycle. An interesting as-
pect of the effect of the treatment 
of HepG2Iso cells with sHA was 
that, while increasing amounts of 
sHA (6-10 DS) led to a reduction of 
the fraction of interacting cells and 
to an increase of the rolling 
velocity of the cells at a shear stress of approximately 1 dyn/cm², the shear stress at 
which the maximum fraction of interacting cells was reached (    ) did not noticeably 
change. Figure 67 gives a comparison between the mean rolling velocity and      for 
HepG2Iso cells treated with a given concentration of sHA (6-10 DS). This finding was 
remarkable, as it demonstrated that both the probability of binding to the HA surface 
from flow (maximum fraction of rolling cells) as well as the rolling velocity of the cells 
(representing the detachment-attachment rate of a cell to the surface) interacting with 
HA, were strongly dependent on the density of the receptor available on the cell surface. 
 
Figure 67: Comparison of the shear stress at which the 
maximum fraction of interacting cells is reached τmax and the 
rolling velocity at approximately 1 dyn/cm². The data for 
     originates from 3 independent experiments with 2 
repeats each. The rolling velocities were calculated from at 
least 13 traces per treatment with a total of 800 data points 
(for 60 µg/ml) to 25,000 data points (untreated cells).  is 
the mean     ,  is the mean rolling velocity. The box plots 
give the 1
st
 (lower box margin), 2
nd
 (middle line; median) and 
3
rd
 (upper box margin) quartile of the data. The whiskers 
represent the standard deviation. 
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In contrast to this, the     , which can be interpreted as the strength of the CD44-HA 
interaction, was independent of the number of receptor molecules available for 
interaction. It seems that as long as the interaction could take place, the strength with 
which CD44 bound to HA was the same.  
So far it is not fully understood why metastatic cancer cells only extravagate at organs like 
the lung or the liver. As these organs are perfused by small blood capillaries, two 
explanations why the cancer cells extravagate only at these sites present themselves. 
Firstly, cancer cells may aggregate in the blood stream. These cancer cell aggregates may 
get stuck in the small capillaries and then attach to the endothelium of these capillaries as 
an initial step for extravasation.[282] Secondly, rolling, as a first step to extravasation, of 
the cancer cells on the endothelium might be induced by specific shear stress thresholds. 
As the shear stress on the blood vessel walls increases with a reduction of the capillary 
diameter, the smaller capillaries of the organs may offer a sufficient shear stress to induce 
rolling of the metastatic cells. The CD44-HA interaction pattern discussed in this study 
offers such a shear stress induced rolling, thus presenting a possibility for the cells to 
extravagate from the blood stream under sufficient shear conditions with HA present. 
Summarising, the analysis of the role of CD44 in the rolling of leukaemic suspension cells 
and epithelial cancer cells on HA-coated surfaces revealed that CD44 was essential for this 
process. Blocking experiments using a CD44 antibody (BU52) and knock down 
experiments using panCD44 siRNA resulted in inhibition of the flow-induced rolling 
interaction, suggesting a decisive role of CD44 in the rolling process. Furthermore, sHA 
fragments with a size of 6-10 DS were able to prevent the rolling of HepG2iso cells on HA-
coated surfaces. Both BU52 and sHA led to an increase in rolling velocity with increasing 
concentration. The findings presented in this section gave deep insight into the 
interaction with HA mediated by CD44. 
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4.2 INTERACTION OF HAEMATOPOIETIC PROGENITOR 
CELLS AND LEUKAEMIC BLASTS WITH HYALURONIC 
ACID 
CD44 has been reported to be relevant both for the homing and engraftment of 
haematopoietic progenitor cells (HPC)[9] and of leukaemic stem cells[6-7] into the bone 
marrow (BM) and spleen of non-obese diabetic/severe combined immunodeficiency 
(NOD/SCID) mice. Furthermore, it could be shown that an activating monoclonal CD44 
antibody could reduce the leukaemic repopulation of human acute myeloid leukaemia 
(AML) cells transplanted in NOD/SCID mice.[6] The mechanism underlying this effect is not 
yet understood. Thus, after unravelling the nuances of the interaction with HA mediated 
by CD44 as presented in the previous section it was of great interest to further 
understand its role both for healthy haematopoietic cells and for leukaemic cells. 
4.2.1 INTERACTION OF HEALTHY HAEMATOPOIETIC PROGENITOR 
CELLS WITH HYALURONIC ACID 
The results of the characterisation of the interaction of CD34 positive HPC with hyaluronic 
acid (HA) under flow conditions are described in this section. The HPC were derived from 
three different sources: cord blood (CB), 
mobilised peripheral blood (mPB) and the 
BM directly. This selection allowed the 
comparison between different cell sources. 
The HPC were kindly provided by the group 
of Prof. Anthony D. Ho from the Universi-
tätsklinikum Heidelberg. 
First interaction experiments with freshly 
isolated HPC from CB on HA (Figure 68) 
yielded only negative results. Consistent 
with the findings of Legras et al., Figure 68 
demonstrates that incubation of HPC sam-
ples in cytokine-rich medium for 24 h prior 
to measurement of rolling on HA-coated 
surfaces was necessary.[283] As described in 
 
Figure 68: Effect of Stemline II pre-incubation of 
CD34
+
 HPC from CB. Only the cells incubated in 
Stemline II medium supplemented with TPO, G-
CSF, SCF and Flt-3L showed the flow-induced 
interaction with HA known from the model cell 
lines KG-1a and HepG2Iso. 
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section 3.6, the cells were incubated in StemlineTM II Haematopoietic Cell Expansion 
Medium supplemented with 100 ng/mL TPO, 100 ng/mL G-CSF, 100 ng/mL SCF, 
500 ng/mL Flt-3L, 2 mmol/L L-glutamine, 1,000 U/mL penicillin and 100 U/mL 
streptomycin (hereafter referred to as Stemline II medium) for 24 h prior to measurement 
in the microfluidic shear force setup. Flow cytometry measurements (examples shown in 
Figure 69 for CB, in Figure 70 for mPB and in Figure 71 for BM) showed that the 
incubation in Stemline II medium did not lead to a differentiation of the cells. The graphs 
not only show that nearly all cells remained CD34 positive after the 24 h in Stemline II 
medium, but also that most were CD44 positive. Further data concerning the fractions of 
cells remaining CD34 after incubation in Stemline II medium for 24 h and on the CD44 
expression are shown in Table S6 (Appendix section 7.2.4.1) 
 
 
Figure 69: Flow cytometry measurement of CB HPC after 24 h incubation in Stemline II. Based on their 
SSC- and FSC-properties the cell population was gated (R1 in A). These cells were then tested for their 
integrity by Pi-staining and dead cells were excluded (R2 in B). In the example depicted here from the live 
cells nearly all were CD34 (98.82 % in C) and CD44 (99.85 % in D) positive. From the CD34 positive cells also 
nearly all were CD44 positive (99.88 % in E). Other measurements yielded comparable results. 
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Figure 70: Flow cytometry measurement of mPB HPC after 24 h incubation in Stemline II. Based on their 
SSC- and FSC-properties the cell population was gated (R1; A). These were also tested for their integrity by 
Pi-staining and dead cells were excluded (R2; B). In the example depicted here from the live cells nearly all 
were CD34 (99.66 %; C) and CD44 (99.96 %; D) positive. From the CD34 positive cells also nearly all were 
CD44 positive (99.96 %; E). Other measurements yielded comparable results. 
 
 
Figure 71: Flow cytometry measurement of BM HPC after 24 h incubation in Stemline II. Based on their 
SSC- and FSC-properties the cell population was gated (R1; A). These were also tested for their integrity by 
Pi-staining and dead cells were excluded (R2; B). In the example depicted here from the live cells nearly all 
were CD34 (98.32 %; C) and CD44 (97.27 %; D) positive. From the CD34 positive cells also nearly all were 
CD44 positive (97.40 %; E). Other measurements yielded comparable results.  
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As shown in Figure 72 the interaction curves of KG-1a cells with HA were composed of 
two forms of interaction: rolling and immobile adherence (the supplementary Video S2 
shows rolling and immobile adherent cells in comparison; the description can be found in 
section 7.1.2.1, the video is provided on the supplementary CD). Next to the pre-
incubation, this discrimination between the two forms of interaction was the second 
aspect important for the analysis of the HPC interaction data. This discrimination was not 
made for the interaction of the cell lines with HA, as it was of no great importance to the 
analysis or the findings. In Figure 72 the discrimination is made for untreated KG-1a cells 
and for cells treated with 3 µg/mL and 9 µg/mL BU52. It can be seen that the fraction of 
rolling cells increased after a critical shear stress of approximately 0.2 dyn/cm² was 
reached. In contrast to this flow-induced behaviour of the rolling cells, the immobile 
adherent cells only marginally increased and then detached from the surface with 
increasing shear stress applied. This behaviour could be observed not only for the 
untreated KG-1a cells, but also for the cells incubated with BU52. 
 
Figure 72: Discrimination between immobile adherent and rolling cells. A comparison is shown between 
untreated KG-1a cells and KG-1a cells treated with 3 and 9 µg/mL BU52 (n ≥ 4 for each treatment with 
> 300 cells/FOV). All error bars represent the SD. For clarity, no error bars are shown for the discrimination 
curves (dotted and dashed lines).
[266]
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Following the establishment of the experimental protocol (antibody concentration: 
9 µg/mL, pre-incubation in cytokine-rich Stemline II medium, discrimination between 
rolling and immobile adherent cells), the interaction curves for HPC shown in Figure 73 
were measured. A critical shear stress of approximately 0.2 dyn/cm² was required to 
induce rolling in HPC derived from healthy donors, irrespective of the source, i.e. CB, mPB 
or BM. The maximum fraction of rolling cells was also observed in the same region as 
previously described for KG-1a for all types of HPC (approximately (0.7-1) dyn/cm²; 
Figure 73). While the maximum fraction of rolling cells was very similar between HPC 
from different sources, it was significantly lower (approximately (15-25) %) than that 
found for KG-1a (approximately 60 %, see section 4.1) Due to the limited number of HPC 
that could be isolated from the blood and bone marrow samples, BU52 and anti-IgG1 
blocking studies were not performed for all samples. Overall, the addition of 9 µg/mL 
BU52 suppressed the rolling and partially also the immobile adhesion, while the anti-IgG1 
isotype control did not affect the interaction between the HPC and HA. While the rolling 
interaction was comparable for all types of HPC measured, the immobile adhesion was 
not. Relatively higher percentages of immobile adherent cells were observed in BM HPC 
than in CB or mPB (< 5 % for CB and mPB HPC and ~ 10 % for BM HPC). Furthermore, BM 
HPC generally showed a lower tendency to interact with HA. Only 1 of 4 BM HPC samples 
showed a prominent flow-induced rolling at a comparable level as observed for the CB or 
mPB HPC samples. 
In contrast to the homogeneous interaction of the HPC with HA under shear stress, flow 
experiments with leukocytes from the PB of healthy donors showed no rolling on HA. The 
data is shown in Figure S9 (Appendix section 7.2.4.1).  
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Figure 73: Comparison of the interaction of HPC from different sources with HA. Interaction measured in 
untreated HPC from CB (n = 6 from 5 groups of donors; > 200 cells/FOV), mPB (n = 4 from 3 donors; 
> 250 cells/FOV) and BM (n = 1 from 1 donor; 221 cells/FOV) and in HPC treated with 9 µg/mL BU52 (CB: 
n = 2 from 2 groups of donors; > 260 cells/FOV; mPB: n = 3 from 3 donors; > 230 cells/FOV) or with 9 µg/mL 
anti-IgG1 control (mPB: n = 1; 234 cells/FOV). In all cases, the interaction curve is comprised of immobile 
adherent and rolling cells, similar to KG-1a. Error bars represent the SD. For clarity, no error bars are shown 
for the discrimination curves (dotted and dashed lines).
[266]
 
4.2.2 INTERACTION OF BLASTS FROM PATIENTS WITH ACUTE 
MYELOID LEUKAEMIA WITH HYALURONIC ACID 
The leukaemic cell material used in this study was kindly provided by the group of Prof. 
Anthony D. Ho from the Universitätsklinikum Heidelberg. The blasts from patients with 
freshly diagnosed AML were isolated from the raw cell material by FAC sorting and stored 
in liquid nitrogen until use. In this study the blasts from 11 individual patients (named 
AML 1-11) were used. If not mentioned otherwise the leukaemic blasts were isolated 
from the BM of the respective patient. Cells isolated from samples from the PB are 
marked appropriately. As shown in the exemplary overviews (Figure 74, Figure 75) the 
cells were sorted based on their side scatter (SCC) and CD45 characteristics (SSClow, 
CD45dim). The cells were then incubated in Stemline II medium for 24 h, as established for 
the HPC, to ensure equivalent treatment of all cell types allowing later comparison.  
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Figure 74: FAC sorting of the blasts from AML 1. Based on their SSC- and FSC-properties the cell population 
was gated (R1; A). These were also tested for their integrity by Pi-staining and dead cells were excluded (R2; 
B). From the live cells the blasts were selected by their SSC and CD45 characteristics (SSC
low
, CD45
dim
, C). The 
CD44 expression was measured for the live cells (99.82 %; D) and for the leukaemic blasts (99.99 %; E). 
 
 
Figure 75: FAC sorting of the blasts from AML 2. Based on their SSC- and FSC-properties the cell population 
was gated (R1; A). These were also tested for their integrity by Pi-staining and dead cells were excluded (R2; 
B). From the live cells the blasts were selected by their SSC and CD45 characteristics (SSC
low
, CD45
dim
, C). The 
CD44 expression was measured for the live cells (99.95 %; D) and for the leukaemic blasts (99.98 %; E). 
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Microfluidic shear force measurements revealed a remarkably variable behaviour in 
terms of rolling and immobile adhesion of leukemic blasts. This was surprising as the 
CD44 expression was high in all 11 samples (CD44pan expression of ≥ 95.7 %, Table S7 in 
the Appendix section 7.2.4.2). In contrast to HPC from healthy donors which all showed 
basically the same interaction pattern, the rolling interactions of leukaemic blasts could 
be divided into 3 patterns (Figure 76): (A) pronounced rolling interaction, with most of the 
rolling cells detaching from the surface prior to (5-10) dyn/cm²; (B) rolling interaction 
persistent beyond (5-10) dyn/cm²; and (C) no rolling observed at all. An overview of all 
samples is shown in the supplementary Figure S10 (Appendix section 7.2.4.2). In all cases, 
flow-induced rolling was observed only beyond a critical shear stress of approximately 
0.2 dyn/cm² and reached the maximum at approximately (0.7-1) dyn/cm², in analogy to 
healthy HPC and KG-1a cells. The amount of immobile adherent cells varied, however, 
greatly among the AML samples (from < 5 % to approximately 20 % of the initially visible 
cells   ). No direct relation between the two different interactions, i.e. rolling versus 
immobile adhesion, could be observed in the sample cohort. 
 
Figure 76: Adhesion patterns found for the interaction of leukaemic blasts with HA. The blasts 
(CD45
dim
SSC
low
) were isolated from 11 different frozen AML samples. Despite the heterogeneity of the 
samples, 3 subclasses were characterised. Pattern A: High numbers of rolling cells that detach prior to a 
shear stress of (5-10) dyn/cm². Pattern B: High numbers of rolling cells that remain adherent beyond a 
shear stress of (5-10) dyn/cm². The A and B adhesion patterns show varying numbers of immobile adherent 
cells. Pattern C: Very few rolling cells and high numbers of immobile adherent cells. Each experiment was 
conducted with > 160 cells/FOV. If error bars are given they represent the SD from two measurements. If 
none are shown the sample material was not sufficient for more than one measurement. For clarity, no 
error bars are shown for the discrimination curves (dotted and dashed lines).
[266]
 
Treatment with BU52 completely inhibited rolling in all samples, while suppression of the 
immobile adhesion to HA was at best achieved partially. In three cases, no effect was 
observed at all. Whether the immobile adhesion could be blocked by BU52 or not, was 
not related to the rolling pattern as shown in Figure 77. Here, an example for both an 
effective and en ineffective suppression of the immobile adhesion by BU52 is presented 
for each of the three rolling patterns found for the leukaemic blasts. For two samples of 
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leukaemic blasts isolated from the BM and in which the treatment with BU52 was 
ineffective concerning the suppression of the immobile adhesion, a comparison was 
made to the blasts isolated from the PB of the same patient (Figure 78 and Figure S11 in 
the Appendix section 7.2.4.2). Remarkably, although blocking of the immobile adhesion 
with BU52 was ineffective for the BM blasts an effective suppression was observed for 
the corresponding PB blasts. The rolling interaction in turn was completely suppressed in 
both cases. 
 
 
Figure 77: Effectiveness of BU52 on the suppression of interaction with HA. An exemplary comparison of 
samples for which treatment with BU52 was either effective or ineffective is shown in this graph. Each 
experiment was conducted with > 160 cells/FOV and error bars are the SD. For clarity, no error bars are 
shown for the discrimination curves (dotted and dashed lines).
[266]
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Figure 78: Comparison between leukemic blasts from BM and PB. No significant difference in the 
interaction curves for leukemic blasts was observed between PB and BM (A). Treatment with BU52 was 
highly effective in blasts from PB (B), while large numbers of blasts from the BM remained capable of 
adhering to HA (C). Each experiment was conducted with > 160 cells/FOV and error bars are the SD. For 
clarity, no error bars are shown for the discrimination curves (dotted and dashed lines).
[266]
 
The AML samples with immobile blast adhesion to HA of greater than 10 % upon BU52 
treatment were clinically associated with poor response to induction chemotherapy 
compared to the other patients in which the blast interaction to HA could be inhibited by 
BU52 (Table 7). In the group in which BU52 was ineffective, only one of five patients 
achieved complete remission (CR) after induction chemotherapy. Whereas in the group of 
six patients, in whom the adhesion of the leukemic cells to the HA-surface could be 
inhibited by BU52, three of them achieved CR. Furthermore, the overall survival for the 
latter group of patients (mean: 375.5 days, 95 % confidence interval: 265.5-485.5) was 
also significantly longer than that for the former group (mean: 100.6 days, 95 % 
confidence interval: 0-219.2), in which BU52 did not show any effect (log-rank test: 
p = 0.016, Figure 79). Further comparisons in terms of cytogenetic and molecular genetic 
risk factors did not show a significant difference between the two groups, but it was 
remarkable that all patients with favourable risk factors belonged to the group in which 
BU52 was effective (Table S8, Appendix section 7.2.4.2). 
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Figure 79: Kaplan-Meier curve showing the patients’ overall survival for the two subclasses of BU52 
blocking efficiency. It is evident that efficient blocking of the immobile adhesion to HA by BU52 was directly 
correlated to a longer overall survival.
[266]
 
 
Table 7: BU52 blocking efficiency for each blast sample and the associated patient’s outcome. The 
efficiency of the suppression of the immobile adhesion to HA by BU52 is shown. Light grey marks the 
samples for which efficient blocking could be observed. Dark grey marks the inefficient samples.
[266]
 
Sample 
No. 
BU52 blocking efficiency 
(remaining % of N0) State after induction chemo-
therapy 
Deceased 
< 10 % > 10 % 
1   Persistence No 
2   CR No 
3   Persistence Yes 
4   Persistence Yes 
5   Deceased during chemotherapy Yes 
6   Persistence Yes 
7   CR No 
8   CR No 
9   CR Yes 
10   No chemotherapy Yes 
11   Persistence No 
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4.2.3 DISCUSSION 
In this section the ability of CD44 to mediate rolling and immobile adhesion of HPC and 
leukaemic blasts to HA-coated surfaces under physiological shear stress conditions was 
analysed. Using a microfluidic shear force device, it was possible to precisely quantify the 
shear stress required to induce rolling and to overcome adhesion for HPC versus 
leukaemic cells on HA-coated surfaces. Whereas HPC from healthy donors behaved 
relative homogeneously on HA-coated surface, there was a much broader range of 
behavioural patterns concerning the rolling and immobile adhesion for leukaemic cells 
under identical conditions. The monoclonal CD44 antibody BU52 was able to completely 
abrogate the shear stress-induced rolling of HPC from healthy donors and leukaemic cells 
from patients with AML in contrast to the incomplete inhibition of the immobile adhesion 
exhibited by the leukaemic blasts. Another remarkable finding was that those patients, in 
whom the immobile adhesion of the leukaemic blasts was not affected by BU52, were 
associated with poor response to induction chemotherapy and an adverse long-term 
clinical outcome. 
It was shown that expression of CD44 was not the only prerequisite for an interaction 
with HA. Consistent with the findings of Legras et al., the necessity to pre-incubate HPC in 
cytokine-rich medium for 24 h prior to measurement of rolling on HA-coated surfaces was 
established.[283] In the case of healthy leukocytes even this incubation could not initiate 
the interaction, suggesting that the mechanism controlling the interaction of CD44 with 
HA was highly complex or may have become redundant in the highly differentiated cell 
types. 
Whereas all types of HPC analysed displayed a high expression of CD44pan, the 
expression of CD44variant isoforms was mostly low.[265-266] Two forms of interaction were 
of interest throughout the healthy HPC and the leukaemic blasts; the flow induced rolling 
interaction and the immobile adherence. If rolling was observed the shear stress at which 
the maximum interaction was observed was always in the range of approximately 
(0.7-1) dyn/cm². This corresponds well with the shear stress observed in post-capillary 
venules. In the latter venular system, the shear stress has been estimated to be in the 
range of (1-4) dyn/cm², which is consistent with the parameters reported for the selectin-
dependent leukocyte rolling.[116-117,284] Though the interaction of HPC with HA-coated 
surfaces was significantly weaker (a smaller maximum fraction of interacting cells) than 
that of KG-1a, the maximum fraction of cells undergoing the rolling interaction was 
comparable throughout all HPC samples from CB, mPB and BM. Furthermore, the 
threshold shear stress of approximately 0.2 dyn/cm², beyond which rolling was induced, 
was also observed throughout all cell types if rolling was observed at all. While KG-1a and 
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HPC isolated from the blood stream (CB, mPB) hardly showed immobile adherence to HA, 
a significant fraction of HPC from the BM exhibited this form of interaction. A possible 
explanation for this result could be the inactive, dormant state of the HPC derived from 
the BM niche, in contrast to cells that had been mobilised out of the niche into the 
peripheral blood. Wilson et al. demonstrated that dormant BM haematopoietic stem cells 
were activated to self-renewal upon exposure to stress to the BM, e.g. blood loss, 
infection, or G-SCF stimulation.[285] Accordingly, the activation status probably alters the 
adhesion mechanisms, either rolling or immobile adherence, of HPC to the marrow niche.  
In leukemic blasts the immobile adherence to HA was a remarkable finding. The fraction 
of immobile adherent cells varied greatly among the 11 leukemic blast samples and no 
correlation between the rolling patterns and the fraction of immobile adherent cells was 
found. Moreover, the CD44 antibody BU52 in some cases had little or no effect on this 
adhesion, whereas rolling of the leukemic blasts was completely abrogated by the same 
antibody. In addition, a correlation between an ineffective blocking of the immobile 
adherence and a poor long-term outcome of the respective patients could be 
demonstrated. This trend was independent of the risk stratification according to the 
cytogenetic and molecular genetic risk factors. Furthermore, the suppression of the 
immobile adhesion by BU52 was less effective for AML blasts isolated from the BM than it 
was for those isolated from the PB, although the fractions of rolling and adherent cells 
were nearly identical for the untreated cells. This again strengthened the notion that the 
immobile adhesion to HA could be associated with the vicinity to the BM niche. Saito et 
al. reported that leukemic stem cells in the stem cell niche were more chemotherapy 
resistant and that mobilisation enhanced the induction of apoptosis and elimination of 
these cells.[22] As the immobile adhesion is linked to the niche it may be involved in the 
retention of the leukaemic stem cells in the niche and could present a valid target for 
mobilisation of leukaemic stem cells in the future. 
Similar to the observations reported by Bendall et al.,[286] the expression of CD44variant 
isoforms in AML was more divergent than that found for the normal HPC from the 
marrow.[265-266] This might explain the more heterogeneous adhesion patterns and the 
BU52 blocking efficiency in AML. Assuming that the leukaemic blasts show a behaviour 
similar to that of the LSC it is possible that a special CD44variant isoforms, which BU52 is 
not able to neutralise, might be involved in the retention of leukemic cells in the BM 
niche, rendering them invulnerable to chemotherapy. In line with this, Jin et al. 
demonstrated that blocking of CD44 reduced leukemic repopulation of human AML 
transplanted in NOD/SCID mice.[6] This indicates that CD44 somehow contributes to the 
homing and engraftment of LSC. All in all the occurrence of the CD44 mediated rolling and 
immobile adhesion on HA was highly diverse. Similarly the heterogeneity of the 
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leukaemia initiating cells in AML might be highly diverse as well, such that an antibody 
against CD44pan might not be effective for different patients with differing over-
expressions of CD44variant isoforms. 
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4.3 CELL INTERACTION WITH LAYERS OF 
MESENCHYMAL STROMAL CELLS 
The study of the interaction of cells with HA artificially immobilised on a surface presents 
an ideal scenario for the characterisation of interactions specific for HA, as it was 
described in the previous sections. In vivo, however, a far broader spectrum of ligands 
and, therefore, of ligand-receptor interactions is possible. In the context of homing the 
most important cell-cell contacts are between the homing HSC, of course, and either the 
endothelial cells, forming the blood vessels, or the mesenchymal stromal cells (MSC), 
found abundantly in the BM niche.[57,71] To gain an impression of the relevance of the 
CD44-HA interaction, discussed so far in this work, in a more realistic environment, the 
interaction with surfaces covered with MSC was analysed. In this section the 
establishment of the procedure to conduct such analysis in the microfluidic shear force 
setup is described. Subsequently, first cell-cell interaction curves of the model cell line 
KG-1a and HPC with MSC are presented. 
4.3.1 EXPERIMENTAL DETAILS FOR THE ESTABLISHMENT OF MSC 
FEEDER LAYERS 
To analyse the interactions between suspension cells, as previously used in this work, and 
MSC under flow conditions it was necessary to prepare surfaces completely covered with 
convergent MSC, the so-called feeder layers. As the MSC were harvested from the BM, 
they were, like other primary cell materials, only available in relatively low quantities. It 
was, therefore, desirable to require as few MSC as possible to develop a feeder layer. For 
this reason the glass sample holder, on which the feeder layer was to grow, was not pre-
coated with MSC, but the MSC were rather directly injected into the fully assembled 
channel system and allowed to settle there. In principle the procedure was adapted from 
experiments concerning the detachment of fibroblast cells from different sample 
surfaces.[11-12] It was important for the cells to be fully adhered and in a healthy state, as 
impairment of the cells may lead to modified interaction behaviour by e.g. differing 
receptor expression. The most easily analysable parameters that are determined by the 
condition of the MSC were the morphology and shear stress required for detachment. 
Both were studied for MSC cultured in the microfluidic shear force system. Due to the 
limited amount of cell culture medium in the channel system the most critical factor 
influencing the condition of the MSC was the amount of nutrients available to the cells. 
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Figure 80 and the corresponding supplementary Video S4 (description found in the 
Appendix section 7.2.5, video provided on the supplementary CD) show the adhesion of 
MSC to a glass substrate in the microfluidic channel system. With the MSC density used 
for this experiment the best cell morphology was observed after approximately 5 h of 
incubation. Figure 81 A shows such well spread healthy cells. Longer incubation led to 
unhealthy, elongated cells (Figure 81 B).  
 
Figure 80: Incubation of MSC in an assembled microfluidic channel setup. The images show different time 
points of the incubation of MSC inside an assembled microfluidic channel setup. It can be seen that while 
the cells spread broadly initially the cells appear thin and elongated after longer period of incubation. 
 
Figure 81: Images of well spread MSC (A) and unhealthy, elongated MSC (B). 
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To determine whether cell-feeder layer interaction experiments could repeatedly be 
conducted without detaching the MSC and to evaluate the effect such experiments had 
on the MSC, the interaction with the model suspension cell line KG-1a was investigated. 
As seen in Figure 82 A the shear stress required to detach all KG-1a cells from the MSC 
was approximately one order of magnitude below that required to detach the MSC from 
the glass surface. This was the prerequisite for being able to use an MSC feeder layer for 
repeated measurement of the interaction with other cells, such as KG-1a cells, under 
flow. This meant that the MSC could be used far more efficiently, than if the feeder layer 
had been a single-use surface. As shown in Figure 82 B the interaction with the KG-1a 
cells had no noticeable effect on the shear stress required to detach the MSC from the 
glass substrate on which they were adhered. This, like the cell morphology, can be seen 
as a measure for the viability of the MSC. It required at least 1,000 dyn/cm² to detach 
50 % of the MSC independent of the number of interaction experiments conducted prior 
to their detachment. Exact numbers could not be determined in all measurements as the 
maximum flow rate applicable in the microfluidic system was not always sufficient to 
detach the MSC. That the viability of the MSC was directly correlated to the shear stress 
required to detach them could well be seen in channels with strongly elongated MSC, 
which could not even be brought into contact with other cells as they were so weakly 
adhered that they detached even during injection of the KG-1a cells. 
 
Figure 82: Demonstration of the strong adhesion of healthy MSC to glass. A) The adhesion strength of MSC 
on glass is compared to the interaction strength of KG-1a cells (n = 4, > 68 cells/FOV, reduced number of 
cells visible because video microscopy was conducted with 10x Ph1 objective to better determine between 
the different cells types) with the MSC. B) Shear stress required to detach MSC from glass (n = 2, 
> 130 cells/FOV). Prior interaction of KG-1a cells with the MSC had no effect on the shear stress required to 
detach the MSC. The error bars represent the SD. 
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4.3.2 INTERACTION OF SUSPENSION CELLS WITH MSC FEEDER 
LAYERS UNDER FLOW 
This section goes into more detail on the interaction of KG-1a cells with MSC, introduced 
in the last section, and presents how HPC from different sources behaved in this system. 
As shown in Figure 83 for the untreated cells an interaction curve similar to that of KG-1a 
cells with HA was measured. A nearly identical 
interaction curve was observed for KG-1a cells 
preincubated with 9 µg/mL BU52. As this 
concentration of BU52 was sufficient to fully 
suppress the interaction with HA, this 
observation indicated that the interaction with 
MSC was independent of CD44. Although 
altogether weaker the same interaction 
pattern and, by treating the cells with BU52, 
the same independence of CD44 was observed 
for HPC from both CB and mPB (Figure 84). In 
all cases the number of interacting cells 
increased directly after a flow was applied. 
The maximum fraction of interacting cells 
reached was approximately 100 % for KG-1a, 
60 % for CB HPC and 40 % for mPB HPC. After 
the maximum was reached the cells were 
continuously detached from the surface. In 
contrast to the flow induced interaction 
discussed in the previous sections (sections 
4.1 and 4.2) the interaction here was not of a 
rolling, but more of an immobile nature. As 
can be seen in the supplementary Video S5 (description found in the Appendix 
section 7.2.5, video provided on the supplementary CD) the practically ‘stuck’ to the 
surface from the flow, similar to the immobile interaction observed mostly for leukaemic 
blasts (section 4.2). However, such a distinctive increase of the fraction of immobile 
adherent cells was not observed on HA-coated surfaces.  
 
Figure 83: Interaction of KG-1a cells with MSC 
under flow conditions. The fraction of KG-1a 
cells interacting with the MSC increased until a 
maximum was reached at ~ 1 dyn/cm² (n = 4, 
> 68 cells/FOV, video microscopy with 10x Ph1 
objective to better determine between the 
different cells types). After this the cells 
detached from the MSC. Treatment of the 
KG-1a cells with 9 µg/mL BU52 did not lead to 
an abrogation of the interaction. The error bars 
represent the SD. 
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Figure 84: Interaction of HPC from CB (A) and mPB (B) with MSC under flow conditions. The HPC from 
both sources show nearly the same interaction with the MSC (n ≥ 1, > 53 cells/FOV, video microscopy with 
10x Ph1 objective to better determine between the different cells types). The error bars represent the SD. 
4.3.3 DISCUSSION 
In this section the possibility to culture MSC inside the microfluidic shear force setup was 
demonstrated and the interaction of other cells with the MSC was analysed under flow 
conditions. The aim was to prepare a closed layer of convergent MSC. It could be shown 
that, if the correct conditions were upheld, the culture of MSC inside a fully assembled 
channel system was possible and well spread, strongly adherent MSC could be cultured. 
Albeit no full confluence was reached, successful experiments concerning the interaction 
of other cells with the MSC could be undergone. By analysing the repeated interaction 
with KG-1a cells it could be demonstrated that the shear stress at which the KG-1a 
detachment and the MSC detachment occurred were sufficiently wide apart so that the 
MSC were not detached. Furthermore, this analysis showed that the shear stress required 
to detach the MSC did not change due such repeated interaction analysis. These findings 
demonstrated that the MSC cultured directly in the channel system presented a robust 
system for the analysis of the interaction of suspension cells with the MSC under flow 
conditions. Concerning the interaction of the KG-1a cells with the MSC it could be shown 
that dependent on the flow rate the cells accumulated on the MSC. The same behaviour 
was also observed for HPC from CB and mPB. For all three cell types tested accumulation 
commenced as soon as a flow was applied. The maximum fraction of interacting cells was 
observed in the range of approximately 1 dyn/cm². Beyond this shear the cells were 
detached from the surface by the flow. Pre-treatment of the cells with 9 µg/mL BU52 had 
no effect on the interaction of the cells with the MSC. This concentration of BU52 was 
sufficient to fully suppress the flow induced interaction with HA as shown in the 
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sections 4.1 and 4.2. However, the number of receptor-ligand interactions was limited in 
that setup, as only immobilised HA was available for interaction. When investigating the 
interaction with MSC a vast variety of interactions were possible.[27] Amongst others 
possible receptors mediating interaction between the cells and MSC were integrins and 
cadherins. These typically mediate a firm adhesion and are the first obvious candidates 
for mediating the firm interaction observed in the experiments. It is possible that the 
catch-bond mediated capture of the cells directly resulted in a firm adhesion, possibly 
mediated by the above mentioned receptors. Future experiments should surely address 
the questions which receptors mediate this ‘sticking’ of the cells and whether the CD44 
mediated flow induced rolling can be observed if the appropriate other receptors are 
blocked. 
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4.4 THE EFFECT OF SDF-1α AND PLERIXAFOR® ON 
CELL MOTILITY 
The flow induced rolling of cells, which can be mediated by CD44, as described in the 
previous sections, or by selectins, as discussed in section 2.3, is an important step in the 
extravasation of cells from the blood stream. This in turn is a crucial step in the process of 
HSC homing to the BM niche.[99-101] That the CD44-HA interaction is in fact relevant in this 
context has been described in literature.[9] As both HA[237] and CD44[130-132] are 
ubiquitously expressed in the mammalian cells a regulation of this interaction is required. 
It was shown for example that proinflammatory stimuli could upregulate the expression 
of HA on endothelial cells to induce CD44 mediated binding.[287] In the context of HSC 
homing another regulation is possible. The homing process is directed by a gradient of the 
cytokine stem-cell-derived factor-1 alpha (SDF-1α).[9,16,69-70] Fuchs et al. recently described 
a molecular link between SDF-1α and CD44 via the SDF-1α receptor CXCR4,[288] raising the 
question whether SDF-1α could regulate the CD44 mediated flow induced interaction 
with HA. The investigation of the possibility of this form of regulation is presented in this 
section. 
4.4.1 THE EFFECT OF SDF-1Α ON THE MIGRATION OF HPC 
It is well known that SDF-1α induces migration.[16-19,289] To determine whether, in the in 
vitro environment used in this work, the HPC reacted to SDF-1α as expected by migrating, 
transwell assays were applied. Plerixafor® (syn.: AMD3100; 1,1-[1,4-phenylene-bis(methy-
lene)]-bis-1,4,8,11-tetra-azacyclo-tetradecane) was used as a control reagent. In the 
clinical environment this is used to mobilise HSC from the BM niche.[93-95] While the 
mechanism of action is not yet understood in detail,[96-97] it has been shown to block the 
CXCR4 receptor,[98] and, therefore, functions as SDF-1α antagonist.  
For the analysis HPC derived from CB were seeded in the top compartment of a transwell 
setup and the migration through a membrane with a pore size of 3 µm was analysed by 
fixing the cells after 4 h and counting the number of cells that had migrated through the 
membrane into the lower compartment. First the effect of the isolated cytokine and of 
Plerixafor® was studied. As baseline-level, only HPC were added to the upper 
compartment and migration through the membrane into the lower compartment was 
measured (Figure 85 A). The migration rate was significantly increased upon addition of 
SDF-1  into the lower compartment (p < 0.01, 2-sided Student´s t-test). This migration 
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inducing effect of SDF-1  could be abrogated almost fully by the addition of Plerixafor® 
(p < 0.01, 2-sided Student´s t-test). This clearly demonstrated that the HPC used in this 
work were susceptible to SDF-1  and that Plerixafor® could successfully be applied to 
suppress this effect. 
As MSC secrete the chemokine SDF-1  and also express the corresponding receptor 
CXCR4 themselves[15] the migration towards these cells and, therefore, towards natural 
SDF-1 , was also analysed (Figure 85 B). For this MSC were seeded into the lower 
compartment of the transwell setup. Directly prior to the experiments the medium in 
which the MSC were cultured was removed and replaced by SDF-1  free medium. This 
ensured that the induction of migration was solely due to cytokines (presumably SDF-1 ) 
secreted by the MSC. The bar graph in Figure 85 B shows a clear while not significant 
increase of the migration rate when comparing the CB HPC control to those migrating 
towards the MSC. The migration rate could be further increased by addition of synthetic 
SDF-1  to the lower compartment. Again this effect could be nearly fully antagonised by 
the addition of Plerixafor® to the upper compartment. 
 
 
Figure 85: Transwell assay to determine the effect of SDF-1α and Plerixafor® on the migration of HPC. A) 
Effect of synthetic SDF-1α on the migration of CB HPC. The unspecific migration through the transwell 
membrane (HPC control) is compared to the addition of either 100 ng/mL SDF-1α alone or in combination 
with 500 ng/mL Plerixafor® to the lower compartment (n = 6).
[289]
 B) Effect of presence of MSC on the 
migration of CB HPC. The lower compartment was seeded with MSC and the effect of 100 ng/mL SDF-1α 
and/or 500 ng/mL Plerixafor® was studied (n = 4). The error bars represent the SD. 
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4.4.2 THE EFFECT OF SDF-1Α ON THE CD44-HA INTERACTION 
After validation of the effectiveness of both SDF-1  and of Plerixafor® in an in vitro 
environment as used in this work, the influence of both on the interaction of cells under 
flow was analysed. As presented in section 4.2.1 the HPC were preincubated in Stemline II 
medium for 24 h prior to microfluidic measurement. Prior to measurement the cells were 
pre-incubated with SDF-1α or a combination of SDF-1α and Plerixafor® for (20-30) min to 
determine whether either of the two has an effect on the flow-induced rolling interaction 
with HA. HPC from CB and mPB were used for this analysis. As shown in Figure 86 the HPC 
from both sources exhibited the flow-induced rolling on HA previously discussed. Rolling 
was observed beyond a critical shear stress of approximately 0.2 dyn/cm² and reached 
the maximum at approximately (0.7-1) dyn/cm². Also as previously described the fraction 
of immobile adherent cells was low. Interestingly, for all treatments no change in the 
rolling interaction or the immobile adherence could be observed. 
 
Figure 86: Effect of SDF-1α and Plerixafor® on the interaction of HPC with HA under flow. Interaction of 
HPC from CB (A; n = 1) and mPB (B; n = 2) with HA under flow. The cells were preincubated with SDF-1α or 
SDF-1α and Plerixafor® prior to measurement for varying lengths of time. The error bars represent the SD. 
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4.4.3 DISCUSSION 
This chapter focussed on determining the relevance of SDF-1α as regulating agent for the 
CD44 mediated flow induced interaction with HA. To determine the viability of the in vitro 
environment in which the experiments were conducted, the effect of both SDF-1α and 
Plerixafor® on the HPC used in this work was evaluated using a transwell migration assay. 
It could be shown that in accordance to the findings of Kim and Broxmeyer SDF-1α was a 
very potent trigger for HPC migration.[18] This effect was best observed upon addition of 
synthetic SDF-1α. A certain increase, however, was also observed for HPC seeded in a 
transwell with MSC grown in the lower compartment as only source of natural SDF-1α. Of 
course, in vivo there may be other systems involved as well inducing chemotaxis as MSC 
produce more chemokines than merely SDF-1α.[27] Both with and without MSC it could be 
shown that addition of Plerixafor® reduced the interaction to the levels of the respective 
control group. This clearly showed that the HPC were susceptible to SDF-1α and 
Plerixafor® in the in vitro environment used in this work and that both reagents were 
highly effective.  
Based on this validation of the effectiveness of SDF-1α and Plerixafor® the possible role of 
SDF-1α as regulatory agent for the CD44 mediated rolling interaction with HA was 
investigated. The CXCR4 antagonist Plerixafor® is a mobilisation reagent for HSC 
commonly used in the clinical environment.[93-95,98] Next to that of SDF-1α, the effect of 
this drug on the rolling on HA was also determined. The analysis was conducted with HPC 
originating from both CB and mPB. It could be shown that neither a pre-treatment with 
SDF-1α, Plerixafor® or a combination of both affected the interaction with a HA-coated 
surface under flow. This was the case both for the CD44 mediated flow induced rolling 
and for the immobile adhesion of the cells to HA. This new insight suggested that 
although some aspects of the function of the two receptors were linked[288] others, such 
as the CD44 mediated flow induced rolling on HA, were not. It should be noted that the 
absence of an effect of SDF-1α or Plerixafor® may be related to the pre-treatment of the 
cells in Stemline II medium (Table S5, Appendix section 7.2.1). Amongst others this 
medium contained the cytokine ‘granulocyte colony-stimulating factor’ (G-CSF), which is 
known for its stem cell mobilising abilities. In a clinical environment G-CSF is often used in 
combination with Plerixafor® as this is more effective than the standard procedure with 
G-CSF alone.[290-292] Possibly this cytokine negated the effect of SDF-1α or Plerixafor®. 
Another possibility is that the mechanistic determination between migration, where the 
molecular link between CD44 and CXCR4 was observed,[288] and the flow induced rolling is 
so sophisticated that the two forms of interaction are under certain circumstances strictly 
separated. Further experiments concerning this dependency would be desirable. 
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5 STABILITY AND BIOCOMPATIBILITY OF 
SURMOF 2 AS CANDIDATE FOR A DRUG RELEASE 
SYSTEM 
 
Figure 87: Overview over the work presented in this chapter. In the first section of this chapter the 
stability of Cu-/Zn-SURMOF 2 in different media is analysed. It was tested whether SURMOF 2 was generally 
applicable for cell culture and whether it could function as smart-release coating under the right conditions. 
As elaborated in the introduction to this work (section 1) there are two major pathways in 
the improvement of the therapy of acute myeloid leukaemia (AML). The first is the 
selective mobilisation of leukaemic stem cells (LSC) out of their niche. As this requires a 
detailed understanding of the interactions between the LSC and their niche and the CD44-
HA interaction was reported to be such an interaction,[6-7,9] this was characterised in this 
study. The second pathway is to improve the culture of haematopoietic stem cells (HSC) 
in vitro to make sufficient amounts of HSC for successful haematopoietic stem cell 
transplantation (HSCT) more easily accessible.[27-28] The HSCT are required to rescue the 
haematopoietic system after failure due to intensive chemotherapy.[24] Mimicking the in 
vivo conditions of a slow and continuous release of cytokines and growth factors to the 
HSC is a key step in doing so. Porous materials such as zeolites, porous metals or porous 
silicon are widely used in many applications involving the incorporation of small 
molecules, e.g. gas purification.[35-42,293-294] The pore size, the stability and of course the 
biocompatibility are three major aspects of a material that shall be used for drug delivery 
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in vivo. A relatively new class of porous materials, the metal-organic frameworks (MOF), 
are due to their building blocks, chemically and structurally highly flexible.[43-45] The 
synthesis of such frameworks on surfaces (surface-anchored MOF; SURMOF) is 
straightforward[191,201,204] and allows the coating of devices, such as stents, or cell culture 
dishes. A novel 2-D structured SURMOF, namely SURMOF 2, was recently developed in 
the group of Prof. Christof Wöll at the Karlsruhe Institute of Technology (IFG, KIT, 
Karlsruhe, Germany).[209,295] Figure 87 gives an overview over the work conducted with 
this type of SURMOF. The stability of SURMOF 2 in different media, the compatibility of 
the same with cell culture and its potential as a drug release system were studied in 
corporation with the group of Prof. Christof Wöll. 
5.1 STABILITY OF SURMOF 2 
In this study a copper ([Cu2(bdc)2]n; Cu-SURMOF 2; bdc = benzene-1,4-dicarboxylic acid) 
and a zinc ([Zn2(bdc)2]n; Zn-SURMOF 2) based derivative of SURMOF 2 were studied. Both 
were assembled from solutions of the precursors of the divalent cations (Cu2+ and Zn2+) 
and the linker molecule bdc. In contrast to most 3-D crystalline MOF structures this type 
of SURMOF exhibited a 2-D layer structure as shown in Figure 88.  
 
Figure 88: Schematic representation of the proposed structure of SURMOF 2. The structure of SURMOF 2 
[Zn2(bdc)2(H2O)2] and [Cu2(bdc)2(H2O)2] is proposed to be 2-D; A) front view and B) side view. Image taken 
from Arslan et al., 2011.
[209]
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In order to study the stability of Cu- and Zn-SURMOF 2 towards different media the re-
spective SURMOF 2 was incubated in MilliQ® water, artificial sea water (ASW, type: 
Instant Ocean®), phosphate buffers saline (PBS buffer), 1 mg/mL fibrinogen in PBS and 
the cell culture medium Dubelcco´s modified eagle medium (DMEM, relevant media for a 
range of biological applications) supplemented with 10 % FBS and 5 % L-Glutamine for 
1 h. After the incubation the SURMOF was carefully rinsed with MilliQ® water, dried in a 
nitrogen stream and analysed by XRD (by Hasan K. Arslan or Zhengbang Wang from the 
group of Prof. Christof Wöll, IFG, KIT, Karlsruhe, Germany), XPS (by Stella Bauer from our 
workgroup) and spectral ellipsometry. 
Figure 89 A shows the XRD data obtained after the incubation of the Zn-SURMOF 2 in the 
above mentioned media. It is clearly visible that the crystallinity of the Zn-SURMOF 2 was 
lost after the incubation for 1 h in every of the tested media. The instability of the 
Zn-SURMOF 2 could be underlined by XPS measurements (Figure 89 B, C) which showed 
an increase of the Zn 3p peak together with a decrease of the C 1s peak for both the 
incubation with MilliQ® water and ASW. The increase of the Zn 3p peak can be explained 
by the exposure of zinc by removal of the outer bdc layers. This is in line with the 
decrease of the C 1s peak which can only originate from a loss of the bdc linker. 
Incubation in the remaining media also led to a disassembly of the SURMOF 2 (data not 
shown as no peaks were visible). 
 
 
Figure 89: Spectroscopic analysis of the stability of Zn-SURMOF 2 in aqueous media. XRD spectra (A) of 
pristine Zn-SURMOF 2 and of the same after incubation in MilliQ® water, ASW, PBS buffer, PBS buffered 
fibrinogen solution and the cell culture medium DMEM (supplemented with 10 % FCS and 1 % L-Glutamine) 
for 1 h. All tested media led to a loss of crystallinity. The corresponding C 1s (B) and Zn 3p (C) XP spectra of 
the samples shown in A are also given. For clarity only the spectra for MilliQ® water and ASW are shown. 
Both the C 1s and Zn 3p spectra clearly show the disassembly of the Zn-SURMOF 2. 
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While the XRD data revealed the instability of Zn-SURMOF 2 in all media it also showed 
that immersion in MilliQ® water and ASW for times of up to 1 h had no detectable effect 
on the crystalline nature of the copper based SURMOF 2 (Cu-SURMOF 2). After incubation 
of the same with PBS buffer, PBS buffered fibrinogen solution and DMEM a loss of 
crystallinity was detectable (Figure 90 A), however.  
XPS was used to gain a more detailed insight into the chemical composition of the surface 
after immersion of the Cu-SURMOF 2s into the different media (Figure 90 B-E). No change 
of the Cu 2p signal could be observed for the samples incubated in MilliQ® water and 
ASW, while the sample incubated in PBS showed a slight increase of the Cu 2p signal. For 
the samples containing proteins (PBS buffered fibrinogen solution and DMEM 
supplemented with 10 % FCS and 5 % L-Glutamine) a complete disappearance of the 
Cu 2p signal was observed. Evaluation of the C 1s XPS signals in Figure 91 C, D allowed 
similar conclusions. In the case of the incubation in MilliQ® water and ASW no change in 
the signal intensity or shape could be observed which was in good agreement with the 
unchanged crystallinity found by XRD. Incubation in PBS led to a strong decrease of the 
C 1s signal. This was in accordance with the loss of crystallinity indicated by the XRD data. 
After immersion of the Cu-SURMOF 2 films into buffered solutions of fibrinogen or cell 
culture medium DMEM (supplemented with 10 % FCS and 5 % L-Glutamine), a 
pronounced change of the C 1s peak shape was observed. This indicated changes in the 
chemical composition of the organic components after immersion into the protein 
containing media as expected due to the deposition of proteins on the surface. Since at 
the same time the Cu-SURMOF 2 diffraction peak intensities decreased it could be 
concluded that the protein deposition was accompanied by dissolution of the SURMOF 2 
coating. The N 1s spectra recorded before and after immersion into the different aqueous 
solutions is shown in Figure 90 E. As it could be anticipated from the compositions of the 
different building units for the Cu-SURMOF 2, the pristine surfaces did not contain any 
nitrogen. After incubation in the protein rich (and thus nitrogen rich solutions) a distinct 
N 1s signal appeared. This underlined the conclusion from the C 1s spectra that 
macromolecules such as proteins adsorbed from solution. 
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Figure 90: Spectroscopic analysis of the stability of Cu-SURMOF 2 in aqueous media. XRD spectra (A) of 
Cu-SURMOF 2 before and after incubation in MilliQ® water, ASW, PBS buffer, PBS buffered fibrinogen 
solution and the cell culture medium DMEM (supplemented with 10 % FCS and 1 % L-Glutamine) for 1 h. 
Crystallinity was retained during the incubation in MilliQ® water and ASW. The Cu 2p spectra (B) and the 
C 1s spectra (C, D) show nearly no changes in MilliQ® water and ASW, while obvious changes are visible in 
the other media. Nitrogenous species were deposited on the surface from the proteinacous media as seen 
in the N 1s spectra (E).
[296]
 
Additionally, spectral ellipsometry was used to investigate the effect of the incubation in 
the different media on the film thickness. As shown in Figure 91 A Cu-SURMOF 2 was 
stable with regard to MilliQ® water and ASW for at least 1 h. This was in agreement with 
the XRD and XPS data. In case of the analysis of the film thickness after the PBS incubation 
problems fitting the ellipsometric data to the theoretical model were encountered. The 
mean square error (MSE) of the corresponding fit (numbers above the bar graph in 
Figure 91 A) was much larger for the PBS incubated surface (142) than for the other 
surfaces (less than 70). This finding could be explained by a very high roughness, for 
which the Cauchy layer model[214] was not adequate any more. A high degree of 
roughness was also consistent with the XRD data showing that the remaining overlayer 
was non-crystalline. As reference the film thickness of a HKUST-1 (Hong Kong University 
of Science & Technology-1) SURMOF after different times of incubation in MilliQ® water is 
shown in Figure 91 B. The rapid decrease of the film thickness stood in strong contrast to 
the high stability observed for Cu-SURMOF 2 after even 1 h. For incubation of the 
Cu-SURMOF 2 in fibrinogen solution and the protein rich medium DMEM an increase in 
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thickness would have been expectable due to absorption of a protein overlayer. Table 8 
shows the protein thicknesses typically obtained on the SAMs onto which the 
Cu-SURMOF 2 was deposited. Both, spectral ellipsometry and XPS show a similar increase 
in thickness by approximately 4 nm, which is in agreement with literature values for a 
single layer of proteins.[220,297] In contrast, incubation of the Cu-SURMOF 2 led to a rapid 
decrease of the thickness of the MOF overlayer (Figure 91 A). 
 
Figure 91: Ellipsometric measurements of SURMOF film thicknesses. A) Film thickness of the pristine 
Cu-SURMOF 2 before and after incubation in different media for 1 h. The size of the error bars corresponds 
to the average film thickness errors as provided by the WVASE32 program for each measurement. The MSE 
of each fit is shown above the graph. In case of PBS problems were encountered in the fitting process, see 
text. B) Time-dependent reduction of the HKUST-1 film thickness in MilliQ® water.
[296]
 
 
Table 8: Comparison of the fibrinogen film thickness on SAMs measured by ellipsometry and by XPS. 
Errors are the SD.
[296]
 
Surface Type 
Film Thickness 
Ellipsometry 
[Å] 
Film Thickness 
XPS 
[Å] 
Fibrinogen on MHDA 42.9 ± 0.6 39.2 
Fibrinogen on HDT 49.1 ± 1.7 45.6 
 
 
Figure 92 shows the overview XPS data comparing the elemental composition of the 
pristine Cu-SURMOF 2 and the Cu-SURMOF 2 after PBS and ASW incubation. For the PBS 
incubation one can see that both the O 1s and O KVV peaks increased and that P 2s and 
P 2p3/2 peaks appeared. The increase of oxygen and phosphorous was connected to the 
decrease of the C 1s peak and the increase of the Cu 2p3/2 peak (Figure 90 B-D), which 
pointed towards a substitution of the organic linker molecules, most likely by phosphate. 
This change in chemistry resulted in a loss of crystallinity as seen in the XRD measurement 
(Figure 90 A). Thus, it could be deduced that the incubation of the Cu-SURMOF 2 in PBS 
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led to a transformation of the crystalline metal-organic framework into an amorphous 
thin film comprised of Cu-SURMOF 2 components and phosphate from the buffer 
solution. In the case of incubation with ASW no new peaks were seen in the XPS data 
(Figure 92), revealing that none of the non-copper metal ions contained in the ASW were 
stored in the Cu-SURMOF 2 material (e.g. by ion incorporation or exchange). 
In order to explore whether and where proteins adhered on patterned Cu-SURMOF 2 
adlayers, patterned Cu-SURMOF 2 surfaces were exposed to green fluorescent protein 
(GFP)-labelled fibrinogen for 30 min and subsequently investigated by fluorescence 
microscopy. Although it was known from the spectroscopy data that the Cu-SURMOF 2 
was completely removed during this experiment, it was still interesting to investigate if 
protein affinity varied spatially, i.e. whether the adhesion of proteins was affected initially 
when the Cu-SURMOF 2 was still present. The corresponding fluorescence micrographs 
are shown in Figure 93 A. The fluorescence on top of the patterned areas was higher than 
on the HDT SAM, a material which was known to be very proteophilic.[220] The intensity 
was roughly 4 times larger on the MHDA structures compared to the HDT SAM. 
Interestingly, the largest fluorescence was observed directly at the borders between HDT 
SAM and the Cu-SURMOF 2 squares. 
 
 
Figure 92: XPS spectra of pristine Cu-SURMOF 2 and of Cu-SURMOF 2 incubated in PBS and ASW for 1 h. 
The overview spectra shows phosphate peaks in the SURMOF.
[296]
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Figure 93: Adhesion of GFP-labelled fibrinogen to structured Cu-SURMOF 2 surfaces. The fluorescence 
image (A) of a structured Cu-SURMOF 2 substrate incubated for 30 min with GFP-labelled fibrinogen, the 
intensity profile (B) of the fluorescence signal detected and the greyscale (C) along the red line depicted in A 
show the preference of the protein to adhere to the borders of the MHDA squares.
[296]
 
5.2 BIOCOMPATIBILITY AND CELL CULTURE 
APPLICATION 
The fact that Cu-SURMOF 2 was stable in water at least for a limited duration made it 
interesting for the application in life and environmental sciences. The dissolution of the 
Cu-SURMOF 2 in cell culture media as described above might be the basis for using such 
coatings as slow release matrix for drugs or soluble control factors for cell differentiation 
and growth. In this section the general compliance of Cu-SURMOF 2 substrates with cell 
culture is investigated. For this wild type rat embryonic fibroblasts (REF52WT), a well 
characterised model cell line from the connective tissue frequently used for cell adhesion 
studies [298] and mechanistic studies on the formation of focal contacts and integrin 
clustering,[299] were used. For this prototype cell, time-lapse cell adhesion analysis and 
microfluidic detachment experiments were conducted in vitro on different substrates. 
The optical micrograph images (Figure 94) obtained after 3 h of incubation show that the 
initial adhesion and spreading of REF52WT cells proceeded similarly on the homogeneous 
Cu-SURMOF 2 surfaces as it did on the MHDA SAM. This analysis was conducted in the cell 
culture medium DMEM in which REF52WT cells were typically cultured. As the stability 
studies presented in section 5.1 showed that the Cu-SURMOF 2 was dissolved upon 
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immersion in DMEM, it could be concluded that the Cu2+-ions liberated during this 
process into the solution did not harm the cells or delay their life cycle. Adhesion to both 
the patterned (Video S6, description found in the Appendix section 7.3.2, video provided 
on the supplementary CD) and the homogeneous Cu-SURMOF 2 took place immediately 
after the cells got in contact with the surface and spreading occurred on the same 
timescale as on the control substrate, the MHDA SAM. Proliferation of the cells took place 
after approximately 7 h on both surfaces, thus supporting the notion that the 
concentration of solvated Cu2+-ions did not harm the cells (Figure 95). XRD data recorded 
after the coating with fibroblast cells (data not shown) showed no Cu-SURMOF 2 
diffraction peaks, thus revealing that the dissolution of the SURMOF 2 into the cell culture 
medium was not substantially delayed by cell adhesion. 
 
Figure 94: Microscopic images taken after incubating Cu-/Zn-SURMOF 2 with REF52WT for 3 h. The border 
of the structured SURMOF 2 area is indicated by the red dotted line.
[296]
 
 
Figure 95: Microscopic images of a REF52WT cell proliferating on a homogeneous Cu-SURMOF 2 
substrate. Six steps (1-6) in the proliferation process are shown. The images show the fully spread cell (1), 
which detached from the surface (2-4), divided into two daughter cells (5), which both adhered to the 
surface (6). Proliferation was observed after ~ 7 h. This time span corresponded well with that found on the 
SAM reference. 
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Besides cell adhesion dynamics and analysis of proliferation the critical shear stress 
required to detach 50 % of the REF52WT cells from Cu-SURMOF 2 was quantified. This 
aimed at providing further evidence for the normal adhesion behaviour of the cells and 
for the full integrity of the cell-surface contact. MHDA and HDT SAMs were measured as 
control surfaces. The REF52WT cells were incubated in the microfluidic channel system 
for 5 h according to a well-established protocol.[11] Figure 96 shows the adhesion curves in 
A) and     values determined by microfluidic shear force measurement in B). The curves 
in Figure 96 A show the decrease in the fraction of adherent cells on a surface against the 
applied shear stress. It can be seen that the critical shear stress needed for removal of 
50 % of the cells    
 was nearly the same for the homogeneous Cu-SURMOF 2, the MHDA 
SAM and the structured Cu-SURMOF 2 (Figure 96 B). Only for the hydrophobic 
background, the HDT SAM, the adhesion strength was reduced. This was in agreement 
with the time-lapse microscopy images shown in Figure 94, in which the REF52WT cells 
hardly adhered to the HDT SAMs after 3 h, thus proving that the presence of the copper 
released from the dissolving Cu-SURMOF 2 did not affect the adhesion and allowed for a 
normal development of the fibroblasts. 
 
 
Figure 96: Microfluidic adhesion measurement of REF52WT cells on different sample surfaces. The 
measurements were conducted on the two reference SAMs, MHDA and HDT, as well as on homogeneous 
and structured Cu-SURMOF 2 samples. The mean detachment curves are shown in A, while B gives the 
corresponding mean     values. The MHDA SAM and both Cu-SURMOF 2 samples yield the same mean     
values while adhesion to the HDT SAM is significantly weaker. Each measurement was repeated at least 3 
times with > 60 cells/FOV. The error bars are the SD.
[296]
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5.3 APPLICATION AS SMART-RELEASE SURFACE 
As the stability of Cu-SURMOF 2 in ASW for at least 1 h could be demonstrated in 
section 5.1 this medium offered the possibility to test the applicability of Cu-SURMOF 2 as 
smart-release surface. However, ASW was not adequate for cell culture. For this reason a 
substitutive organism, the marine bacterium Cobetia marina (C. marina), was chosen. 
C. marina is a model bacterium used in many adhesion studies due to its relevance in 
marine biofouling. [300-302] The studies with the bacterium were conducted in cooperation 
with Maria Pilar Arpa Sancet from our workgroup. 
The stability of Cu-SURMOF 2 in ASW was again analysed by XPS and XRD. Figure S13 
(Appendix section 7.3.2) shows virtually the same XP spectra of the Cu 2p (A) and the C 1s 
(B) peak for the pristine surfaces and after an incubation for 2 h in MilliQ® water. After an 
equally long incubation in ASW, minor peak changes became visible. The Cu 2p peak 
slightly increased, while the C 1s peak showed a marginal reduction. This indicated a 
disassembly of the top layers of the SURMOF structure resulting in better spectroscopic 
accessibility of the Cu2+ building units and a loss of some bdc linkers. The XRD 
measurements proved that all samples retained their crystallinity (Figure S13 C, D, 
Appendix section 7.3.2). 
XPS analysis yields the elemental composition of the sample in dependency of the sample 
depth. Measurements of the SURMOF with bacteria present would have led to 
superimposed signals in which a differentiation between signals originating from the 
SURMOF and signals from the bacteria would have been near impossible. XRD in contrast 
only generates signals from regularly structured objects such as crystals. The overall 
amorphous structure of the bacteria did not contribute to the signal detected. Therefore, 
only XRD was applied for detecting changes in the SURMOF. It could be shown that 
incubation of Cu-SURMOF 2 with C. marina in ASW led to a significant reduction of the 
XRD signal intensity over the course of 2 h (Figure 97 A) hinting a disassembly of the 
Cu-SURMOF 2 initiated by the adhesion of the bacteria. On the basis of these 
observations the scenario depicted in Figure 97 B was proposed. After attaching to the 
SURMOF substrate (which was stable in ASW), the bacteria released biomolecules which 
diffused into the MOF and led to a structural rearrangement of the MOF material. This 
structural arrangement was likely to include an exchange of ions, which in turn led to a 
release of a small amount of Cu2+ ions that are toxic to microorganisms.[303]  
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Figure 97: Stability analysis of Cu-SURMOF 2 in the presence of the marine bacterium C. marina and a 
proposed mechanism for the active degradation of the same by the bacterium. XRD spectra (A) of 
Cu-SURMOF 2 before and after incubation with ASW as reference and a suspension of the bacterium 
C. marina in ASW. The inlayed graph shows the decrease of the intensity of the (001) peak during the 
incubation with C. marina. A possible mechanism for this loss of crystallinity is shown in (B). (a) Healthy 
bacteria on initial contact with the SURMOF. (b) Bacteria settled on the intact SURMOF begin secretion of 
EPS and other molecules. (c) Disassembly of the SURMOF and release of Cu
2+
 ions. (d) Adverse effect on 
bacteria leading to reduced viability and adhesion strength.
[304]
 
In the process of attaching to a surface the bacteria secrete extracellular polymeric 
substances (EPS) composed of macromolecules (mostly polysaccharides[305] such as alginic 
acid (AA)[306]). That such biomolecules can affect the metal-organic frameworks was 
demonstrated by incubation of test samples in a variety of solutions related to the 
bacterial physiology. These solutions were pure ASW as reference, a solution of 0.5 µg/mL 
AA in ASW, an EPS solution and the supernatant after the growth of bacteria in a glass vial 
for 2 h. Figure 98 A shows the XRD spectra obtained after the incubation of the 
Cu-SURMOF 2 substrates for 2 h in the test solutions. For both the AA solution and the 
EPS solution a dramatic decrease of the XRD peak intensities was observed. After 
immersion into the supernatant of a bacterial suspension, a complete loss of the 
crystalline order could be detected. Inductively coupled plasma optical emission 
spectrometry (ICP-OES) measurements of the test solutions after the incubation of 
Cu-SURMOF 2 samples in them, revealed significantly increased copper concentrations 
(Figure 98 B). The highest copper concentrations of approximately 2 mg/L were measured 
after 2 h exposure of the Cu-SURMOF 2 to the supernatant of a bacterial suspension and 
after incubation in suspensions of C. marina. These findings together with AFM 
measurements of the bacterial morphology (Figure S14 and Figure S15 in the Appendix 
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section 7.3.3) and the Cu-SURMOF 2 height after incubation with the bacteria (Figure S16 
in the Appendix section 7.3.3), SEM imaging of bacteria (Figure S17 in the Appendix 
section 7.3.3), viability assays (Figure S18 A in the Appendix section 7.3.3) and 
detachment experiments (Figure S18 B in the Appendix section 7.3.3) clearly underlined 
the hypothesis of the active degradation of the SURMOF by the bacteria. 
 
Figure 98: Stability analysis of Cu-SURMOF 2 in different media connected with the physiology of the 
bacteria C. marina and measurement of the corresponding copper release. A) XRD spectra of the SURMOF 
after the 2 h incubation. B) Copper concentration in the supernatant after the incubation as determined by 
ICP-OES.
[304]
 
5.4 DISCUSSION 
The development of viable methods for the in vitro culture of HSC to improve HSCT 
presents a second route to optimising the treatment of AML, next to selectively 
mobilising the LSC from their niche to make them more susceptible to chemotherapy. In 
the context of the latter approach the CD44-hyaluronic acid interaction was investigated 
and the results were presented in chapter 4. This chapter focussed on new matrix 
systems for the in vitro culture of HSC. One good approach when aiming at improving cell 
culture conditions, is to mimic the in vivo environment of the cells.[307-308] In the bone 
marrow niche, where the HSC dwell,[55-57] they undergo many different forms of 
interaction with their surroundings.[27] Some of these are the exhibition to soluble factors, 
such as cytokines or growth factors. In an in vitro approach such drugs should ideally be 
released continuously to the HSC as is the case in vivo. The material type predestined for 
use in such an application is a porous material. Of the various porous materials available 
the MOFs are by far the chemically and structurally most flexible. In this study the first 
fundamental investigations concerning the application of a novel 2-D surface-bound MOF, 
namely SURMOF 2, as drug release substrate in cell culture were undergone. Therefore, 
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the stability of the structure and the biocompatibility of the building blocks were 
analysed. First tests as smart-release substrate were also undergone in a marine 
environment. 
Stability analysis of Cu-SURMOF 2 demonstrated a pronounced stability with regard to the 
exposure to MilliQ water. After immersion times of 2 h, the integrity of the 
Cu-SURMOF 2 was completely maintained, as evidenced by ellipsometry, XPS and XRD. 
This result was somewhat surprising, as HKUST-1,[309] a SURMOF which was also based on 
copper dinuclear carboxylate paddlewheel-units, and the structurally nearly identical 
Zn-SURMOF 2 were unstable even in MilliQ water. Ellipsometric measurements showed 
that HKUST-1 was removed in less than 5 min. It could furthermore be demonstrated that 
while PBS buffer induced an amorphisation of the SURMOF, proteinacous media led to a 
complete disassembly of the same. 
The stability of Cu-SURMOF 2 in water opened the possibility to test the suitability of 
these MOF thin films for environmental and life science applications. The Cu-SURMOF 2 
substrates showed an overall compliance with eukaryotic cell culture (culture of REF52WT 
cells in DMEM), even though the dissolution of the Cu-SURMOF 2 substrates was 
accelerated in the cell culture media. No toxic or inhibitory effects on the proliferation or 
adhesion of fibroblast cells were observed on the Cu-SURMOF 2 coated substrates, 
despite the rapid release of Cu2+-ions. Therefore, the experiments represented an 
extreme case in which cells were exposed to the maximum copper concentration possible 
in this setup. A smart-release system, similar to that aimed for in cell culture, could 
already be realised with the Cu-SURMOF 2 substrates and bacteria, which thrived in ASW. 
It could be demonstrated that Cu-SURMOF 2 was, next to MilliQ water, also rather 
stable in this salt based medium for up to 2 h. Based on this stability it could be shown 
that incubation with the marine bacterium Cobetia marina led to a localised disassembly 
of the SURMOF. This disassembly, which presumably was induced by chemicals secreted 
by the bacteria, locally released the copper ions incorporated in the SURMOF matrix, 
which in turn led to most bacteria dying and detaching from the surface. 
Overall the major requirements for the application of a structure as drug release surface 
are the possibility to incorporate the drug (pores of the appropriate size), a mode of slow 
and continuous drug release (diffusion, disassembly of the framework) and if used in 
contact with biological material the biocompatibility of the structure and its building 
blocks. Considering these prerequisites the findings presented in this section 
demonstrated the high potential of Cu-SURMOF 2 for the future application in this field. 
The release of the incorporated drug, cytokine or growth factor by a slow disassembly of 
the framework could be the means of choice. For this the foundations were laid by the 
pronounced stability in water. Slight structural modifications of the organic linker 
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molecules should be sufficient to increase the stability so far that a slow release should be 
possible. The biocompatibility of the building units, most specifically the Cu2+ ions, was 
demonstrated by the unimpaired adhesion and proliferation of eukaryotic fibroblast cells 
to Cu-SURMOF 2 substrates. Finally, based on the stability of Cu-SURMOF 2 in marine 
conditions, experiments with marine bacteria could demonstrate the principal 
applicability of Cu-SURMOF 2 substrates as smart-release matrix. The mechanism of 
localised disassembly induced by the bacteria may possibly be transferred to cell culture, 
where the presence of the cells could trigger the release of the drug, cytokine or growth 
factor. The refinement of the framework structure and the application as drug release 
structure are currently successfully being pursued by the workgroup around Prof. Christof 
Wöll at the Karlsruhe Institute of Technology (IFG, KIT, Karlsruhe, Germany).[310] 
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6 SUMMARY AND OUTLOOK 
Acute myeloid leukaemia (AML) is the most common form of acute leukaemia in adults. 
Although most patients reach complete remission after initial chemotherapy the overall 
survival rate is as low as 30-40 % over 4 years. This is ascribed to leukaemic stem cells 
(LSC) which survive the chemotherapy in the bone marrow (BM) niche and later cause the 
relapse.[2-3] Therefore, two aspects of the treatment need to be improved. The first is the 
efficiency of the apoptosis induction in LSC by chemotherapeutic agents whilst ideally 
sparing the haematopoietic stem cells (HSC). The second is the efficiency of the 
haematopoietic stem cell transplantation, as this currently presents the only method of 
rescuing the haematopoietic system after failure due to intensive, potentially LSC-
eradicating chemotherapy. An overview over the analysis conducted in this work is shown 
in Figure 99. 
 
Figure 99: Overview over the aspects of the HSC/LSC-niche interaction studied in this work. The 
interaction of the cell surface receptor CD44 with HA under flow (I; section 4.1 and 4.2), the interaction of 
CD44
+
 cells with MSC under flow (II; section 4.3), the effect of the cytokine SDF-1α and the mobilisation 
reagent Plerixafor® (III; section 4.4) and the first analysis of the possibility to utilise a novel 2-D surface 
bound metal-organic framework structure as release matrix for future applications in cell culture (IV; 
section 5) were studied. Image inspired by Barrett et al., 2008.
[68]
 
The cell surface receptor CD44 has been reported to be involved in the retention of LSC in 
their niche[6-7] and in the homing and engraftment of healthy HPC to the bone marrow 
(BM) niche.[9] The exact step, though, where this involvement occurs is still unclear, as 
indicated in Figure 99 (I). It has been hypothesised that CD44, similar to selectins,[63-67] is 
involved in the primary adhesion of leukocytes under flow during extravasation.[119] As 
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the receptor is the same there is no apparent reason why this role should not be upheld 
in HSC or leukaemic cells. In fact C. Christophis et al. identified a flow induced interaction 
of CD44 positive leukaemic cells and haematopoietic progenitor cells (HPC) isolated from 
umbilical cord blood (CB) with hyaluronic acid (HA). The first step of this study was to fully 
characterise the interaction of this receptor with its major ligand HA. To do so a 
microfluidic shear force device, established in our group,[10,12] was utilised. With this the 
flow conditions found in vivo were mimicked and the interaction of two cell lines, namely 
the leukaemic suspension cell line (KG-1a) and the epithelial liver cancer cell line 
(HepG2Iso), was characterised and compared. It could be demonstrated that the flow-
induced rolling interaction observed on HA was specific for HA, could only be observed if 
CD44 was expressed by the cells and that it was dependent on the HA binding domain of 
CD44. This analysis matrix clearly proved that the flow-induced rolling interaction was 
mediated by the cell surface receptor CD44. Interestingly, the CD44 mediated rolling 
interaction observed on HA was independent of the cell type. For the leukaemic 
suspension cell line and the epithelial liver cancer cell line, but also for healthy HPC and to 
a certain extent leukaemic blasts, the characteristics of the flow-induced interaction were 
nearly identical. In all cases rolling was induced beyond a critical shear stress of 
approximately 0.2 dyn/cm², reaching the maximum fraction of rolling cells at roughly 
(0.7-1) dyn/cm². Beyond this region of shear stress the cells continuously detached from 
the surface. This was in good correlation with previous findings of C. Christophis et al. 
who first observed this flow induced rolling for KG-1a cells and HPC isolated from CB.[10] 
Analysis of the dependency on different CD44variant isoforms revealed that the rolling 
interaction could not be abrogated by suppression of either CD44v3 or CD44v6. The flow-
induced rolling interaction could, however, be suppressed by CD44pan knock down or by 
treatment either with the monoclonal CD44 antibody (clone BU52) or with short chain 
length HA. In the context of the treatment of HepG2Iso cells with the two latter 
mentioned blocking agents a concentration dependency was observed. This 
demonstrated a clear correlation between on the one hand the probability of the cells to 
bind to the HA-coated surface from flow and the rolling velocity and on the other hand 
the density of the receptor available for binding. In contrast to this stood the 
independence of the strength of the CD44-HA binding which was similar throughout all 
experiments. This could be demonstrated by the independency of the shear stress at 
which the maximum interaction was observed from the treatment with different 
concentrations of the blocking reagents. 
As hinted above the rolling interaction was independent of the cell type studied and, 
therefore, could not be identified as a possible therapeutic target distinguishing between 
the leukaemic and the healthy cells. It was, however, not the only interaction observed 
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with the HA-coated surfaces. All cell types expressed a, in most cases low, tendency to 
immobily adhere to the HA-coated surfaces. This tendency was less pronounced for the 
model cell lines and the HPC isolated from CB or mobilised peripheral blood (mPB) for 
which typically a fraction of less than 5 % of immobile adherent cells was observed. For 
HPC isolated from the BM and leukaemic blasts values up to 20 % were not uncommon. 
Even more striking was the effectiveness of the treatment with the CD44 antibody BU52. 
While the rolling interaction of all cell types studied in this work could be suppressed with 
sufficient amounts of BU52, the immobile adhesion could not. In some samples of 
leukaemic blasts (each being isolated from a different patient) treatment with the 
antibody had no or only a marginal effect on the fraction of immobile adherent cells. 
Interestingly, a comparison between blast samples from a single patient originating either 
from the BM or the peripheral blood (PB) revealed that the suppression of the immobile 
adhesion was more effective in the samples originating from the PB. This indicated that 
the resistance towards the antibody may have been correlated to a vicinity to the BM 
niche prior to isolation of the cells. Furthermore, a comparison between patient data for 
the blast samples in which the antibody was effective with those where it was not, 
uncovered a link between the BU52 resistance and a poor long-term therapeutic outcome 
of the respective patients. 
All cells, except for the HSC, the BM niche is comprised of can be derived from 
mesenchymal stromal cells (MSC).[13-14] For this reason and due to the fact that they play 
a significant role for maintaining the self-renewal potential of HSC and HPC, MSC are 
often used as model system for the BM niche.[57,71,73-75] In this work the analysis of the 
interaction of CD44 positive cells with HA-coated surfaces was expanded towards MSC 
feeder layers (Figure 99 (II)). Feeder layers were defined as surfaces completely covered 
with convergent MSC. For this a procedure where the MSC were seeded into and cultured 
in a fully assembled microfluidic channel was developed. Here, the morphology of the 
cells was correlated to the shear stress required to detach the cells and supposedly ideal 
culture conditions were identified. Preliminary experiments concerning the interaction of 
both the cell line KG-1a and HPC (from CB and mPB) were conducted. Rolling was hardly 
observable on the MSC. In contrast to this a high fraction of cells immobily attached to 
the MSC during the experiments. Furthermore, the interaction with MSC could not be 
suppressed by BU52 demonstrating that the overall interaction pattern was more 
complex in this system than the simple CD44-HA interaction observed on the HA-coated 
surfaces. For a more detailed understanding an antibody matrix suppressing a variety of 
receptors, e.g. integrins, selectins or cadherins would need to be applied, thus 
determining the receptors involved and the form of interaction they mediate with MSC. 
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Both CD44[130-132] and its ligand HA[237] are ubiquitously expressed in the mammalian cells. 
Therefore, regulation of the interaction between them is of great importance. One mode 
of regulation is controlling the expression of HA on endothelial cells. It was shown that 
proinflammatory stimuli could upregulate HA expression, thereby, inducing CD44 
mediated interaction with the endothelial cells.[287] HSC homing, where the CD44-HA 
interaction is thought to be relevant (Figure 99 (III),[9] is directed by a gradient of the 
cytokine stem-cell-derived factor-1 alpha (SDF-1α).[9,16,69-70] It is, therefore, possible that 
this cytokine may also be involved in the regulation of the CD44 activity. This notion was 
further supported by the identification of a molecular link between SDF-1α and CD44 via 
the SDF-1α receptor CXCR4.[288] As control reagent the CXCR4 antagonist[98] Plerixafor®, 
which is clinically used for the mobilisation of HSC out of the BM niche,[93-95] was used. As 
SDF-1α is known to induce migration,[16-19,289] the effect of both SDF-1  and Plerixafor® on 
the migration of HPC was evaluated in a transwell assay to determine the effectiveness of 
the reagents in the in vitro environment of the assays applied in this work. It could be 
shown that SDF-1α strongly induced migration and that the effect could successfully be 
suppressed by Plerixafor®, demonstrating the validity of the system. The effect of the two 
reagents on the interaction of HPC with HA under flow was evaluated by pre-treating HPC 
isolated from CB and mPB and subsequently evaluating the interaction in the microfluidic 
shear force device. It could be shown that neither SDF-1α nor Plerixafor® influenced the 
interaction with HA under flow in the system used in this work. These findings 
demonstrated a clear mechanistic separation of the migration form the interaction under 
flow, despite the molecular link[288] between the involved receptors. 
In the context of the evaluation of the interaction of HPC and leukaemic blasts with HA 
the identification of the immobile adhesion to HA, mainly exhibited by the leukaemic 
blasts, could be an important step towards the selective mobilisation of LSC. The fact that 
this immobile adhesion to HA was not only correlated to a vicinity to the niche, but also to 
an adverse therapeutic outcome suggested that it may have been involved in the 
retention of LSC in the BM niche. Under this hypothesis the questions why this interaction 
was stronger in leukaemic cells than in HPC and why it was found primarily in cells 
originating from the BM niche should urgently be addressed. Revealing the exact 
mechanism of this interaction and searching for drugs to selectively target this 
mechanism of LSC retention in the niche could lead to means of selectively mobilising LSC 
rendering them more susceptible to chemotherapy. This would make the use of lower 
dosages of chemotherapeutic drugs possible, thus reducing the need for stem cell 
transplantation after chemotherapy. Also the interaction with MSC should not be omitted 
as this cell type is found abundantly in the niche.[75] It is possible that while the role of the 
CD44 mediated interaction could not be demonstrated in this work, it may become 
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apparent when other interactions such as those mediated by integrins or cadherins are 
preempted. 
Next to analysing the interaction of HSC/LSC with their microenvironment in order to 
selectively target the LSC with mobilisation or chemotherapeutic reagents, a second 
approach is to find ways of improving the culture of HSC in vitro. A basis for this is finding 
suitable substrates that can be used to slowly and continuously release cytokines and 
growth factors into solution to mimic the in vivo environment. Today porous materials 
such as zeolites, porous metals or porous silicon are widely used in catalysis, in sensors or 
in filtering processes, e.g. gas or water purification.[35-42] An example is the application of 
porous stents loaded with drugs for the localised application of the same.[311] In the 
context of drug storage and delivery, however, the pore size (determining the size of the 
drug embedded in the structure), the stability of the material under the conditions of 
later use (e.g. in vivo use as a stent) and of course the biocompatibility of the material are 
of great importance. Here, a relatively new class of materials shines. The metal-organic 
frameworks (MOFs) are highly flexible in their structural and chemical properties due to 
framework being grown from a combination of metal precursors and organic linker 
molecules.[43-45] Furthermore, the growth of MOFs on functionalised surfaces, creating so-
called SURMOFs (surface-anchored MOFs), is easily possible.[191,201,204] This enables the 
coating of devices, such as stents, or cell culture dishes. A novel 2-D structured SURMOF, 
namely SURMOF 2, which was recently developed in the group of Prof. Christof Wöll at 
the Karlsruhe Institute of Technology (IFG, KIT, Karlsruhe, Germany)[209,295] presented a 
good basis for such work. In this work first tests concerning the stability of the basic 
SURMOF 2 ([M2(bdc)2]n; M = Cu, Zn) in different media and the biocompatibility of the 
building blocks were undergone (Figure 99 (IV)). Analysis by XPS, XRD and spectral 
ellipsometry could show that Zn-SURMOF 2 was instable in all media tested and that 
while Cu-SURMOF 2 was stable in MilliQ water and ASW it was rapidly disassembled in 
proteinacous solutions such as cell culture medium. Still, the effect of the building units of 
Cu-SURMOF 2 (Cu2+ ions and the bdc linker) on the adhesion and growth of fibroblasts 
(REF52WT) was analysed. Measurement of the shear stress required to detach the 
fibroblasts from a matrix of test surfaces as well as time-lapse observations of the 
proliferation rate and cell morphology revealed no impairment of proliferation or 
adhesion. Due to the demonstrated stability in ASW and the instability in cell culture 
conditions smart-release tests were conducted in a marine environment. Here, it could be 
demonstrated that incubation with the marine bacterium Cobetia marina led to a locally 
induced disassembly of the SURMOF. The copper ions released thereby were toxic for the 
bacteria resulting in bacterial death after adhesion. The biocompatibility and the ability to 
tune the system as smart-release matrix, indicate the principal applicability of 
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Cu-SURMOF 2 as drug delivering substrate in future cell culture applications. The further 
development of the stability of SURMOFs is thereby of great interest. Under the premise 
that the disassembly can be slowed down sufficiently and that the pores can be designed 
such that loading with e.g. cytokines or growth factors is possible, continuous release of 
these reagents to the cells should be achievable.  
Concluding, this work presents new insights in the interaction between CD44 and its 
major ligand hyaluronic acid and elaborates the importance of differences in this 
interaction for the treatment of acute myeloid leukaemia. Additionally, the principal 
applicability of a novel 2-D framework structure as drug release system was 
demonstrated. 
 
 131 
 
7 APPENDIX 
7.1 SUPPORTING INFORMATION CONCERNING THE 
MICROFLUIDIC SHEAR FORCE MEASUREMENT 
This section gives further insight into the theory underlying the microfluidic shear force 
setup and presents alternative modes of measurement not presented in the main 
chapters, but relevant for the supplementary material. Finally, data supporting the 
observations and conclusions made in section 3.8.6 is presented. 
7.1.1 CALCULATION OF THE VARIABLES RELEVANT FOR THE 
MICROFLUIDIC SHEAR FORCE SYSTEM 
7.1.1.1 PRESSURE DROP IN THE MICROFLUIDIC CHANNEL SYSTEM 
With liquid flowing through a pipe as in any other system the laws of conservation of 
energy are upheld. This section elaborates the origin of the pressure loss between two 
points of a channel through which liquid flows. Finally, the implications for the 
microfluidic shear force measurements are also discussed. 
Equation (S1) shows the comparison of the liquid energy at two points (indexed as ‘1’ and 
‘2’). For a steady average velocity flow of incompressible fluids the total energy can be 
summarised as elevation energy, velocity energy and pressure energy.[312] The energy 
equation can then be expressed as 
     
 
 
  ̅ 
            
 
 
  ̅ 
             (S1) 
Here,    is the pressure of the fluid at the different points   = 1 and   = 2,       is the 
pressure loss between the two points,   is the density of the fluid,  ̅  is the average flow 
velocity,   is the acceleration of gravity and   is the elevation.    is the kinetic energy 
parameter, which corrects for the use of an average velocity in case the velocity profile is 
not uniform. Under the assumption of a uniform fully developed flow throughout the 
tubing, both    are the same and neglectable. Taking this into account the kinetic energy 
terms of the fluid flow  
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  ̅ 
  (S2) 
as well as the potential energy terms 
     (S3) 
are easily calculable, given that the variables such as  ̅ ,   or the elevation   are known. 
The remaining term describing the pressure loss       between the two points can be 
divided into two terms. The first is the ‘major loss’ term, which for a fully developed, 
steady state and incompressible flow can be described by Equation (S4), which is also 
known as the Darcy-Weisbach equation. The no-slip clause between a viscous fluid and a 
solid, states that the flow velocity of the fluid is zero relative to the boundary of the solid. 
Therefore, the wall shear stress results in an energy loss of the fluid making the surface 
roughness and flow profile (given by the Reynold´s number which is described in 
section 7.1.1.2) highly important factors for the amount of energy lost due to friction. The 
‘minor losses’ described by Equation (S5) arise from changes in velocity due to bends, 
fittings, valves, elevation etc.  
          
 
  
  ̅ 
  (S4) 
        ∑  
 
 
  ̅ 
  (S5) 
With    being the Darcy friction factor,   the diameter of the pipe, and    the loss 
coefficient. The Darcy friction factor    can be graphically derived from the Moody 
diagram or may be calculated using e.g. the Colebrook equation[313] or the Haaland 
equation.[314] For laminar flow    can be calculated from the Reynold´s number    
according to Equation (S6).[177,312] 
   
  
  
 (S6) 
It should be noted that all formulas calculating the friction factor are approximations 
based on extensive experimental data. Similarly, the dimensionless loss coefficient    is 
well documented for various pipe geometries and can be looked up in the appropriate 
tables. 
In the microfluidic shear force setup used in this work the pressure loss was a variable 
that needed to be considered. The pressure loss was mainly due to the energy loss mainly 
originating from frictional forces and velocity changes, both of which are velocity 
dependent. Therefore, increasing the flow velocity led to an increased pressure loss over 
the system. Reduction of the overall pressure in the system led to the formation of gas 
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bubbles in the system. This had could have various reasons. If the overall pressure in the 
system was reduced below the vapour pressure of the fluid (water based in all 
applications used in this work), this would have resulted in the formation of bubbles of 
aqueous vapour. It is also possible that the low pressure in the system led to the leakage 
of air into the system through e.g. fittings and valves or to the release of gas from the 
liquid. This would have made the calculation of the shear stress at the channel bottom 
impossible as the exact liquid flow would no longer have been known. To avoid this, an 
overpressure of approximately 0.6 bar was applied to the system in all measurements.  
7.1.1.2 DERIVATION OF THE REYNOLDS NUMBER IN THE MICROFLUIDIC CHANNEL 
SYSTEM 
The Reynold´s number    is a dimensionless number that helps characterise different 
flow profiles. Calculation of the Reynold´s number can be used to predict whether a flow 
will be laminar or turbulent. Typically flow with a Reynold´s number below 2300 is 
defined as laminar.[177] For the calculations of the wall shear stress inside the microfluidic 
channels system the establishment of a laminar flow is mandatory as only then a defined 
velocity gradient along the y-axis (orthogonal to the channel bottom/top) can be 
anticipated. This will be further discussed in section 7.1.1.3. 
For circular pipes the Reynold´s number   [177,312] is given as  
   
   
 
 (S7) 
With the viscosity   and the density   of the liquid, die diameter   and the flow speed  . 
For non-circular channels the diameter is substituted by the hydraulic radius    
   
 
 
 
                                
                         
 (S8) 
In order to substitute   in Equation (S7) one must calculate    for a circular tube: 
   
 (               )
 (               )
 
     
  
 
 
 
       (S9) 
Insertion of this into Equation (S7) results in 
   
     
 
 (S10) 
   can now be calculated for a rectangular cross sectional area of the width   and the 
height   as 
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 (   )
 (S11) 
Knowing that      ⁄  the Reynold´s number may be calculated by  
   
 
  
 (   )
 
   
 
 
   
 (   )
 
(S12) 
Under the premise that the width   of the channel by far exceeds the height   (with 
  ≈ 135 µm and   ≈ 1500 µm this is the case in the microfluidic channel system), 
Equation (S12) can be simplified to 
   
   
  
 (S13) 
For the most extreme conditions applied in the microfluidic shear force setup throughout 
this work (  = 81 mL/min maximum applicable flow,   = 0.72 x 10-3 kg m-1s-1 cell culture 
medium at 37 °C[187],   = 1kg/L,   = 135 µm) the Reynold’s number calculates to ~ 1670 
(or to ~ 830 if it is considered that   ≈ 40 mL/min is the maximum practically applicable 
flow rate). This is well below the threshold Reynold´s number of 2300 for laminar 
flow.[177] 
7.1.1.3 DERIVATION OF THE WALL SHEAR STRESS IN THE MICROFLUIDIC 
CHANNEL SYSTEM 
The calculation of the wall shear stress    was a central aspect of the work with the 
microfluidic shear force setup as it gave a value to easily compare between experiments. 
   does, in contrast to e.g. the flow rate, take variables such as the channel dimensions 
into account and, thereby, provided a mean of comparison independent of the variables 
specific for each assembly. 
Shah and London presented both the exact solution, involving Fourier series expansions, 
as well as a simple approximation of the velocity profile originally proposed by Purday.[186] 
Because this approximation is in excellent agreement with classical experimental results, 
and is much easier to compute, it was used to estimate the maximum velocity at the 
midplane of the microchannels, and the shear stress on the microchannel surface. 
The Purday approximation for rectangular channels (shown in Figure 32 in section 3.8.3 is 
repeated here for convenience), as used in the microfluidic shear force setup, gives the 
axial velocity as shown in Equation (S14).[186] 
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Figure 32: Parallel plate model for unidirectional flow. A parabolic flow profile between two immobile 
parallel plates is shown. The height is so much smaller than the width of the channel that the shear at the 
channel sides can be neglected. 
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and 
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) (S15) 
 ,   ,      are the axial, mean and maximum velocities, respectively and  ,   are 
empirical parameters dependent on the aspect ratio   =  /  (height/width). For an 
aspect ratio α smaller than 1/3,  = 1.7 + 0.5 ∙  −1.4 and   = 2. In the channel system used 
in this work   ≈ 1/10. For all Newtonian fluids in laminar flow the shear stress   is 
proportional to the strain rate in the fluid with the viscosity   being the constant of 
proportionality. This correlation is shown in Equation (S16).[177] The laminarity of the flow 
in the microfluidic shear force setup was described both in section 3.8.3 and in more 
detail in the previous section. 
 ( )    
  
  
 (S16) 
The wall shear stress    is defines as 
     (   )   
  
  
|
   
 (S17) 
Differentiation of  (   ) (Equation (S14)) with respect to  , as part of Equation (S17), 
yields 
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] (S18) 
With    = /   with   being the flow rate, and calculating at the centre of the channel 
width (  = 0) 
x
z
y h
w
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Bearing in mind that   = 2 in the setup used in this work this can further be simplified to 
   
   
   
(
   
 
) (S20) 
Note that Equation (S20) has the familiar form of the parallel plate approximation  
   
   
   
 (6) 
with the addition of the (   )  ⁄  term to account for side wall effects. This term is 
neglectable in cases were the width is much larger than the height of the channel system, 
as is the case in the microfluidic channel system applied in this work. This demonstrates 
that the parallel plate approximation of Equation (6) could be applied in this work. 
It should be mentioned that by insertion of Equation (S13) into Equation (6) the shear 
stress may also be estimated from the Reynold´s number as 
  
  
  
 (S21) 
As elaborated in section 3.8.3 the wall shear stress was increased stepwise during the 
commonly applied detachment assay. In principal the wall shear stress applied in each 
step could be calculated from the initially applied shear stress   , the growth coefficient 
  , by which the shear stress was increased in each step, and by the step number  . 
        
  (17) 
In this context Equation (6) was used to calculate the dimension dependent initial shear 
stress    of each experiment. 
   
   
   
          
  (S22) 
As different step durations were used in this work and in related studies using the same 
microfluidic setup with different channel dimensions[268-269] a substitution of    by a 
factor, independent of the step duration, was desirable. This was achieved by introducing 
the growth rate of the shear stress    allowing a more straightforward description of 
experiments with different step durations, but the same overall increase of the shear 
stress. To do so the exponent   was substituted by the duration    for which the 
experiment had been conducted (≙ how many steps had been taken). As the shear stress 
was increased stepwise it must be mentioned that    was a multiple of the duration of a 
step   . 
 137 
 
        (S23) 
With this Equation (S22) could be rewritten as the universal equation for the calculation 
of the wall shear stress (Equation (18)) in each step as follows 
         
    
      (  
 
  )
    
    (  )
   (18) 
An example for the practicality of    can be given when comparing the two forms of the 
detachment assay, that were both used in this work. The first was a stepwise increase by 
approximately 26 % (   = 1.2589) every 5 s. The second was a stepwise increase by 
2.33 % (   = 1.0233) every 0.5 s. From these values it is not apparent that the overall 
increase was the same. For both cases    = 1.047. This common value nicely illustrates 
the common slope of both shear stress curves. 
7.1.2 MICROFLUIDIC DATA ACQUISITION AND ANALYSIS 
7.1.2.1 DATA ACQUISITION IN CELL-SURFACE INTERACTION EXPERIMENTS 
The main focus of the microfluidic cell-surface interaction experiments was the flow 
induced rolling interaction of CD44 positive cells with hyaluronic acid (HA). Video S1 
shows an exemplary HepG2Iso cell (a CD44 positive model cell line) rolling on a HA-coated 
substrate with a shear stress of approximately 1 dyn/cm² applied. The full video can be 
found on the CD provided with the printed edition of this thesis. Next to this rolling 
interaction an immobile adherent interaction of some cell 
types was also observed in the cell-surface interaction 
experiments. These two behaviours of the cells are shown 
in Video S2. Here, the interaction of KG-1a cells, another 
CD44 positive model cell line used in this work, with HA 
again with approximately 1 dyn/cm² applied is shown. The 
immobile adherent cells are marked in green, while rolling 
cells are labelled in red. The full video can be found on the 
CD provided with the printed edition of this thesis. 
As discussed in section 3.8.5 the number of cells in contact with the sample surface at a 
given time was normalised either to the number of cells initially visible in the field of view 
(FOV)    or by the mean maximum number of interacting cells. The procedure chosen 
depended on the type of cells analysed. All cell types (the model cell lines KG-1a, Jurkat 
and Kasumi-1, the HPC from cord blood, mobilised peripheral blood and the bone marrow 
as well as the leukaemic blasts) except for the HepG2Iso and HepG2 cells were 
normalised all normalised by   . Video S3 shows the correlation between the cells 
 
Video S1: HepG2Iso cell rolling 
on a HA surface. 
 138 
 
counted in the FOV in the microfluidic channel and the interaction curve generated after 
normalisation. This is shown for the first analysis method (correction to   ) as this was 
the standard procedure in this work. This video is presented to help the reader visualise 
the procedure of analysing the videos recorded during measurement. The number of cells 
interacting with the sample surface was counted by hand in a 5 s interval. This number 
was then corrected appropriately and plotted as shown in the graph on the right in 
Video S3. For labelling the cells in the FOV a differentiation is made between rolling 
(marked in red) and immobile adherent cells (marked in green). The evaluation is, 
however, only shown for the overall interaction of the cells with the surface (the sum of 
all cells interacting with the surface at a given time is plotted) as this should only give an 
example. The full video can be found on the CD provided with the printed edition of this 
thesis.  
 
Video S2: Video demonstrating the difference between rolling and immobile adherent cells. Rolling cells 
are marked in green. The immobile adherent cells are marked in red.
[266]
 
 
Video S3: Video demonstrating the creation of a detachment curve by counting the cells interacting with 
a surface at a given time. The rolling cells (marked in red) and the immobile adherent cells (marked in 
green) are summed and divided by the number of cells initially visible in the FOV. Plotting this against the 
shear stress applied at the time of counting yields the detachment curve shown on the right.
[266]
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7.1.2.2 ACCUMULATION ASSAY 
The accumulation assay was a second method next to the detachment assay to compare 
the effects of different treatments on the interaction of cells with surfaces under shear 
flow. For this assay the cells were not injected into the channel system directly but were 
rather flushed through the channel during the entire assay. The channel was initially 
flooded with the cell suspension (typically 1∙106 cells/mL). A strong flow pulse of 
approximately 1,200 dyn/cm² was then applied. This not only ensured a sufficient amount 
of cells in the channel but also detached all cells interacting with the surface after 
injection. The flow was then reduced to approximately 7.8 µL/min (≈ 0.2 dyn/cm²) and 
kept constant. This flow rate was sufficient to trigger the flow induced interaction of the 
cells with the surface, while remaining slow enough to allow the initial contact with the 
surface from flow. Analysis of this form of experiment was straightforward as the number 
of cells interacting with the surface at a given time simply was counted and plotted 
against the time. 
 
Figure S1: Flow profile of an accumulation assay. A first high pulse detached all cells from the surface. The 
flow was then reduced and kept constant at approximately 7.8 mL/min. 
7.1.2.3 EVALUATION OF DATA WITH HISTOGRAMS AND BOX PLOTS 
Histograms and box plots present the most straightforward method of graphically 
depicting distributions of large numbers of data points, while giving clear information 
about the distribution of the data and allowing an easy determination of trends. The 
histogram (Figure S2) gives a nice visualisation of the distribution of the data points. Here, 
a bar is plotted for each interval. An interval is a region of data points.[315] It the specific 
case of the rolling velocities measured in this work it may for example be the range of 
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(5-10) µm/s. From the histogram the range of the most frequent value (e.g. rolling 
velocity) is easily deducible.  
Figure S2 presents a typical box plot. As shown in the figure the box plot in this example is 
comprised of three values (five are also typical). Mostly these represent the 1st (lower box 
margin), 2nd (middle line) and 3rd (upper box margin) quartile of the data.[315] The 1st 
quartile is also known as the 25th or the 25 % percentile. Equally, the 2nd quartile is the 
50th or the 50 % percentile and the 3rd quartile is the 75th or 75 % percentile. These are all 
specific forms of quantiles, commonly used in descriptive statistics. Quantiles are defined 
as values, which divide the distribution of a random variable into data subsets of equal 
size. Accordingly, a percentile represents a per cent of the data points and a quartile 
represents a quarter of the data points. Therefore, the 1st quartile is defined as the value 
below which 25 % of the values can be found. The 2nd quartile (50 % percentile) is more 
commonly known as the median of the values. As the median value is defined as the 
value which halves the data set, it is clear that this value corresponds to the 2nd quartile 
(50th percentile, 50 % percentile). The mean value  ̅ is the average value of all values and 
is given by  in the box plot. It can be calculated by 
 ̅  
∑    
 
 (S24) 
Where    is each value of the data set,    is the frequency of    and   is the sample 
size.[315] The whiskers represent the standard deviation    of the data, which is 
calculated as follows 
   √
∑(    ̅)  
   
 (S25) 
Where    is each value of the data set,  ̅ is the mean value,    is the frequency of    and   
is the sample size.[315] 
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Figure S2: Exemplary analysis of rolling velocity data with a histogram and a box plot. The histogram best 
shows the most frequent velocity. The boxplots gives statistical values such as the mean velocity, the 
median velocity or the 1
st
 and 3
rd
 quartile.  
7.1.3 OPTIMISATION AND PROOF OF APPLICABILITY OF THE 
MICROFLUIDIC SHEAR FORCE DEVICE 
Section 3.8.6 focussed on understanding the origin of the inaccuracy, concerning the 
measurement of the critical shear stress     required to detach 50 % of the objects of 
interest from a sample surface, recently observed by M.P. Arpa Sancet and M. Alles in our 
workgroup. This section provides data either undergirding the findings presented in that 
section or giving the full data set given there in short. 
7.1.3.1 INFLUENCE OF THE CHANNEL DIMENSIONS 
As M. Alles demonstrated an improvement of the intra-channel reproducibility by 
application of a 130 µm thick aluminium spacer in the 13 mm channels used by her, this 
was also investigated in this work. By analysing the detachment of carboxy-terminated 
polystyrene microspheres (diameter   ≈ 4.5 µm, hereafter referred to as particles) from 
HUDT SAMs, an independence of the initial channel dimensions (before an experiment 
was conducted) of the application of a spacer was demonstrated in section 3.8.6.1. It was, 
furthermore, shown that in an experimental series conducted in one channel (without 
reassembly between the measurements) a change of the     value was independent of 
the channel dimensions in the relaxed state (no experiment run, but with the 
overpressure applied). In the experimental series presented in section 3.8.6.1 the     
values decreased before reaching a plateau. Figure S3 presents the reverse trend. The     
values increased over the first three measurements and then reached a plateau. This was 
in no correlation to the channel dimensions in the relaxed state of the system, which 
remained the same throughout the experimental series. 
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Figure S3: τ50 values measured in succession in one single channel without application of a spacer. The     
value increased over the first three measurements before reaching a plateau. The channel dimensions were 
measured between the experimental runs, thereby only representing the dimensions if no flow was 
applied. The errors given for the channel dimensions are estimated measuring errors. 
7.1.3.2 EFFECT OF THE APPLICATION OF SPACERS ON THE REPRODUCIBILITY OF 
THE MEASUREMENT 
The influence of the application of a spacer on the inter-channel reproducibility was 
presented in section 3.8.6.2. Table S1 gives an overview over all mean     values and the 
corresponding errors determined in the cause of the investigation. The number of repeats 
conducted in each experimental run ranged from at least 5 to up to 16 repeats. The data 
was homogenised by only considering the first five repeats. From the data it can be seen 
that the mean percentage error and the SD of the same were reduced by application of a 
spacer. Without spacer the mean percentage error was 18.1 ± 12.0 %. This was reduced 
to 10.9± 3.9 % by use of a spacer, meaning that the use of a spacer increased the 
reproducibility in each series of measurements. 
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Table S1: Overview over the     values measured in one channel either with or without application of a 
spacer. Only the first 5 repeats of each experimental series were taken into account for the calculation of 
the mean     values and the corresponding errors. 
 1 Channel without spacer 1 Channel with spacer 
Exp. 
number 
Mean τ50 
[dyn/cm²] 
SD 
[dyn/cm²] 
Error 
[%] 
Mean τ50 
[dyn/cm²] 
SD 
[dyn/cm²] 
Error 
[%] 
1 75.4 12.0 15.9 14.9 1.8 12.1 
2 42.2 3.5 8.4 220.5 10.0 4.6 
3 18.9 2.0 10.8 37.5 3.5 9.3 
4 29.9 6.9 23.0 32.6 4.8 14.7 
5 9.7 0.7 7.0 24.3 1.1 4.4 
6 25.4 5.2 20.3 87.1 7.0 8.1 
7 30.3 6.4 21.2 27.6 2.9 10.6 
8 7.9 1.2 14.8 63.8 7.4 11.6 
9 13.2 1.2 9.1 103.9 17.9 17.3 
10    96.3 13.0 13.5 
11    50 6.8 13.6 
Mean 
error 
[%] 
18.1 ± 12.0 10.9 ± 3.9 
 
7.1.3.3 DEPENDENCY ON THE STEP DURATION AT A CONSTANT OVERALL 
INCREASE 
To evaluate the effect of different sampling procedures on the reproducibility of 
successive measurements two different sampling procedures were applied in the 
microfluidic shear force device. Both procedures followed the same overall increase with 
one procedure being sampled every    = 0.5 s (growth rate    = 1. 047) and one being 
sampled every 5 s (   = 1. 047). As shown in Figure S4 and in contrast to the example 
discussed in section 3.8.6.3 the fluctuations were slightly higher in the measurement 
series presented here. This may be due to the fact that this measurement was conducted 
without a spacer. However, the conclusion that the results obtained were independent of 
the sampling procedure can be drawn from this data set as well as the detachment curves 
on the one hand and the     values on the other hand clearly overlapped. This undergirds 
the findings presented in section 3.8.6.3. 
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Figure S4: Evaluation of the effect of the experimental procedure on the     values measured. The step 
duration    was varied while the growth rate    was constant. No spacer was used. The     values 
remained nearly constant throughout the measurement. The errors given for the channel dimensions are 
estimated measuring errors. 
7.1.3.4 DEPENDENCY ON THE MAXIMUM SHEAR STRESS APPLIED 
The effect of the maximum shear stress applied to the channel system was discussed in 
section 3.8.6.4. Here, it was demonstrated that while the application of a spacer 
improved the intra-channel fluctuation at low shear stresses, it had no effect if high shear 
stresses were applied. In this case the fluctuation was not only generally smaller, but it 
was also independent of the application of a spacer. As deviations of the channel 
dimensions were one possible explanation for the shifts of the     values, the progression 
of the     values in dependence of the channel dimensions and the maximum shear 
stress applied is shown here. Figure S5 and Figure S6 each present a successive series of 
measurements in a channel without and with application of a spacer, respectively. 
Figure S5 demonstrates that while the     values changed during the measurement, 
especially after the application of high shear stresses of approximately 1,000 dyn/cm², the 
channel dimensions did not. This behaviour was not typical for channels lacking a spacer 
under high shear stress, but it does nicely demonstrate the independency of the channel 
dimensions from the     values observed in this setup. The same conclusion can be drawn 
from Figure S6 that shows both stagnating channel dimensions and     values. These 
findings indicate that any errors observed during the measurements were not correlated 
with the channel dimensions in the relaxed state (over pressure applied, but no suction 
generated by the syringe pump). 
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Figure S5: Dependency of the     value measured on the maximum shear stress applied to the system 
without a spacer applied. The measurements were conducted in succession in one single channel. The 
channel dimensions were measured between the experimental runs, thereby only representing the 
dimensions if no flow was applied. The errors given for the channel dimensions are estimated measuring 
errors. 
 
Figure S6: Dependency of the     value measured on the maximum shear stress applied to the system 
with a spacer applied. The measurements were conducted in succession in one single channel. The channel 
dimensions were measured between the experimental runs, thereby only representing the dimensions if no 
flow was applied. The errors given for the channel dimensions are estimated measuring errors. 
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7.1.3.5 DEPENDENCY ON THE ATTRACTIVENESS OF THE SAMPLE SURFACE 
In section 3.8.6.5 the dependency of the errors of the measurement was correlated with 
the region of shear stress in which the objects of interest detached from the surface. For 
this the detachment of particles from DDT SAMs (highly attractive) was compared to that 
from HUDT SAMs (moderately attractive). While the main text provides the direct 
comparison of the data obtained during the measurements the full data is presented in 
Table S2. The mean     values and the corresponding errors (SD and percentage error, 
PE) obtained in all measurement series conducted on DDT or HUDT SAMs without a 
spacer are given. While the overall deviation was large in all experimental series, the 
mean PE was far larger of the measurements on DDT, the SAM which required higher 
shear rates to detach the particles from. This hinted that measurements at even lower 
shear stresses should provide an even higher accuracy. 
Table S2: Overview over the     values measured on HUDT and DDT without application of a spacer. 
 
Measurements on HUDT 
without spacer 
Measurements on DDT 
without spacer 
Exp. 
number 
Mean τ50 
[dyn/cm²] 
SD 
[dyn/cm²] 
PE 
[%] 
Mean τ50 
[dyn/cm²] 
SD 
[dyn/cm²] 
PE 
[%] 
1 29.4 8.1 27.6 333.2 107.6 32.3 
2 31.9 4.0 12.4 797.7 389.3 48.8 
3 13.6 0.1 0.9 1318.2 689.1 52.3 
4 15.2 0.8 5.4 1562.6 1317 84.3 
5 20.7 1.5 7.4 283.8 148.2 52.2 
6 81.4 6.7 8.2 318.3 122.4 38.4 
7 41.1 3.7 8.9 337.8 106.8 31.6 
8 20.1 0.3 1.5 708.2 565.1 79.8 
9 26.7 7.4 27.5 1733.4 1095.5 63.2 
10 49.8 11.6 23.3 574.2 26.8 4.7 
11 9.9 0.6 5.8 387.1 129.2 33.4 
12 28.2 4.8 17.0    
13 33.4 6.6 19.9    
14 7.1 0.9 12.0    
15 12.6 0.9 7.1    
16 9.9 0.6 5.8    
Mean PE 
[%] 
11.9 ± 8.4 42.1 ± 24.3 
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7.2 SUPPORTING INFORMATION CONCERNING THE 
ANALYSIS OF THE INTERACTION OF CD44 WITH 
HYALURONIC ACID 
This section provides background information concerning the investigation of the 
interaction of the cell surface receptor CD44 with its major ligand hyaluronic acid (HA) 
under shear flow conditions presented in section 4. 
7.2.1 OVERVIEW OVER THE CELL CULTURE MEDIA COMPOSITIONS 
USED IN THIS WORK 
As always when handling cells the culture conditions were of great importance. 
Therefore, this section presents the compositions of the cell culture media in which the 
different cell types used in this work were cultured.  
Table S3: Cell culture medium used for the model cell lines KG-1a, Jurkat and Kasumi-1. 
Component Concentration Company 
RPMI 1640 88 % Invitrogen 
FCS 10 % Invitrogen 
L-Glutamine 1 % PAA Laboratories GmbH 
Penicillin/Streptomycin 1 % PAA Laboratories GmbH 
 
Table S4: Cell culture medium used for REF52WT and HepG2Iso. 
Component Concentration Company 
DMEM 88 % Invitrogen 
FCS 10 % Invitrogen 
L-Glutamine 1 % PAA Laboratories GmbH 
 
  
 148 
 
Table S5: Cell culture medium used for healthy human cells from the PB, for human HPC from CB, mPB 
and BM and for leukaemic blasts. 
Component Concentration Company 
StemlineTM II Haematopoietic 
Cell Expansion Medium 
95.4 % Sigma-Aldrich 
L-Glutamine (2 mmol/L) 1 % PAA Laboratories GmbH 
TPO (100 ng/mL) 1 % PAA Laboratories GmbH 
SCF (100 ng/mL) 1 % PAA Laboratories GmbH 
G-CSF (10 µg/mL) 0.1 % PAA Laboratories GmbH 
FLT3-L (500 ng/mL) 0.5 % R&D Systems 
Penicillin 1,000 U/mL 
Streptomycin 100 U/mL 
1 % PAA Laboratories GmbH 
 
7.2.2 EFFECT OF BU52 ON THE ACCUMULATION OF KG-1A CELLS ON 
HA 
The accumulation assay was used to further strengthen the finding, presented in 
section 4.1.2, that the HA binding domain of the cell surface receptor CD44 was required 
for the interaction of the CD44 positive cells studied in this work with HA-coated surfaces 
under flow. For this the effect of the treatment of KG-1a cells with different amounts of 
the CD44 antibody BU52 was analysed. Figure S7 A shows the accumulation curves 
acquired. It can be seen that the number of untreated cells interacting with the surface 
steadily increased until a plateau was reached after approximately 3 min. Increasing 
amounts of BU52 led to decreasing numbers of cells interacting with the surface. Full 
suppression was achieved with 9 µg/mL BU52. The CD44 negative cell line Kasumi-1 
served as negative reference for the experiment. The amount of BU52 required for a 
complete suppression of the interaction was is good accordance with that determined by 
measurement using the detachment assay as presented in section 4.1.2. Furthermore, the 
same concentration dependent reduction of the interaction potential with HA could be 
observed in these measurements.  
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Figure S7: KG1a accumulation on HA in dependence of the BU52 concentration. KG-1a cells were 
incubated with varying amounts of BU52 prior to investigation of the interaction with HA under shear flow. 
The accumulation curves (A) and the bar graphs depicting the maximum number of cells interacting with 
the surface (B) show the reduction of the interaction by BU52. The graph shows the results of one set of 
measurements (n = 3). This was repeated thrice with comparable results. The maximum number of cells 
interacting with the surface was highly sensitive to experimental variations making an averaging of the data 
difficult. In all cases increasing amounts of BU52 led to a reduction of the interaction. 
7.2.3 VIABILITY OF HEPG2ISO CELLS INCUBATED WITH SHA 
In the course of the study of the characteristics and dependencies of the CD44-HA 
interaction the effect of the treatment of the cells with glycosaminoglycans (GAGs) such 
as the otherwise surface-bound HA was analysed. For this HepG2Iso cells were incubated 
with soluble macromolecular and oligomer GAGs. As high concentrations of the oligomer 
HA (short chain length; sHA; length: 6-10 disaccharide units, DS) were used for this study 
the viability of the model cell line HepG2Iso in such concentrations of sHA was tested. The 
analysis was conducted by Katharina Fuchs (group of Dr. Véronique Orian-Rousseau at 
ITG, KIT, Karlsruhe, Germany). HepG2Iso cells were incubated with 50 µg/mL sHA 
(6-10 DS) for 1 h in cell culture conditions before imaging the cells by light microscopy. 
The cellular shape, the area of adhesion and the overall appearance of the cells was then 
compared to untreated cells to estimate whether the incubation had an impairing effect 
on the cells. As shown in Figure S8 the incubation had no negative effects on the 
HepG2Iso cells after 1 h. This time span was longer than the incubation time before 
microfluidic shear force measurements (30 min) plus the duration of the measurement 
(5 min per measurement with 2 measurements per incubated vial, resulting in 40 min in 
total) and, therefore, safely covered the necessary time span of exposure. 
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Figure S8: Treatment of HepG2Iso cells with sHA for 1 h. HepG2Iso cells were incubated with sHA (6-10 DS) 
for 1 h before they were imaged using a Canon Power Shot S620 digital camera connected to an Axiovert 
40c Zeiss microscope (10x objective). The cells showed no obvious change indicating no impairing effects 
resulting from the incubation. 
7.2.4 INTERACTION OF PRIMARY HUMAN HAEMATOPOIETIC AND 
LEUKAEMIC CELLS WITH HA 
This section provides supporting or more extending information concerning the 
interaction of healthy haematopoietic and leukaemic cells with HA. This shall undergird or 
elaborate the findings presented in section 4.2. 
7.2.4.1 INTERACTION OF HEALTHY BLOOD CELLS WITH HA 
As demonstrated for haematopoietic progenitor cells (HPC) isolated form umbilical cord 
blood (CB) a preincubation of the cells in StemlineTM II Haematopoietic Cell Expansion 
Medium supplemented with 100 ng/mL TPO, 100 ng/mL G-CSF, 100 ng/mL SCF, 
500 ng/mL Flt-3L, 2 mmol/L L-glutamine, 1,000 U/mL penicillin and 100 U/mL 
streptomycin for 24 h (hereafter referred to as Stemline II medium) was required to 
enable the rolling interaction of the cells with HA. Table S6 depicts the results of the flow 
cytometry measurements for some of the HPC samples from CB, mobilised peripheral 
blood (mPB) and the bone marrow (BM) used in this work as measured by Isabel 
Hoffmann from the group of Prof. Anthony D. Ho at the Universitätsklinikum Heidelberg. 
Not all samples were analysed as the material was available only in small quantities and 
was needed for the microfluidic measurements. However, Table S6 clearly shows that 
after the incubation in Stemline II medium all HPC maintained their stemcellness marked 
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by expression of the CD34 receptor. It was also shown that the cells expressed high levels 
of CD44pan. 
Table S6: Flow cytometry measurements of HPC after Stemline II incubation for 24 h. 
HPC source 
(sample number) 
CD34 positive 
cells 
[%] 
CD44pan positive 
cells 
[%] 
CB (1) 98.88 99.64 
CB (2) 99.39 99.94 
CB (3) 98.82 99.85 
mPB (1) 99.66 99.96 
BM (1) 98.20 97.27 
 
The interaction of the different HPC with HA under flow conditions was extensively 
discussed in the main text (section 4.2.1). Here, the interaction of blood cells isolated 
from the peripheral blood (PB) of healthy donors with HA is discussed. The data shown in 
Figure S9 represents one of two independent, but comparable sets of measurements. In 
each set of measurements the interaction of mononuclear cells (MNC; also known as 
peripheral blood mononuclear cells PBMC) with HA under flow was compared to that of 
granulocytes, monocytes and lymphocytes. Here, MNC present the totality of all cells 
isolated from the peripheral blood containing a round nucleus (rather than a lobed 
nucleus) with the granulocytes, monocytes and lymphocytes covering most of the other 
blood cells less the red blood cells. As shown in Figure S9 A there was hardly any 
interaction of the cells from the healthy PB observable with HA. Lymphocytes and 
monocytes did not roll or adhere to HA, despite expression of CD44. For MNC and 
granulocytes a certain amount of immobile adherent cells could be observed (B). In the 
case of the granulocytes firm adhesion to and spreading on the surface could be observed 
in the time-lapse videos obtained during measurement in the microfluidic channel 
system. This led to a strong, non-rolling adhesion to the surface. Pre-incubation of cells 
with cytokines in Stemline II medium did not increase the number of cells that interacted 
with HA. These findings demonstrated that rolling on HA-coated surfaces could not be 
observed for the highly differentiated cell types although all expressed CD44. 
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Figure S9: Interaction curves for healthy cells from the PB with HA. The interaction curves (A) show 
absence of interaction with HA for both monocytes and lymphocytes. MNC and granulocytes exhibit a weak 
interaction with HA that is only comprised of immobile adhesion (B). 
7.2.4.2 INTERACTION OF LEUKAEMIC BLASTS WITH HA 
The leukaemic blasts were isolated from frozen samples of patients freshly diagnosed 
with acute myeloid leukaemia (AML) by FAC sorting based on their SSC and CD45 
characteristics (SSClow, CD45dim). The CD44 expression was also measured to determine 
whether an investigation in the context of this work was expedient. The percentage of 
blasts gated from the isolated cell material and the fraction of those cells expressing CD44 
is shown in Table S7. If not mentioned specifically the blasts were isolated from the BM of 
the respective patient. At least 95.70 % of the blasts were CD44 positive. The data was 
obtained by the group of Prof. Anthony D. Ho at the Universitätsklinikum Heidelberg. 
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Table S7: Fraction of cells that were blasts isolated from the frozen patient material as sorted by FACS 
and the CD44 expression of the leukaemic blasts. 
Leukaemic Blast Sample 
Blasts gated from 
the cell material 
[%] 
CD44pan positive 
cells 
[%] 
AML 1 72.90 99.99 
AML 2 86.30 99.98 
AML 3 75.70 99.70 
AML 4 BM 89.50 99.90 
AML 4 PB 91.60 99.40 
AML 5 BM 36.40 99.20 
AML 5 PB 75.90 99.30 
AML 6 72.50 98.20 
AML 7 60.60 100.00 
AML 8 83.90 99.30 
AML 9 66.50 99.34 
AML 10 66.50 100.00 
AML 11 58.70 95.70 
 
The interaction of the leukaemic blasts with HA-coated surfaces was later measured in 
the microfluidic shear force setup. During data evaluation a discrimination was made 
between the cells undergoing the CD44 mediated flow induced rolling (extensively 
described and characterised in the main text in section 4.1) and those demonstrating an 
immobile adhesion to the surface. Furthermore, the effect of a CD44 antibody (clone 
BU52, hereafter referred to as BU52) on both forms of interaction was studied. A 
concentration of 9 µg/mL BU52 was used for these experiments as this concentration had 
previously (section 4.1.2 in the main text and Figure S7 in the Appendix section 7.2.2) 
been shown to fully suppress the interaction with HA. An overview of the interaction 
patterns obtained from the microfluidic measurements for the untreated blasts and for 
those treated with 9 µg/mL BU52 is shown in Figure S10. 
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Figure S10: Overview of all 11 AML blast samples measured. AML samples 1-5 represent interaction 
pattern A with flow-induced rolling and detachment of the interacting cells from the surface prior to 
~ 10 dyn/cm². AML samples 6-8 represent interaction pattern B with flow-induced rolling that persisted 
beyond ~ 10 dyn/cm². Both cases were accompanied by varying numbers of immobile adherent cells. AML 
samples 9-11 represent interaction pattern C with few rolling cells but large numbers of immobile adherent 
cells. 
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From the interaction curves or more specifically from the curves after treatment with 
BU52 it can be seen that while the antibody effectively suppressed the flow induced 
rolling of the cells in all cases the effect on the immobile adhesion was always so 
pronounced. The samples AML4 and AML5 both showed an ineffective blocking of the 
immobile adhesion by BU52. For these patients a comparison was made between both 
the overall interaction and the effectiveness of the BU52 treatment for blasts isolated 
either from the BM or from the PB. As shown in Figure S11 the interaction patterns of the 
untreated cells were nearly identical in both cases. The effect of the treatment with 
9 µg/mL BU52, however, differed. While the rolling interaction was fully supressed in all 
four samples the immobile adhesion was more effectively blocked in the samples isolated 
from the PB than in those isolated from the BM. 
 
Figure S11: Comparison of the interaction patterns from blasts from BM and PB in AML 4 (A) and AML 5 
(B).
[266]
 
A fraction of at least 10 % immobile adherent cells after treatment with BU52 was defined 
as ineffective blocking. Table S8 gives an overview over the patient characteristics, the 
risk group stratification according to the European LeukaemiaNet[316] and Foran et al.,[317] 
the blocking efficiency of the immobile adhesion to HA by BU52 and the outcome of the 
induction chemotherapy. While a correlation of the blocking efficiency with the risk group 
stratification was not apparent, one with the overall survival of the patients was. In the 
group in which BU52 was ineffective, only one of five patients achieved CR after induction 
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chemotherapy. Whereas in the group of six patients, in whom the adhesion of the 
leukaemic cells to the HA-surface could be inhibited by BU52, three achieved CR. A 
Kaplan-Meier plot (Figure 79), visualising the correlation between the blocking efficiency 
and the overall survival of the respective patient, is shown in section 4.2.2 in the main 
text.  
Table S8: Patient characteristics, risk group stratification, efficiency of the blocking of the immobile 
adhesion to HA by BU52 and state after induction chemotherapy for all AML samples.
[266]
 
Sample 
No. 
Gender Age Abnormalities 
Risk Group BU52 efficiency State after 
induction 
chemo-
therapy 
Deceased 
ELN
[31
6]
 
Foran
[
317]
 
N*N0
-1
 >10 % <10 % 
1 male 52 
add(2)(q33), -7, 
del(7q22), 
del(7q36) 
high high < 5   Persistence No 
2 male 65 
-Y ,t(8;21) 
(q22;q22), c-Kit 
mutation 
high high ~ 5   CR No 
3 male 66 
del(4)(q21),t(5;
16)(q11.2;q11.2
),t(6;12)(q13;p1
1.2),del(7)(q22q
32),-17, -
18,del(20)(q11.
2),add(20)(q11.
2) amplification 
of MLL-Gene 
+11q23 
fav. int. ~ 5   Persistence Yes 
4 female 71 
amplification of 
MLL-Gene 
+11q23 
int. int. ~ 20   Persistence Yes 
5 female 56 none int. int. ~ 15   
Deceased 
during 
chemo-
therapy 
Yes 
6 male 67 -Y,+13 int. int. ~ 15   Persistence Yes 
7 male 56 NPM1 positive int. fav. ~ 5   CR No 
8 male 32 
t(8;21)(q22; 
q22) 
fav. fav. 5-10   CR No 
9 male 53 
FLT3-ITD 
positive ratio 
0,74 
int. high ~ 15   CR Yes 
10 male 87 +8 int. int. ~ 15   
No chemo-
therapy 
Yes 
11 male 63 del(12)(p13) int. int. < 5   Persistence No 
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7.2.5 VISUALISATION OF THE GROWTH OF MSC FEEDER LAYERS AND 
THE INTERACTION WITH KG-1A CELLS UNDER FLOW 
This section presents two videos connected to the work with feeder layers (surfaces 
completely covered with convergent 
cells) of mesenchymal stromal cells 
(MSC). Video S4 gives an impression of 
how MSC grew inside a fully assembled 
microfluidic channel system over the 
course of ~ 23 h. It can be seen that 
during the first hours the MSC spread 
in the typical flat manner of epithelial 
cells reaching ideal spreading after 
roughly 5 h. Later the cells elongated 
until they appeared string-like. The 
video can be found on the CD provided 
with the printed edition of this thesis. 
Video S5 shows the interaction of the 
cells of the model cell line KG-1a with a 
reasonably good example of an MSC 
feeder layer. The KG-1a cells were not 
allowed to settle on the surface prior 
to measurement to minimise the 
number of cells ‘sticking’ to the MSC 
before the experiment was started. 
The video clearly shows that the KG-1a 
cells did not roll across the MSC as 
they did across the HA-coated 
surfaces. The KG-1a cells instead 
‘stuck’ to the MSC. Detachment of the 
KG-1a cells then involved elongation of 
the cells before the force of the liquid 
detached the cells from the MSC. This 
too was an observation, which could 
not be made for KG-1a cells on HA. The 
video can be found on the CD provided 
with the printed edition of this thesis. 
 
 
Video S4: Supplementary video demonstrating the 
growth of MSC inside a microfluidic channel. From the 
cell morphology alone it can be seen that an overnight 
incubation inside the channel was too long. Ideal 
spreading of the cells was reached after roughly 5 h. 
 
 
Video S5: Interaction of KG-1a cells with MSC under 
flow conditions. 
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7.3 SUPPORTING INFORMATION CONCERNING THE 
ANALYSIS OF THE STABILITY AND 
BIOCOMPATIBILITY OF SURMOF 2 
This section provides supplementary information undergirding and expanding the studies 
presented in section 5 of the main text. 
7.3.1 CHARACTERISATION OF THE MHDA SAMS USED FOR THE 
GROWTH OF THE SURMOFS 
As mentioned in section 3.2.3 self-assembled monolayers (SAMs) of 16-Mercaptohexa-
decanoic acid (MHDA) were used as functional surfaces on which the surface anchored 
metal-organic frameworks (SURMOFs) were grown. If used for this purpose the SAMs 
were prepared either by Hasan K. Arslan or by Zhengbang Wang from the workgroup of 
Prof. Christof Wöll (IFG, KIT, Karlsruhe, Germany). The MHDA SAMs were characterised by 
infrared reflection adsorption spectroscopy (IRRAS) prior to use. 
IRRAS grounds on the absorption of certain wavelengths of light (typically infrared light, 
hence the name) by molecules if the energy of the wave corresponds to the energy of a 
molecular rotation or vibration. The IRRAS surface selection rule states that only those 
molecular vibrations are visible of which a component is orthogonal to the surface. Such 
dynamic dipoles will be enhanced by the electric field induced by polarisation of the 
metal surface on which the measurement takes place.[318-319] A typical spectrum for a 
MHDA SAM used in this work was kindly provided by Zhengbang Wang and is shown in 
Figure S12. The spectrum shows the symmetric and the asymmetric vibrations of CH2 
groups at 2850 cm-1 and 2919 cm-1, respectively. The C=O vibrations for monomeric 
carboxylic groups are observed at 1717 cm-1 and the C=O vibrations for acyclic dimeric 
carboxylic groups are observed at 1742 cm-1. These values correspond well with those 
found by Arnold et al.[253] giving good evidence for the quality of the SAMs used. 
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Figure S12: IRRA spectrum of an MHDA SAM. The spectrum shows the symmetric and asymmetric CH2 
vibrations as well as the stretching vibrations νC=O for monomeric and acyclic dimeric carboxylic groups. 
7.3.2 EXTENDED STABILITY ANALYSIS OF CU-SURMOF 2 IN 
DIFFERENT MEDIA AND CELL SUSPENSIONS 
The stability of Cu-SURMOF 2 in MilliQ® water, artificial sea water (ASW), phosphate 
buffered saline (PBS) with and without fibrinogen added and the cell culture medium 
DMEM (relevant media for the culture of wild type rat embryonic fibroblasts, REF52WT) 
supplemented with 10 % FCS and 5 % L-Glutamine over a period of 1 h was presented in 
section 5.1. In the following section (section 5.2) the compatibility to the culture of 
eukaryotic cells was studied using 
REF52WT cells. Although the in-
stability of the Cu-SURMOF 2 sam-
ples in PBS or the proteinacous 
media resulted in a release of the 
building units (benzene-1,4-dicarb-
oxylic acid, bdc and Cu2+ ions) to the 
solution no impairment of the ad-
hesion or proliferation of the cells 
was observed. Video S6 shows the 
unimpaired adhesion and prolifer-
ation of REF52WT cells on a struc-
tured Cu-SURMOF 2 substrate over 
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Video S6: Proliferation of REF52WT cells on a structured 
Cu-SURMOF 2. 
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the course of 22 h. The temperature in the incubator was set to 37 °C and 5 % CO2 was in 
the atmosphere. Under these ideal conditions the cells were monitored by time-lapse 
microscopy in the TE2000-U microscope described in section 3.8.1. It can be seen that the 
cells adhered to and spread on the structured surface. Proliferation of the cells could also 
be observed. The video can be found on the CD provided with the printed edition of this 
thesis. 
Testing of the SURMOF substrates towards their general applicability as smart-release 
substrates was one of the aims of this work. As a pronounced stability of Cu-SURMOF 2 
was observed in ASW the substrate was tested with the marine bacterium Cobetia 
marina, which thrives in ASW. C. marina is a model bacterium used in many adhesion 
studies due to its relevance in marine biofouling.[300-302] The studies with the bacterium 
were conducted in cooperation with Maria Pilar Arpa Sancet from our workgroup. As a 
length of incubation of C. marina on sample surfaces of 2 h was typical for adhesion 
experiments[268,302] the stability analysis was expanded to this time span. Figure S13 A-C 
shows XP and XRD spectra clearly demonstrating the stability of Cu-SURMOF 2 in MilliQ® 
water for up to 2 h. The XP spectra were recorded by Stella Bauer from our workgroup 
and the XRD spectra were recorded by Hasan K. Arslan or Zhengbang Wang from the 
group of Prof. Christof Wöll (IFG, KIT, Karlsruhe, Germany). As seen in the same spectra 
the stability in ASW was nearly as pronounced as that of MilliQ® water. Here only a 
disassembly of the outermost layer(s) could be observed making the copper slightly more 
accessible by spectroscopy, seen by the increase of the Cu 2p peak and the decrease of 
the C 1s. The retention of the crystallinity during the incubation in ASW as measured by 
XRD is shown in Figure S13 D. Figure S13 E demonstrates that incubation with C. marina 
led to a gradual loss of crystallinity over time. 
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Figure S13: Stability analysis of Cu-SURMOF 2 in different media for 2 h. X-ray photoelectron spectra of (A) 
the Cu 2p and (B) the C 1s core level of Cu-SURMOF 2 for pristine samples and after incubation for 2 h in 
MilliQ water and ASW. (C) X-ray diffraction data before and after immersion of the Cu-SURMOF 2. (D) XRD 
of Cu-SURMOF 2 after incubation in ASW and (E) XRD after exposure to C. marina in ASW for different 
times.
[304]
 
7.3.3 CU-SURMOF 2 AS SMART-RELEASE SURFACE IN CONTACT 
WITH C. MARINA 
This section presents the study of the effect the bacteria C. marina had on the 
Cu-SURMOF 2 substrates and vice versa. The main tools used for this analysis were atomic 
force microscopy (AFM), microfluidic shear force detachment assays measuring the shear 
stress required to detach C. marina from the sample surfaces and a viability assay. AFM 
images were recorded by Carlos Azucena from the group of Prof. Christof Wöll (IFG, KIT, 
Karlsruhe, Germany) and the bacteria samples were provided, measured and analysed by 
Maria Pilar Arpa Sancet from our workgroup. Before discussing the results the methods 
are briefly presented. 
Atomic force microscopy (AFM) After 2 h incubation on the sample surface, the bacteria 
were air dried overnight following published protocols [320-321]. Bacteria were imaged 
using an Asylum Research Atomic Force Microscope, MFP-3D BIO. The AFM was operated 
at 25°C in an isolated chamber in alternating current mode (AC mode). AFM cantilevers 
were purchased from Ultrasharptm MikroMasch. Three types of AFM-cantilevers were 
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used, an NSC-35 (resonance frequency 315 kHz; spring constant 14 N/m), an NSC-36 
(resonance frequency: 105 KHz; spring constant: 0.95 N/m) and an NSC-18 (resonance 
frequency: 75 kHz; spring constant: 3.5 N/m). 
Bacterial viability assay The widely used[322-323] live/dead® BacLightTM bacterial viability kit 
was used to determine the viability of the bacteria after 2 h incubation on Cu-SURMOF 2 
substrates (120 nm thickness) and MHDA SAM as non-toxic control. The assay was 
performed following the manufacturer´s protocol. Prior to staining, the surfaces were 
incubated in a bacterial suspension in ASW with an optical density OD600 = 0.1 for 2 hours. 
Subsequently, 3 µl of a 1:1 mixture of both stains (red- and green-fluorescent nucleic 
stain) was added per millilitre of bacterial solution and incubated at RT in the dark for 
15 min. The samples were removed from the solution and rinsed with MilliQ® water. All 
samples were analysed by florescence microscopy with an upright Nikon microscope 90i 
and suitable optical filters (BV-2A and Texas red HYQ, Nikon, Tokyo, Japan) using a 40x 
objective.  
Microfluidic bacterial detachment assay The adhesion strength of the bacterium Cobetia 
marina on SURMOF 2 was quantified using a custom built microfluidic shear force 
setup[11] which has previously been utilised for the study of bacterial adhesion on 
surfaces.[302] Four fully assembled channel systems (dimensions: 13 mm x 1 mm x 140 µm) 
were mounted on an inverted microscope (Nikon TE2000-U). Bacteria suspensions with 
an OD600 = 0.1 were injected into all four channels and incubated for 2 h in parallel as 
established in previous protocols.[302] After the incubation phase, medium from a 
reservoir was sucked through the channels by a computer controlled syringe pump 
generating a flow which was increased stepwise by 26 % every 5 s. The detachment was 
followed via video microscopy with a 40x Ph2 objective and the fraction of adherent 
bacteria was determined every 5 s. The removal from all four channels was done 
sequentially. The wall shear stress    created by the liquid flow was calculated as 
described in section 7.1.1.3. From the removal curves, the critical shear stress required to 
detach 50 % of the adherent bacteria (   ) was derived. Each measurement was repeated 
at least four times.  
The first step in the evaluation of the influence the bacteria and the Cu-SURMOF 2 had 
each other was to record AFM images to determine the morphology of the bacteria after 
incubation on Cu-SURMOF 2. A HDT SAM served as reference substrate to compare the 
morphology of healthy well adhered bacteria. Figure S14 A shows the bacteria on a HDT 
SAM. In comparison to this the bacteria incubated on the Cu SURMOF 2 (Figure S14 B) 
were wrinkled and deformed. It could be shown that the roughness of the bacteria on the 
Cu-SURMOF 2 was approximately 50 % higher than that of those on the HDT SAM 
(Figure S14 C). Similarly, the mean width of the bacteria on the Cu-SURMOF 2 was 
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approximately 25 % larger compared to that of those seeded on the HDT SAM 
(Figure S14 D). Figuratively speaking the bacteria could be described as more wrinkled 
and flatter when incubated on the Cu-SURMOF 2. 
 
Figure S14: Analysis of the bacterial width and height after incubation on a Cu-SURMOF 2 substrate. AFM 
images of the bacteria on (A) HDT SAM and (B) Cu-SURMOF 2. (C) Mean roughness and (D) mean width of 
the bacteria. Measurements were obtained on seven individual bacteria. Error bars are the standard 
errors.
[304]
 
The impression of a deformation of the bacteria upon incubation on a Cu-SURMOF 2 
surface was further supported by measurement of the height profiles as shown in 
Figure S15. Here, it can be seen again that the bacteria incubated on the Cu-SURMOF 2 
surface were flatter than those incubated 
on the HDT SAM reference. Analysis of an 
overview of a Cu-SURMOF 2 surface on 
which the bacteria had been cultured for 
2 h showed that the SURMOF layer was 
still present. Such an overview is shown in 
Figure S16 A. The Cu-SURMOF 2 sample 
used for this analysis had an initial thick-
ness of approximately 160 nm, the typical 
thickness of a Cu-SURMOF 2 consisting of 
20 layers. From the height profile shown 
in Figure S16 B it can be seen that this 
height was still measureable after 
incubation with the bacteria. A possibility 
to consider the observation of an intact 
SURMOF layer after incubation with the bacteria, while still explaining the deformation of 
the bacteria, is a localised disassembly of the SURMOF upon contact with the bacteria. 
 
Figure S15: Analysis of the bacterial morphology. 
AFM images of C. marina on a Cu-SURMOF 2 (A) and 
on an HDT SAM (B). Height profile (C) indicated by 
the blue dotted and red line in (A) and (B).
[304]
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Figure S17 presents the proposed mechanism for this localised disassembly. The overview 
is the same as shown in Figure 97 with SEM 
images of bacteria appropriate to the 
scenario depicted shown. In the process of 
attaching to a surface C. marina secrete 
extracellular polymeric substances (EPS) 
composed of macromolecules (mostly 
polysaccharides[305] such as alginic acid 
(AA)[306]) functioning as glue for the bacteria 
to the surface. This may then induce a 
localised disassembly of the Cu-SURMOF 2 
in the direct vicinity of the bacteria. The 
copper ions released by this disassembly are 
toxic for the bacteria and are the reason for 
the deformation of the same. 
 
 
Figure S17: Proposed mechanism for the release of copper from a Cu-SURMOF 2 substrate by C. marina. 
(A) Healthy bacteria in initial contact with the SURMOF. The SEM image shows a pristine Cu-SURMOF 2. (B) 
Bacteria settled on an intact SURMOF begin secretion of EPS and other molecules. The SEM image shows a 
unaffected bacterium on a HDT reference SAM. (C) Disassembly of the SURMOF and release of Cu2+ ions. 
The SEM image shows a bacterium on a Cu-SURMOF 2 surface after 2 h incubation on the substrate. The 
bacterium is clearly deformed. (D) Adverse effect on bacteria leading to reduced viability and adhesion 
strength. The SEM image shows a bacterium with adhesion weakened by the SURMOF 2 so that it detached 
during preparation for the SEM leaving behind a dark spot.
[304]
 
 
 
Figure S16: AFM measurement of the SURMOF 2 
height after bacteria incubation. AFM image of a 
Cu-SURMOF 2 substrate incubated with C. marina 
for 2 h (A) and the height profile (B) along the red 
line shown in (A).
[304]
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To undergird the notion of a dying of the bacteria due to the copper ions released from 
the SURMOF, the viability of the bacteria on a MHDA SAM reference was compared to 
that on a Cu-SURMOF 2 substrate. Figure S18 A, B show the fluorescence microscopy 
images acquired after a 2 h incubation of the bacteria on these substrates. The images 
show a large number of damaged bacteria on the Cu-SURMOF 2 substrate. The ratio of 
damaged versus all bacteria was determined by evaluating the fluorescence signal in the 
microscopy images. A majority of the bacterial population was damaged on the 
Cu-SURMOF 2 (88 %). In contrast, the fraction of dead bacteria was only 0.9 % on the 
MHDA SAM. To further validate this finding microfluidic detachment assays were 
performed on Cu-SURMOF 2 (thickness ~ 120 nm and ~ 80 nm) and on HDT and MHDA 
SAMs as copper-free controls. Additionally, two types of surfaces with known low 
adhesion strength were included, polyethylene glycol (PEG)[302] and hyaluronic acid 
(HA).[244] Both surfaces were known for their protein and cell resistance, thus, providing 
suitable controls as typical inert surfaces. As shown in Figure S18 C, the shear stress 
needed to detach 50 % of the bacteria (   ) was significantly lower for both Cu-SURMOF 2 
coatings of differing thicknesses compared to the HDT and MHDA SAM controls. Even 
though the trend was similar within the error bars, it seems the 120 nm thick 
Cu-SURMOF 2 reduced adhesion more effectively than the 80 nm thick sample. The shear 
stress required to detach the bacteria was also in the range of the PEG and HA controls 
demonstrating the low interaction between the bacteria and the SURMOF. 
 
 
Figure S18: Viability and adhesion strength analysis of C. marina. Fluorescence microscopy images of 
adherent bacteria after BacLightTM bacterial viability staining on (A) MHDA SAM and (B) Cu-SURMOF 2 
(15 layers). (C) Critical shear stress (50) required to remove the bacteria from Cu-SURMOF 2 surfaces for 
different controls. Error bars indicate the standard error of the mean of six experiments in the case of 
Cu SURMOF 2 (10 layers) and HDT SAM, and four experiments for all other surfaces.
[304]
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7.5 ABBREVIATIONS 
AFM Atomic force microscope 
AML Acute myeloid leukaemia 
a.u. Arbitrary units 
BE Backscattered electrons 
BM Bone marrow 
BP Band Pass Filter 
CB (umbilical) Cord blood 
CD44 Cluster of differentiation 44 
CD44s Standard isoform of CD44 
CD44v Variant isoform of CD44 
DM Dichroic Mirror 
ECM Extra cellular matrix 
FACS Fluorescence activated cell sorting 
FSC Forward Scatter 
GAG Glycosaminoglycan 
HA Hyaluronic Acid 
HSCT Haematopoietic stem cell transplantation 
HPC Haematopoietic progenitor cell 
ICP OES Plasma optical emission spectrometry 
IRMOF isoreticular metal-organic framework 
LP Long Pass Filter 
LSC Leukemic Stem Cell 
MNC Mononuclear cell 
MOF Metal-organic framework 
mPB Mobilised peripheral blood 
MSC Mesenchymal stromal cell 
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NOD/SCID Non-obese diabetic/severe combined immunodeficiency 
PB Peripheral blood 
Ph Phase contrast 
Pi Propidium iodide 
SAM Self-assembled monolayer 
SD Standard deviation 
SE Secondary electron 
SEM Scanning electron microscope 
SSC Side Scatter 
SP Short Pass Filter 
SURMOF Surface anchored metal-organic framework 
XPS X-ray photoelectron spectroscopy 
XRD X-ray diffraction 
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7.6 CHEMICALS & REAGENTS 
Abbreviation Full name Details Company 
Alkanethiols 
DDT Dodecane-1-thiol HS-(CH2)11-CH3 
Prochimia, Sopot, 
Poland 
HDT 16-Hexadecanethiol HS-(CH2)15-CH3 
Sigma-Aldrich, 
Munich, Germany 
HUDT 11-mercapto-1-undecanthiol HS-(CH2)11-OH 
Prochimia, Sopot, 
Poland 
MHDA Mercaptohexadecanoic acid HS-(CH2)15-COOH 
Sigma-Aldrich, 
Munich, Germany 
Chemical Reagents 
AA 
Alginic acid sodium salt from 
brown algae 
Kat. No. 05550 
Sigma-Aldrich, 
Munich, Germany 
APTMS 
3-Aminopropyltrimethoxy-
silane 
H2N(CH2)3Si(OCH3)3 
Sigma-Aldrich, 
Munich, Germany 
bdc 
benzene-1,4-bicarboxylic 
acid; 
terephthalic acid 
Kat. No. 185361 
Sigma-Aldrich, 
Munich, Germany 
btc 
benzene-1,3,5-tricarboxylic 
acid 
Kat. No. 482749 
Sigma-Aldrich, 
Munich, Germany 
Cu(II)Ac2∙ 
2H2O 
Copper(II)acetate Cu(CH3COO)2∙2H2O 
Sigma-Aldrich, 
Munich, Germany 
EDC 
N-(3-dimethylaminopropyl) -
N′-ethylcarbodiimide 
hydrochloride 
C8H17N3 HCl 
Sigma-Aldrich, 
Munich, Germany 
HA 
Hyaluronic acid sodium salt 
from streptococcus equii 
Kat. No. 53747 
(M = 1,63∙106 Da) 
Sigma-Aldrich, 
Munich, Germany 
HS Heparan sulphate  
Sigma-Aldrich, 
Munich, Germany 
KS Keratan sulphate  
Sigma-Aldrich, 
Munich, Germany 
NHS N-Hydroxysuccinimide C4H5NO3 
Sigma-Aldrich, 
Munich, Germany 
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Abbreviation Full name Details Company 
Solvents 
AcOH Acetic acid 99.9 % C2H4O2 
Merck, Darmstadt, 
Germany 
EtOH Ethanol absolute 99.9 % C2H5OH 
Sigma-Aldrich, 
Munich, Germany 
i-Propanol 2-Propanol 99.9 % C3H7OH 
Sigma-Aldrich, 
Munich, Germany 
2% Extran 
30 % alkaline Extran, diluted 
with MilliQ® water 
Aqueous 
detergent 
Merck KGaA, 
Darmstadt ,Germany 
HEPES 
4-(2-Hydroxyethyl)piperazine-1-
ethanesulfonic acid 
C8H18N2O4S 
Sigma-Aldrich, 
Munich, Germany 
Milli-Q water 
Deionized water filtered by a 
MilliQ® plus filter system 
H2O 
Millipore, 
Schwalbach, Germany 
PBS 
Phosphate buffered saline pH 
7.4 (Tablets dissolved in MilliQ® 
water) 
Kat. No. 18912 
Invitrogen, Karlsruhe, 
Germany 
Proteins, Cell Culture Reagents and Antibodies 
 BacLightTM bacterial viability kit Kat. No. L7007 
Invitrogen, Karlsruhe, 
Germany 
BD Pharm 
Lyse 
Lysing buffer 
Kat. No. 
555899 
Becton Dickinson, 
Heidelberg, Germany 
BSA Bovine serum albumin Kat. No. A7030 
Sigma-Aldrich, 
Munich, Germany 
BU52 
Monoclonal anti-CD44 antibody, 
clone BU52, mouse anti human 
Kat. No. 
MCA2504 
AbD Serotec, 
Düsseldorf, Germany 
BU52-FITC 
Fluorescein isothiocyanate-
marked monoclonal anti-CD44 
antibody, clone BU52, mouse 
anti human 
Kat. No. 
MCA2504F 
AbD Serotec, 
Düsseldorf, Germany 
CD44pan 
siRNA 
5’-CTGAAATTAGGGCCCAATT-3’; 
5’-AATGGTGCATTTGGTGAAC-3’; 
5’-CAGAAACTCCAGACCAGTT-3’ 
Kat. No. 
SI00012775; 
SI03037419; 
SI03062661 
Qiagen, Hilden, 
Germany 
CD44v3 
siRNA 
5’-TGAAGATGAAAGAGACAGA-
3’; 5’-
AGGCATTGATGATGATGAA-3’ 
 
Qiagen, Hilden, 
Germany 
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Abbreviation Full name Details Company 
CD44v6 
siRNA 
5’-GGATATC GCCAAACACCCA-
3’;5’-
AGTAGTACAACGGAAGAAA-3’ 
 
Qiagen, Hilden, 
Germany 
Control 
siRNA 
5’-
UAAUGUAUUGGAACGCAUAUU-
3’; 5’-
AGGUAGUGUAAUCGCCUUGUU-
3’; 5’-
UGCGCUAGGCCUCGGUUGCUU-
3’ 
 
Eurofins MWG GmbH, 
Ebersberg, Germany 
DMEM 
Dulbecco’s Modified Eagle 
Medium, high glucose 
Kat. No. 10938 
Invitrogen, Karlsruhe, 
Germany 
FCS 
Fetal calf serum also fetal 
bovine serum 
Kat. No. 10270 
Invitrogen, Karlsruhe, 
Germany 
fibrinogen 
Fibrinogen from bovine plasma 
Type I-S, 65-85 % protein 
Kat. No. F8630 
Sigma-Aldrich, 
Munich, Germany 
Ficoll-
Hypaque 
Biocoll Separation Solution  
Biochrom, Berlin, 
Germany/Merck, 
Darmstadt, Germany 
Flt-3L 
Fms-like tyrosine kinase-3 
Ligand 
Kat. No. 308-
FK 
R&D Systems, 
Wiesbaden-
Nordenstadt, 
Germany 
G-CSF 
Granulocyte-Colony 
Stimulating Factor 
Kat. No. 17-
5483 
PAA Laboratories 
GmbH, Pasching, 
Austria 
Hoechst 
33342 
2′-(4-Ethoxyphenyl)-5-(4-
methyl-1-piperazinyl)-2,5′-bi-
1H-benzimidazole 
trihydrochloride 
Kat. No. B2261 
Sigma-Aldrich, 
Munich, Germany 
--- L-glutamine Kat. No. 25030 
Invitrogen, Karlsruhe, 
Germany 
Lipofectamin
 2000 
Transfection reagent Kat. No. 11668 
Life technologies, 
Carlsbad, California, 
USA 
LTBMC 
Long-Term Bone Marrow 
Culture 
self-mixed 
medium 
University of 
Heidelberg 
PenStrep Penicillin/streptomycin Kat. No. 15140 
Invitrogen, Karlsruhe, 
Germany 
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Abbreviation Full name Details Company 
PFA Paraformaldehyde HO(CH2O)nH 
Sigma-Aldrich, 
Munich, Germany 
Abbreviation Full name Details Company 
RPMI 
Roswell Park Memorial Institute 
Media 1640 
Kat. No. 31870 
Invitrogen, Karlsruhe, 
Germany 
SCF Stem cell factor  
PAA Laboratories 
GmbH, Pasching, 
Austria 
STAR 
Goat anti mouse IgG (h/l):FITC 
(multi species adsorbed) 
Kat. No. 
STAR117F 
AbD Serotec, 
Düsseldorf, Germany 
StemlineTM II 
medium 
StemlineTM II Haematopoietic 
Cell Expansion Medium 
Kat. No. S0192 
Sigma-Aldrich, 
Munich, Germany 
TPO Thrombopoetin  
PAA Laboratories 
GmbH, Pasching, 
Austria 
Trypsin/ 
EDTA 
0.05 % Trypsin–EDTA solution Kat. No. 25300 
Invitrogen, Karlsruhe, 
Germany 
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7.7 MATERIALS 
Name Description Company 
Au 99.99 % pure gold 
Chempur, Karlsruhe, 
Germany 
Nexterion® 
Ultra flat polished, clean room float 
glass 
Schott AG, Mainz, 
Germany 
COOH- PS-beads 
Carboxylate terminated polystyrene 
microspheres, 4.5 µm 
Polysciences, Eppelheim, 
Germany 
PDMS 
poly-dimethoxysiloxane, elastomer 
and curing agent Sylgard 184 
Dow Corning, MI, USA 
EasyFlasks™ tissue culture flasks 25 cm2, 75 cm² 
Nunc, Langenselbold, 
Germany 
Pattex Powerkleber Repair Extreme 
Henkel, Düsseldorf, 
Germany 
Gas Metering Valve 
back regulated precision gas pressure 
valve 
Pressluft Götz, Mannheim, 
Germany 
Heating Cable 
Teflon covered and metal meshwork 
protected 3 mm wire 
Fritz-Schwarz GmbH, 
Schwabach, Germany 
Medium Reservoir 
screw cap, GL 45, 4 port and DURAN® -
pressure plus 
Schott, Mainz, Germany 
Luer Lock Adapter Upchurch LuerTight (P-836 & P-836) 
IDEX Health & Science LLC, 
Oak Harbor, USA 
Multifold Upchurch 7-Port (P-150) 
IDEX Health & Science LLC, 
Oak Harbor, USA 
Selection Valve Valco Cheminert C25-3186 
VICI AG, Schenkoon, 
Switzerland 
Silicon wafers for 
HA referencing 
Silicon wafer [100] p-doped with 
boron 
CrysTec, Germany 
Silicon wafers for 
MOF preparation 
Silicon wafer 
Wacker Chemie AG, 
Germany 
PFA tubing 1/16 ” OD, 0.04 ” ID 
VICI AG, Schenkoon, 
Switzerland 
Pump-Syringe 60 mL Luer Lock, silicon rubber stamp 
Becton Dickinson, 
Heidelberg, Germany 
T-connector 
2-way and 3-way Luer Lock 
connection 
Neolab, Heidelberg, 
Germany 
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